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Summary 
All cells in a mammalian body share the same DNA content but have a distinct appearance 
and function. This is achieved by activation and repression of genes by epigenetic 
mechanisms, which are crucial for stable differentiation of cells in a multi-cellular 
organism. DNA methylation, established by DNA methyltransferase (DNMT) enzymes, 
regulates gene expression and is essential for mammalian development. Histone tail post-
translational modifications modulate the recruitment and activity of DNMTs. In 
particular, the PWWP domains of DNMT3A and DNMT3B are posited to interact with 
histone 3 lysine 36 trimethylation (H3K36me3). In this study, I characterise a mouse 
model carrying a D329A point mutation in the DNMT3A PWWP domain, predicted to 
ablate the DNMT3A-PWWP and H3K36me3 interaction. Similar mutations in humans 
cause primordial dwarfism. I found that oocytes of Dnmt3aD329A mice show no alterations 
in DNA methylation. However, the D329A mutation causes dominant postnatal growth 
retardation in mice. At the molecular level, it results in aberrant progressive acquisition 
of DNA methylation across domains marked by H3K27me3 and bivalent chromatin in 
multiple adult tissues. These domains characteristically contain important developmental 
regulatory genes, and their aberrant methylation is associated with de-repression of these 
genes in the adult hypothalamus. Recapitulation of this mutation in mouse embryonic 
stem cells (mESCs) did not identify new DNMT3AD329A interacting partners. Upon 
differentiation of Dnmt3aD329A carrying mESCs to neuronal progenitor cells, a minor gain 
in DNA methylation is observed. This work provides key molecular insights into the role 
of DNMT3A in regulating postnatal growth, the targeting of DNMT3A to the genome, 
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1 Introduction 
Declaration of author contributions 
An earlier version of this chapter has been published: 
Sendžikaitė, G. and Kelsey, G. (2019). The role and mechanisms of DNA methylation 
in the oocyte. Essays in Biochemistry, 63 (6): 691–705. 
https://doi.org/10.1042/EBC20190043 
1.1 Epigenetic regulation of the genome 
A mammalian body is made of cells and tissues that have a wide range of appearances 
and functions, although they all contain exactly the same genetic material. Cell-specific 
properties are acquired by activation and/or repression of a variety of genes. Epigenetic 
mechanisms, defined as changes to genome function or chromosome properties that are 
heritable but do not alter the underlying DNA code, regulate gene expression by altering 
chromatin accessibility to transcription factors, which allows cell-specific gene activation 
(Bernstein et al., 2006). There are two major epigenetic mechanisms controlling the 
genome – DNA methylation and histone tail modification, and the interplay between the 
two enable complexity in the regulatory system to emerge. Generally, epigenetic 
regulation of gene expression allows lineage specification during development and is 
required for stable differentiation in multicellular organisms. These changes can be 
heritable at a cellular level during proliferation and, in some cases, can be passed on 
through generations, therefore facilitating an intergenerational inheritance of non-genetic 
cues (Xavier et al., 2019).  
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1.2 Histone code 
In all eukaryotic cells DNA is compactly packaged into the cell nucleus by formation of 
chromatin. Approximately 146bp of DNA are wrapped around a nucleosome, the basic 
unit of chromatin. The nucleosome is a scaffold protein complex, containing two of each  
H2A, H2B, H3 and H4 histones in an octamer (Richmond et al., 1984). Protruding C- and 
N-terminal tails of histones can acquire post-translational modifications (PTMs), which 
can alter how compactly multiple nucleosomes might come together. Modifications of 
histone tails are associated with distinct functions, such as opening or closing of the 
chromatin, and recruitment of interactor proteins. For example, actively transcribed genes 
have histone 3 lysine 4 trimethylation (H3K4me3) enrichment at the promoter region and 
H3K36me3 enrichment over the transcribed gene body (Bannister et al., 2005; Santos-
Rosa et al., 2002). In addition to PTMs, there are variants of key histones, which tend to 
be prevalent in particular contexts, such as after DNA damage and during non-replicative 
state changes (Henikoff and Smith, 2015). DNA methylation and histone modifications 
together control chromatin form and function. 
1.3 DNA methylation 
DNA is a double helix made of adenine – thymine, and cytosine – guanine nucleotide 
pairs held by Watson-Crick bonds (Watson and Crick, 1953). In addition to the four base 
nucleotides, there are three chemically modified nucleotides: C5-methylcytosine, N4-
methylcytosine and N6-methyladenine (Ehrlich and Wang, 1981; Jeltsch, 2002). DNA 
methyltransferase enzymes (DNMTs) use a methyl- group from the donor S-adenosyl L-
methionine (SAM) and covalently attach it to the nucleotide (Ehrlich and Wang, 1981). 
The methyl- group is positioned in the major DNA groove, therefore leaving Watson-
Crick bond intact but affecting allosteric conformation of the double helix and binding of 
DNA-interacting proteins. The extent of global DNA methylation is variable in different 
mammalian tissues and at different developmental stages, and was suggested to play a 
role in development and tissue differentiation from the very early days of epigenetic 
research (Ehrlich et al., 1982; Gama-Sosa et al., 1983). 
In prokaryotes, both cytosine and adenine methylation is found. However, unlike in 
mammals, these modifications are used in cell cycle-related gene expression, mismatch 
DNA repair and as a defence mechanism against bacteriophage invasion (Jeltsch, 2002). 
In mammalian DNA, only C5-methylcytosine is prevalent and is usually, but not 
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exclusively, found within a CpG dinucleotide context (Feng et al., 2010; Roy and 
Weissbach, 1975). This creates a symmetric pattern, where palindromic CG dyads are 
methylated on both DNA strands (Bird, 1978). After replication, the newly synthesised 
strand is unmethylated, but the hemimethylated palindrome can be recognised by the 
maintenance DNMT1, which methylates the nascent strand (Hermann et al., 2004). This 
way a symmetric pattern is passed to daughter cells during cell division allowing for a 
mechanism of inheritance (Bird, 2002).  
Overall, DNA methylation is considered to be a repressive mark, especially at 
heterochromatin, pericentromeric regions, gene promoters, repetitive and transposable 
elements (Schübeler, 2015). In contrast, methylation over gene bodies is associated with 
active transcription. Functionally, DNA methylation alters binding of transcription 
factors and other chromatin interacting proteins, chromatin structure and accessibility, 
thus fine-tuning gene expression (Schübeler, 2015). 
The major focus of this thesis is targeting of mammalian DNA methylation enzyme 
DNMT3A to the genome, thus, hereon the focus is on mammalian systems. As well as 
the main model of this thesis, the majority of the studies described below were conducted 
in murine systems or mammalian cell culture.  
1.4 CpG distribution 
Generally, CpG dinucleotides are underrepresented in vertebrate genomes, which show 
high levels of DNA methylation (Bird, 1980). One of the explanations for this is an 
increased chance of spontaneous deamination of methylated cytosine, creating a 
transition from cytosine to thymine (Ehrlich et al., 1986; Holliday and Grigg, 1993). 
Normally, deamination of unmethylated cytosine to uracil is rapidly repaired by uracil-
DNA glycosylase, which cleaves newly incorporated uracil (Ehrlich et al., 1990). In 
contrast, methylcytosine mutates to thymine, and relies on mismatch repair machinery to 
remove the newly mutated nucleotide, with a risk that the wild-type guanine on a sister 
strand is cleaved by chance (Neddermann and Jiricny, 1993). Nonetheless, approximately 
75% of CpG sites are methylated in mammalian genomes (Feng et al., 2010). A notable 
exception to this is CpG islands (CGIs); clusters showing high CpG dinucleotide density, 
high conservation and generally low levels of DNA methylation (Bird et al., 1985; 
Illingworth et al., 2010). Many CGIs found within gene promoters and transcription start 
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sites (TSS) are constitutively unmethylated, but some exhibit a lineage-specific DNA 
methylation status, shaping the transcriptional landscape. 
1.5 DNA methylation machinery 
The DNA methyltransferase enzyme family in mammals consists of five members: one 
maintenance, three de novo methyltransferases, and a co-factor (Figure 1.1).  
 
 
Figure 1.1. Schematic illustration of mammalian DNMT protein family.  DMAPD – 
DMAP1-interacting domain, PBD – PCNA binding domain, NLS – nuclear localisation 
signal, RFTS – replication foci targeting sequence, BAH – bromo-adjacent homology 
domain, MTase – methyltransferase, PWWP – Pro-Trp-Trp-Pro motif, ADD – ATRX-
DNMT3-DNMT3L domain. 
 
DNMT1, the maintenance DNMT, recognises and methylates the unmethylated strand on 
hemimethylated DNA (Hermann et al., 2004). Homozygous deletion of Dnmt1 results in 
embryonic lethality, and mice fail to develop further than embryonic day 8.5/9 (E8.5-E9) 
(Li et al., 1992). DNMT1 is a large protein containing a regulatory N-terminal domain 
and conserved methyltransferase domain. At the very N-terminus there is a DMAP1-
interacting domain (DMAPD) required for interaction with DNA methyltransferase 
associated protein 1 (DMAP1) and Histone Deacetylase 2 (HDAC2) for transcriptional 
repression (Rountree et al., 2000). A second small domain is Proliferating Cell Nuclear 
Antigen (PCNA) binding domain, which leads to DNMT1 recruitment to the replication 
fork, followed by a nuclear localisation signal (NLS) (Chuang et al., 1997; Suetake et al., 
2006). The Replication Foci Targeting Sequence (RFTS) domain is required for DNMT1 
localisation to hemimethylated sites through Ubiquitin-like, PHD and Ring finger-
containing 1 (UHRF1) protein at S phase (Bostick et al., 2007; Sharif et al., 2007). The 
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nearby CXXC domain is involved in an autoinhibitory methyltransferase domain control, 
together with bromo-adjacent homology domains (BAH1 and BAH2) (Song et al., 2012, 
2011).  
In addition to DNMT1, there are three de novo DNMTs, which use unmethylated DNA 
as a substrate. DNMT3s show high similarity and share some of the domains, further 
described in Section 1.11. DNMT3A and DNMT3B exhibit partial redundancy and are 
both required for setting up epigenetic states during embryogenesis (Dahlet et al., 2020; 
Okano et al., 1999). Dnmt3a-/- mice fail to survive longer than 3 weeks postnatally, and 
die for unknown reasons. Meanwhile Dnmt3b-/- is embryonic lethal and developmental 
defects arise at E10.5, characterised by neural tube formation defects and growth 
restriction (Okano et al., 1999). While there is some redundancy, generally Dnmt3b is 
considered to be more important during embryogenesis, as exemplified by a more severe 
phenotype in the knock-out (Borgel et al., 2010; Okano et al., 1999). Double Dnmt3a-/- 
Dnmt3b-/- mutant mice die before E11.5 but developmental defects are thought to arise 
immediately following gastrulation and can be observed at E8.5 (Dahlet et al., 2020; 
Okano et al., 1999). DNMT3C, a third, murine-specific de novo methyltransferase, has 
recently been discovered; it silences evolutionary young retrotransposons in 
prospermatogonia by methylating their promoters (Barau et al., 2016; Jain et al., 2017).  
DNMT3L is the odd member of DNMT family, since it does not have an active catalytic 
domain (Aapola et al., 2000). Dnmt3l-/- mice are viable but sterile. It acts as an essential 
co-factor for establishment of genomic imprints in sperm and oocyte (Bourc’his et al., 
2001). DNMT3L is also less conserved between the species (Yokomine et al., 2006). The 
C-terminal domain of DNMT3L can bind DNMT3A and DNMT3B C-terminal domains 
and significantly enhances their chromatin binding and/or catalytic activity (Chen et al., 
2005; Hata et al., 2002; Jia et al., 2007). This might occur through formation of tetramers 
or conformational changes leading to increased affinity for methyl- donor SAM binding 
(Kareta et al., 2006; Gowher et al., 2005). This stimulatory effect appears to be ubiquitous 
for DNMT3A, but not for DNMT3B (Chédin et al., 2002; Veland et al., 2019). 
Meanwhile, DNMT3L does not appear to have an effect on DNMT1 enzymatic activity 
(Suetake et al., 2004). 
The role of the PWWP domain in the DNA methyltransferase 3A targeting to the genome 
6  Gintarė Sendžikaitė - 2021 
1.6 Epigenetic changes during development 
While in differentiated adult tissues DNA methylation is stably maintained, the ability of 
chromatin to undergo dynamic transitions is especially important during gamete and early 
embryo development, when two major epigenetic reprogramming waves are observed in 
mammals (Figure 1.2). Reprogramming is required to abolish established patterns 
determining cell lineage and to restore pluripotency (Cantone and Fisher, 2013; Lee et 
al., 2014; Seisenberger et al., 2012).  
Both sperm and egg are terminally differentiated cells. After fertilisation, the embryonic 
cells of the new embryo undergo epigenetic reprogramming to erase the gamete-specific 
epigenome and regain totipotency  (Xu and Xie, 2018). During pre-implantation 
development, parental DNA is rapidly demethylated. By the time the inner cell mass of 
the blastocyst is formed at E3.5, the DNA methylation and histone PTM patterns that 
characterised the gametes are almost completely lost and only a small subset of gamete 
differentially methylated regions (gDMRs) and histone PTMs are retained (Borgel et al., 
2010; Smith et al., 2012; Xu and Xie, 2018). After implantation, from the epiblast stage 
to gastrula (in the mouse between embryonic days E4.5 to E6.5), DNA methylation is 
regained and established in a lineage-specific pattern (Borgel et al., 2010). 
 
 
Figure 1.2. DNA methylation dynamics in development. After fertilisation, DNA 
methylation patterns specific to sperm (blue) and egg (pink) are erased and DNA 
methylation is re-established in epiblast at around embryonic day 6.5 (E6.5). Somatic 
tissues acquire further lineage and tissue specific methylation. Meanwhile, primordial 
germ cells (PGCs) undergo another epigenetic erasure and their DNA methylation is 
established in germ line just before birth is sperm and after reproductive maturation in 
females. Image reproduced under CC BY-SA 4.0 license from original by Marius Walter. 
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In mice, primordial germ cells (PGCs) are specified at E6.5-E7.25 in the yolk sac 
endoderm. As PGCs proliferate, they migrate to the genital ridge and undergo erasure of 
global DNA methylation (Guibert et al., 2012; Seisenberger et al., 2012). A second 
epigenetic reprogramming event is observed in these cells at E10.5-E11.5, when parent-
of-origin epigenetic marks are erased, and PGCs differentiate into prospermatogonia or 
oogonia, depending on gonadal sex. Gamete-specific epigenomes are established in the 
germline soon after birth in male and in adulthood in female mice. This is accompanied 
by global transcriptional and epigenetic changes that are crucial for successful 
fertilisation and later development (Bonnet-Garnier et al., 2013). 
1.7 DNA methylation in imprinting 
DNA methylation appears to be dispensable for oocyte development and competence, as 
genetic ablation of oocyte methylation allows for successful fertilisation and ensuing 
embryonic development until the mid-gestation stage (Bourc’his et al., 2001; Branco et 
al., 2016; Hata et al., 2002; Kaneda et al., 2010, 2004). However, it is essential for 
genomic imprinting: a subset of the gamete specific differentially methylated regions 
(gDMRs) that evade embryonic reprogramming during early development result in 
parent-of-origin specific gene expression of the associated genes – imprinted genes. 
Failure to establish imprints leads to lethality or congenital diseases in both mice and 
humans, and the pathologies observed are linked to foetal growth, brain, and metabolic 
function. Interestingly, only three imprinted loci are conferred by methylation in male 
gametes, while there are at least 26 DNA methylation-dependent imprinted regions 
conferred in the oocyte (Kobayashi et al., 2012; Smallwood et al., 2011; Tucci et al., 
2019). Imprinted loci contain a single or a cluster of genes, whose expression patterns are 
determined by imprinting control region (ICR) DNA methylation status. DNA 
methylation at ICRs is set up during oocyte growth, in a transcription-dependent manner. 
Disruption of transcription at the relevant loci leads to failure of DNA methylation 
establishment over ICRs and affects viability and monoallelic expression of imprinted 
gene loci in mice (Chotalia et al., 2009). Oocyte ICRs are composed of CGIs enriched for 
a specific sequence motif, recognised by KRAB zinc-finger protein 57 (ZFP57). ZFP57 
protects imprinted sites from demethylation during embryonic reprogramming by 
recruiting KAP1, SETDB1, HP1 and NP95 to form a robustly silenced locus (Li et al., 
2008; Quenneville et al., 2011). Imprinted genes exhibit stable and heritable monoallelic 
parent-of-origin specific gene expression that can be maintained throughout the 
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lifecourse, and is only overwritten during PGC reprogramming (Li and Li, 2019; Tucci 
et al., 2019).  
Apart from ICRs, some gDMRs show transient or tissue-specific inheritance post 
fertilisation (Proudhon et al., 2012; Rutledge et al., 2014).  Maternal non-imprinted 
gDMRs were shown to play a role in regulation of placental development in mice and a 
number of such gDMRs persist in human placenta and confer monoallelic expression of 
associated genes (Branco et al., 2016; Sanchez-Delgado et al., 2016).  
1.8 DNA methylation in transcriptional regulation 
Classically DNA methylation is considered a repressive, silencing modification 
particularly in gene promoter context and the relative density of CpG methylation at a 
promoter correlates with expression strength  (Hsieh, 1994; Siegfried et al., 1999). The 
establishment of methyl-CpGs at promoter regions masks recognition sites of 
methylation-sensitive transcription factors and therefore prevent transcription (Yin et al., 
2017). DNA methylation can also contribute to genomic stability by silencing of 
transposable elements, retroviruses, satellite repeats and telomeres (Barau et al., 2016; 
Gonzalo et al., 2006; Kuramochi-Miyagawa et al., 2008; Walsh et al., 1998; Xu et al., 
1999).  
In mammals, one of the X chromosomes of females has to be silenced to control the 
expression dosage of X chromosome genes between the sexes. The silencing of one copy 
of X chromosome is initiated by a cis acting long non-coding RNA (lncRNA) Xist, 
expressed from the X copy which is to be silenced (Clemson et al., 1996). Xist coats the 
X chromosome and recruits other chromatin silencing and condensation factors, such as 
polycomb repressor complex 2 (PRC2) which establishes a silencing histone mark 
H3K27me3 over the inactive chromosome (Zhao et al., 2008). The expression of Xist in 
somatic tissues is controlled by DNA methylation: the active X chromosome has a 5’ 
DNA methylation of Xist which results in repression of this lncRNA, meanwhile the 
silenced X chromosome contains unmethylated Xist (Norris et al., 1994).  
Methyl-binding domain (MBD) proteins are recruited by methylated cytosines and 
execute silencing via transcriptional repression domains (Barr et al., 2007; Hendrich and 
Bird, 1998; Stirzaker et al., 2017). MBDs can subsequently reinforce silencing by 
recruitment of other repressors or chromatin remodelling complexes, such as Sin3A and 
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NuRD  (Boeke et al., 2000; Du et al., 2015; Jones et al., 1998; Nan et al., 1998; Ng et al., 
2000; Zhang et al., 1999). Similarly, DNMT3 enzymes are able to recruit histone 
interacting proteins, such as HDAC1, to silence genomic regions independently of their 
DNA methylation function  (Deplus et al., 2002; Fuks et al., 2001). DNMT3B has been 
shown to interact with HDAC1, HDAC2, Heterochromatin protein 1 (HP1), Suv39h1 and 
chromatin remodeller hSNF2H (Geiman et al., 2004). Vice versa, chromatin remodeller 
LSH can recruit DNMTs and HDACs to alter local chromatin environment and silence 
transcription at target loci (Clements et al., 2012; Han et al., 2020; Myant et al., 2011; Xi 
et al., 2009). Lysine methyltransferase G9A recruits DNA methylation to silence germline 
specific loci during embryogenesis (Auclair et al., 2016). Meanwhile, centromere protein 
C (CENP-C) and Suv39h-HP1 recruit DNMT3B to methylate peri- and centromeric 
regions (Gopalakrishnan et al., 2009; Lehnertz et al., 2003).  
Notably, the methylation-transcription dynamic is reversed at gene bodies, where higher 
levels of DNA methylation correlate with higher gene expression (Lister et al., 2009). 
There are two main functions of intragenic DNA methylation: regulation of splicing and 
control of faithful transcription initiation. Methylation differentially marks main exons in 
relation to introns and changes in DNA methylation levels can impact alternative exon 
usage (Gelfman et al., 2013; Shayevitch et al., 2018). This could be an evolutionary 
mechanism of fast and heritable adaptation to the environment (Shukla et al., 2011). A 
second role of DNA methylation over gene bodies is to avert RNA polymerase II binding 
to orphan transcription start sites and to prevent aberrant transcription initiation and 
alternative promoter usage in different cell lineages (Maunakea et al., 2010; Neri et al., 
2017). 
1.9 Non-CpG DNA methylation 
Non-CpG (CpH) methylation is detected in almost all human tissues (Schultz et al., 2015) 
but is present at a high level in oocytes, embryonic stem cells (ESCs) and some 
postmitotic tissues (Lister et al., 2009; Ramsahoye et al., 2000; Shirane et al., 2013; 
Tomizawa et al., 2011). In mouse ESCs, the levels of CpH methylation tend to decrease 
upon differentiation. In contrast, a marked increase in CpH methylation is observed in the 
brain during postnatal neuronal maturation (Lister et al., 2013). CpH methylation in the 
brain is restricted to vertebrates and is highly linked to the CpH reader methyl-CpG-
binding protein 2 (MeCP2) (Guo et al., 2014; Mendoza et al., 2021). The dynamics and 
localisation of CpH methylation follow CpG methylation: neuro- and ESC- specific CpH 
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patterns can be attributed to DNMT3A and DNMT3B expression levels and localisation 
in these tissues (Lee et al., 2017; Ziller et al., 2011). CpH methylation cannot be 
maintained by DNMT1 in proliferating cells, and therefore is likely only functional in 
post-mitotic cells (Guo et al., 2014; Ramsahoye et al., 2000).  
1.10 Demethylation 
Demethylation of 5mC is of particular importance during development, when germ cell 
DNA methylation has to be erased in early embryogenesis, and during germ cell 
specification. There are two main ways for DNA demethylation: passive and active, and 
both of these are employed to alter the methylome of maternal and paternal genomes in 
development (Gu et al., 2011; F. Guo et al., 2014; Mayer et al., 2000; Oswald et al., 2000; 
Shen et al., 2014; Wossidlo et al., 2011). Passive DNA demethylation occurs when 
methylated sites are not maintained during cell replication and are therefore diluted 
(Kagiwada et al., 2013; Ohno et al., 2013; Rougier et al., 1998). A mechanistic example 
of passive dilution is exclusion of DNMT1 or its interacting partners UHRF1 or STELLA 
from the nucleus (Cardoso and Leonhardt, 1999; Du et al., 2019; Mulholland et al., 2020).  
Alternatively, cytosine methylation can be catalysed by ten-eleven translocation (TET) 
methylcytosine dioxygenases, creating three intermediates in transition from 5mC to 
unmodified cytosine: 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-
carboxylcytosine (5caC) (Figure 1.3) (Ito et al., 2011). Any of these intermediates can be 
passively diluted during cell division or actively excised by Thymine DNA Glycosylase 
and subsequently replaced by unmethylated cytosine by the base mismatch repair 
machinery (Cortellino et al., 2011; Hajkova et al., 2010; He et al., 2011). 
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Figure 1.3. (De)methylation of cytosine. Intermediate forms of modified cytosine 
nucleotides and enzymes catalysing transition are shown. Reproduced from (Lio and Rao, 
2019). 
 
1.11 Recruitment of de novo DNMTs  
Many studies have sought to understand how DNA methylation patterns are established 
in different genomic contexts. De novo methyltransferases have distinct intrinsic 
enzymatic sequence biases, where DNMT3A prefer TNC[G/A]CC and DNMT3B prefer 
TAC[G/A]GC, and are sensitive to CpG flanking nucleotides, but DNA sequence is not 
a sole determining factor of DNA methylation status (Jurkowska et al., 2011; Mallona et 
al., 2020; Mao et al., 2020; Wienholz et al., 2010). N-terminal regulatory domains of 
DNMT3s – the ADD (ATRX-DNMT3-DNMT3L) and PWWP (Pro-Trp-Trp-Pro motif) 
– can interact with various histone PTMs, which guide DNMT localisation and enzymatic 
activity.  
1.11.1 The N-terminal domain and H3K27me3 
The main divergence between DNMT3A and DNMT3B is a less studied intrinsically 
disordered N-terminal domain. The N-terminal domain of DNMT3A/B is responsible for 
non-specific DNA binding, association with nucleosomes, and contributes towards 
nuclear localisation (Jeong et al., 2009; Suetake et al., 2004).  The DNMT3A N-terminal 
domain targets it to the shore of bivalent chromatin, harbouring developmental genes 
(Manzo et al., 2017). Bivalent chromatin comprises of an active chromatin mark 
H3K4me3 and a repressive H3K27me3 and is protected from DNA methylation in 
somatic cells (Bernstein et al., 2006; Brinkman et al., 2012). DNMT3A1, the longer 
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isoform containing the intrinsically disordered N-term domain, predominates in adult 
somatic tissues and generally follows the dynamics of the H3K27me3 mark during 
neuronal differentiation, although these two marks do not tend to overlap at CGIs 
(Brinkman et al., 2012; Manzo et al., 2017).  
1.11.2 The ADD domain and H3K4me3 
The ADD domain, present in all DNMT3s, is homologous to a conserved PHD (plant-
homeodomain) zinc finger motif. ADD domains of DNMT3s have a high affinity to the 
N-terminal region of histone 3, which is ablated in presence of H3K4me2/3, H3K4ac, 
H3T3ph, H3S10ph, and/or H3T11ph PTMs (Zhang et al., 2010). Methylated lysine 
H3K4me3 in somatic cells is found at active gene promoters and TSSs, and inhibits 
DNMT3 activity (Li et al., 2011; Ooi et al., 2007; Otani et al., 2009; Zhang et al., 2010). 
Structural studies have found that DNMT3A is intrinsically in an autoinhibitory allosteric 
conformation, driven by the ADD domain: the ADD domain masks the DNA binding site 
of the catalytic domain. Recognition of unmethylated H3K4 specifically allows a 
structural shift and uncouples the ADD-catalytic domain interaction, allowing activation 
of DNMT3A enzymatic function (Figure 1.4a) (Guo et al., 2015; Li et al., 2011; Ooi et 
al., 2007; Otani et al., 2009; Zhang et al., 2010). Similarly, recruitment of catalytically 
inactive DNMT3L ADD domain by unmethylated H3K4 is sufficient to engage the whole 
complex, for example, as may occur in the case of DNMT3L-DNMT3A in the oocyte (Jia 
et al., 2007; Ooi et al., 2007). As a result, DNA methylation and H3K4me3 are mutually 
exclusive in the genome and H3K4me3 protects promoters from silencing by DNA 
methylation. Engineering of the ADD domain to lose sensitivity to H3K4me3 or H3T5ph 
results in aberrant gain of methylation over these domains and ESC differentiation failure 
or chromosomal instability, respectively (Noh et al., 2015).  
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Figure 1.4. DNMT3A/B recruitment mechanisms.H3K4me3, found at promoters of 
active or bivalent (poised) promoters is recognised by the ADD domain, and DNMT3A/B 
remain in an autoinhibitory state. When H3K4 site in unmethylated, e.g. at inactive 
promoters, ADD domain is recruited to this PTM. Engagement of ADD domain leads to 
a change of DNMT3A/B conformation and result in DNMT3 catalytic activity. B. 
H3K36me3 mark, found at gene bodies, together with unmethylated H3K4 are recognised 
by the PWWP and ADD domains, respectively, and lead to DNMT3A/B activation. 
Image reproduced from (Greenberg and Bourc’his, 2019). 
 
1.11.3 The PWWP domain and H3K36me3  
The PWWP domain is a member of the Tudor domain royal superfamily and is mostly 
found in chromatin-interacting proteins. It has an intrinsic and somewhat unspecific 
affinity to chromatin and modified histones, especially lysine residues, via a conserved 
aromatic cage (Qin and Min, 2014; Wu et al., 2011). In the DNMT family, the PWWP 
domain is only found in DNMT3A and DNMT3B. The PWWP domain is responsible for 
non-specific DNA and chromatin binding of DNMT3s (Ge et al., 2004; Qiu et al., 2002) 
and is required for methylation of major satellite repeats at pericentromeric chromatin 
(Chen et al., 2004).  
The role of the PWWP domain in the DNA methyltransferase 3A targeting to the genome 
14  Gintarė Sendžikaitė - 2021 
Extensive biochemical, structural and modelling work suggests that the PWWP domain 
of DNMT3A and DNMT3B interacts specifically and exclusively with H3K36me2/3 
(Bock et al., 2011; Dhayalan et al., 2010; Dukatz et al., 2019; Mauser et al., 2017; 
Rondelet et al., 2016; Weinberg et al., 2019). H3K36me3 is universally found over 
expressed gene bodies, and in mouse ESCs the PWWP domain of DNMT3B is required 
for DNA methylation over H3K36me3 domains (Baubec et al., 2015; Neri et al., 2017). 
This interaction appears to be specific to the PWWP domain of DNMT3B but not 
DNMT3A (Baubec et al., 2015; Morselli et al., 2015). ADD and PWWP domains can 
work in a synergistic manner to recognise a combination of unmethylated H3K4 and 
H3K36me3 on histone tails (Figure 1.4b) (Gong et al., 2020).  
1.12 Generation of a PWWP-DNMT3A mutant mouse model 
In vitro studies show that the PWWP domain of DNMT3A interacts with H3K36me2/3 
but a point mutation (D329A) in a conserved aspartic acid residue in the PWWP domain 
abrogated the ability of the DNMT3A-PWWP domain to bind H3K36me2 and 
H3K36me3 peptides or pull down H3K36me2/3-containing native nucleosomes 
(Dhayalan et al., 2010). The D329A mutation also reduced the preferential 
heterochromatin localisation of DNMT3A2 in transfected cells and decreased catalytic 
activity on unmethylated native nucleosomes. While the PWWP domain is responsible 
for DNMT3B gene-body targeting, the function role of the PWWW domain in DNMT3A 
recruitment to the genome in vivo remained unknown. A mouse model carrying the 
previously described D329A mutation in Dnmt3a was generated to investigate the in vivo 
significance of the DNMT3A PWWP domain. 
The D329A mutation was introduced in the endogenous Dnmt3a exon 8 locus using 
homologous recombination in mouse ESCs (Figure 1.5) (Sendžikaitė et al., 2019). The 
targeting vector with a point mutation flanked by homology arms and selection cassettes 
was transfected into black-coated C57BL/6 ESCs. After confirmation of successful 
recombination, ESCs were injected into albino C57BL/6 recipient blastocysts and re-
implanted into pseudo-pregnant females. Offspring showing high chimerism rate were 
used for the breeding with mice carrying constitutively expressed Cre recombinase, to 
remove the positive selection cassette.  
Litters with paternal transmission of mutant Dnmt3aD329A showed over 50% post-weaning 
survival, whilst there were no survivors when the mutant allele was transmitted 
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maternally. Therefore, Dnmt3aD329A males were crossed to females with heterozygous 
oocyte-specific conditional ablation of Dnmt3a (Δ) (Kaneda et al., 2010, 2004), 
generating four genotypes amongst offspring: +/+, Δ/+, +/D329A and Δ/D329A (where 
the maternal allele is listed first); the last carries the D329A mutation as the only 
functional Dnmt3a allele (Figure 1.6). 
 
 
Figure 1.5. Introduction of the D329A mutation at endogenous Dnmt3a locus. A. 
Schematic representation of targeting construct used to generate mice carrying the 
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Dnmt3aD329A mutation. Targeting construct, endogenous locus and selected targeted locus 
are shown together with final neo cassette-excised mutant allele. Exon 8 with the D329A 
mutation is coloured in red; loxP sites indicated as blue arrowheads. Abbreviations: DTA: 
diptheria toxin A negative selection cassette, neo: neomycin selection cassette, TK: 
herpes simplex virus thymidine kinase, TSS: transcription start site, ex.: exon. B. 
Schematic representation of the DNMT3A protein isoforms and location of the base 
substitution, coloured red, introduced to generate the D329A mutation. NCBI IDs: 
CCDS36397.1, CCDS25784.1. Known domains are indicated by coloured boxes, based 
on the PROSITE database. Numbers indicate amino acids. 
 
 
Figure 1.6. Transgenic mice breeding scheme. Breeding scheme used to generate 
offspring of four different genotypes. fl: Dnmt3a containing loxP sites surrounding exon 
18; : loxP sites after recombination leading to deletion of exon 18; Zp3-Cre: oocyte-
specific Zp3 promoter-driven Cre recombinase (Kaneda et al., 2010, 2004); D329A: a 
Dnmt3a allele point missense mutation in exon 8. 
 
1.13 Aims 
The work outlined below aims to deepen the understanding of methyltransferase 
regulatory domain roles in DNMT targeting to the genome. In particular, it aims to 
understand the functional role of the DNMT3A PWWP domain in vivo by use of a mouse 
model carrying the D329A mutation, previously shown to be important in DNMT3A-
PWWP and H3K36me3 interaction (Dhayalan et al., 2010).  
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First, the oocyte was utilised as a system where DNMT3B does not play a role and strong 
correlation between DNA methylation and H3K36me3 is found. It was initially 
hypothesised that introduction of the D329A mutation would result in loss of DNA 
methylation in the affected oocytes; this work is described in Chapter 3. After the 
serendipitous observations of phenotypic changes and rejection of the initial hypothesis 
in the oocyte, further aims were set to understand the phenotypic consequences of the 
presence of the Dnmt3aD329A mutation in mice. Brain is another tissue, apart from oocyte, 
where DNMT3A is a dominant de novo methyltransferase. Therefore, I aimed to utilise 
this tissue to describe the molecular changes in DNA methylation patterns introduced by 
DNMT3AD329A, altered transcriptional and chromatin environment and protein 
interactions of mutant DNMT3AD329A.  
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2 Methods and materials 
2.1 Animal experimental procedures and sample collection 
All animal experimental procedures were approved by the Animal Welfare and Ethical 
Review Body at the Babraham Institute, and were conducted under authority of the UK 
Home Office issued licenses in accordance with the Animal (Scientific Procedures) Act 
1986.  
The Dnmt3aD329A mutant strain was generated by GenOway (France) by targeting a point 
mutation GAT to GCT resulting in aspartic acid to alanine amino acid change at the 
endogenous locus of Dnmt3a codon 329 (Sendžikaitė et al., 2019). These mice were inter-
crossed with C57BL/6Babr mice carrying a conditional Dnmt3a deletion allele Dnmt3afl 
and oocyte-specific Zp3 promoter driven Cre recombinase (Kaneda et al., 2010). In order 
to obtain experimental litters Dnmt3afl/+ Zp3-Cre+ve females, which carry oocytes with a 
conditionally deleted Dnmt3a∆ allele, were crossed with Dnmt3aD329A/+ males; yielding 
litters with four possible genotypes: Dnmt3a+/+, Dnmt3a∆/+, Dnmt3a+/D329A, and 
Dnmt3a∆/D329A (Figure 1.6). 
When possible, body weights of experimental litters were recorded at 1.4, 4, 6, 8, 10, and 
12 weeks and analysed using mixed-model ANOVA with post-hoc pairwise comparisons 
using Bonferroni correction.  
Litters were sacrificed and tissues were collected at embryonic day 7.5 (E7.5), postnatal 
day 1 (P1), P25, and adulthood (~14 weeks old). At E7.5 ectoplacental cone (EPC) and 
epiblast were collected in PBS and EZ Nuclear Lysis buffer (Sigma), respectively.  
2.2 Oocyte collection 
For collection of bulk oocyte samples, dissected ovaries were submerged in digestion 
buffer (2mg/ml collagenase (Sigma-Aldrich) and 0.025% Trypsin (Sigma-Aldrich) 
diluted in PBS) and put into the thermomixer at 37°C for 30min incubation. The ovaries 
were manually dissociated by short repetitive pipetting after 5, 15 and 25min. After 
digestion, dissociated tissue suspension was mixed with M2 medium (Sigma-Aldrich) in 
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1:1 ratio. Oocytes were then collected using a mouth-controlled glass pipette and snap-
frozen on dry ice in PBS. 
For single cell oocyte samples, ovaries in M2 medium were scraped using a sterile needle 
to release oocytes. These were then collected using a mouth-controlled glass pipette and 
snap-frozen on dry ice in RLT+ buffer (QIAGEN). 
2.3 Genotyping  
E7.5 EPCs were lysed in embryo lysis buffer (1M Tris pH8.5, 0.5M EDTA pH8, 10% 
Tween, 0.2mg/ml Proteinase K) and used for genotyping by PCR with primers for 
Dnmt3a+/fl/∆ alleles (D3A-F 5’-CTGTGGCATC TCAGGGTGAT GAGCA-3’, D3A-R1 
5’-GCAAACAGAC CCAACATGGA ACCCT-3’, and D3A-R2 5’-TGAGTGGTGA 
GGCCCAGCTT ATCGA-3’) and Dnmt3aD329A allele (D329A-F 5’-CAGATCCTTG 
CCTGAACTGT GGTGC-3’ and D329A-R 5’-TCCCTCTTGG TCCAGCATGT 
ACCCT-3’). Adult mice were genotyped by the same PCR assay using genomic DNA 
extracted from ear clips, or by service provider Transnetyx (US) using real-time PCR. 
2.4 ELISA 
Blood samples from experimental animal hearts were collected into Microvette 500 Z-
Gel tubes (Sartstedt), centrifuged for 5 min at 10,000 g at RT. Serum collected was used 
in Rat/Mouse Growth Hormone ELISA kit (Millipore) and Quantikine ELISA for 
Mouse/Rat Igf-1 kit (R&D systems) as per manufacturers’ instructions. 
2.5 Post-bisulphite adaptor tagging  
Post-bisulphite adaptor tagging (PBAT) was used to generate genome-wide DNA 
methylation profiles. Approximately 50ng of genomic DNA or 10% of MNase-digested 
E7.5 Epiblast DNA, purified using solid phase reversible immobilization (SPRI) beads, 
was used as an input material. For bulk oocyte samples, approx. 100-oocyte sample in 
PBS was used as an input.  
If needed, DNA was extracted using DNeasy blood and tissue kit (QIAGEN), as per 
manufacturers’ instructions. Imprint DNA modification kit (MOD50, Sigma) one-step 
procedure was used to bisulphite-convert the DNA. Sample volumes were adjusted with 
Elution Buffer (EB) (Qiagen) to final volume of 25µl and 125µl of bisulphite conversion 
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reagents from the kit were added. Samples were incubated at 99°C for 6min and at 60°C 
for 90mins. Samples were cleaned using Sigma Imprint columns and eluted in 20µl of 
EB. First strand synthesis was done by addition of 0.4mM dNTP mix (Invitrogen), 10x 
NEB buffer 2 (B7002, NEB), 0.4µM Illumina adaptor and 9 random nucleotide 9N31F 
primer. Samples were incubated at 65°C for 3mins and cooled down to 4°C. Five units of 
Klenow exo- (M0212, NEB) were added and samples were incubated at 4°C for 5mins, 
then temperature was increased from 4°C to 37°C in 1°C per 15sec steps. Then samples 
were incubated at 37°C for 90mins. This was followed by addition of 20 units of 
Exonuclease-I (M0293, NEB) and incubation at 37°C for 60mins. DNA was purified 
using 0.8:1 ratio SPRI beads. 
For biotinylated DNA capture, 20µl of Dynabeads Strepatavidin M-280 beads (11205, 
ThermoFisher Scientific) per sample were washed twice in Bind and Wash buffer (10mM 
Tris-HCl pH7.5, 1mM EDTA, 2M NaCl) and resuspended in 50µl volume per sample. 
DNA from first strand synthesis was added to washed streptavidin beads and incubated 
for 20min at RT with overhead rotation. Afterwards the supernatant was discarded and 
beads were washed twice in 0.1 N NaOH and then twice in EB. Second strand synthesis 
was assembled by addition of 0.4mM dNTP mix, 10x NEB buffer 2, 0.4µM 9N31R 
primer and water to final volume of 48µl. Samples were incubated at 95°C for 1min and 
cooled down to 4°C. Ten units of Klenow exo- (M0212, NEB) were added and samples 
were incubated at 4°C for 5mins, then temperature was increased from 4°C to 37°C in 
1°C per 15sec steps. Then samples were incubated at 37°C for 90mins.  
The beads were washed twice in EB buffer and resuspended in library amplification mix, 
containing 0.2mM dNTPs, 5x KAPA HiFi buffer (Kapa Biosystems), 1 unit KAPA HiFi 
polymerase, 0.2µM of Illumina forward primer P1.0 and 0.2µM selected Illumina 
multiplex reverse oligonucleotide and water to the final volume of 50µl. Sample DNA 
was initially denatured at 95°C for 2mins, followed by 10 cycles of 80sec at 98°C, 30sec 
at 60°C and 30sec at 72°C; with final extension of 3mins at 72°C. Libraries were purified 
using 0.8:1 ration SPRI beads. Libraries were quantitated and quality control checked 
using Agilent High Sensitivity DNA kit and Kapa Illumina library quantitation kit, as per 
manufacturers’ instructions. Libraries were sequenced using 100bp single-end for oocyte, 
P1, P25, adult tissues, and ESCs; and 150bp for E7.5 epiblast sequencing mode on the 
Illumina NextSeq500 platform at the Babraham Institute Sequencing Facility. 
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2.6 Single-cell bisulphite sequencing 
Single cells in 10µl of RTL+ buffer were used as an input. EZ DNA methylation direct 
kit (D5021, Zymo) was used to bisulphite-convert the DNA. First, the sample was 
incubated in 65µl of CT conversion Reagent for 8min in 98°C, then at 64° for 3 hours. 
Bisulphite converted DNA was purified following EZ DNA methylation direct kit 
instructions. First strand synthesis was done by addition of 0.4mM dNTP mix 
(Invitrogen), 10x blue buffer (B0110, enzymatics), 0.4µM adaptor 6 random nucleotide 
6NF primer and water to the final volume of 49µl. Samples were incubated at 65°C for 
3mins and cooled down to 4°C. 50 units of Klenow exo- (P7010-HC-L, Enzymatics) were 
added and samples were incubated at 4°C for 5mins, then temperature was increased from 
4°C to 37°C in 1°C per 15sec steps. Then samples were incubated at 37°C for 30mins.  
Samples were incubated at 95°C for 45secs and cooled down. Additional 2.5µl of first 
strand synthesis master mix were added and the same thermocycling protocol was 
followed. These steps were repeated 4 times in total. This was followed by addition of 40 
units of Exonuclease-I and incubation at 37°C for 60mins. DNA was purified using 0.8:1 
ratio AMPureXP beads (Beckman), leaving the beads in the sample for the next steps. 
Second strand synthesis was assembled by addition of 0.4mM dNTP mix, 10x blue buffer, 
0.4µM 6NR primer and water to final volume of 49µl. Samples were incubated at 98°C 
for 2min and cooled down to 4°C. 50 units of high concentration Klenow exo- were added 
and samples were incubated at 4°C for 5mins, then temperature was increased from 4°C 
to 37°C in 1°C per 15sec steps. Then samples were incubated at 37°C for 90mins.  
DNA was then purified by addition of AMPureXP buffer only to complement the beads 
present in the sample. Beads were resuspended in library amplification mix, containing 
0.2mM dNTPs, 5x KAPA HiFi buffer (Kapa Biosystems), 1 unit KAPA HiFi polymerase, 
0.2µM of Illumina forward primer P1.0 and 0.2µM selected Illumina multiplex reverse 
oligonucleotide and water to the final volume of 50µl. Sample DNA was initially 
denatured at 95°C for 2mins, followed by 14 cycles of 80sec at 94°C, 30sec at 65°C and 
30sec at 72°C; with final extension of 3mins at 72°C. Libraries were purified using 0.8:1 
ratio of AMPure buffer and beads already present in the sample. Libraries were 
quantitated and quality control checked using Agilent High Sensitivity DNA kit and Kapa 
Illumina library quantitation kit, as per manufacturers’ instructions. Libraries were 
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sequenced using 75bp single-end sequencing mode on the Illumina NextSeq500 platform 
at the Babraham Institute Sequencing Facility. 
2.7 RNA sequencing 
Samples were processed by Elena Ivanova. 
Total RNA from 14-week old animal hypothalami was extracted by submerging in 
TRIsure (Meridian bioscience) and dissociating the tissue using electric homogenizer. 
Samples were incubated at RT for 5mins, centrifuged at 12,000 g for 15mins at 4°C and 
the aqueous phase was taken for RNA extraction. Cold isopropyl alcohol in ratio 1:2 was 
added to the samples and incubated for 10mins at RT. Samples were centrifuged at 12,000 
g for 10mins at 4°C and the supernatant was removed. Pellets were washed once with 
75% ethanol in ratio 1:1 to initial TRIsure used. Samples were centrifuged at 7,500 g for 
5mins at 4°C. Pellets were air-dried and dissolved in water. 
RNA was cleaned using Ribo-Zero rRNA removal kit (Illumina), where DNA probes to 
rRNA are hybridised and selectively cleaved using RNA-DNA hybrid targeting RNAse. 
Libraries were generated using NEBNext Ultra RNA library preparation kit (E7420, New 
England Biolabs) as per manufacturers’ instructions. Briefly, RNA was fragmented by 
incubation at 94°C for 15mins. cDNA was synthesised using ProtoScript II reverse 
transcriptase and random primers, the first and second strands were synthesised using 
reagents provided in the kit and purified using AMPure XP Beads. The ends in cDNA 
library were repaired and NEBNext adaptors for Illumina were blunt ligated. The ligation 
reaction was purified using AMPure XP beads and library was amplified using NEBNext 
Q5 polymerase, USER enzyme, and Illumina sequencing index primers. Libraries were 
purified using 0.9:1 ration of AMPure buffer and beads already present in the sample. 
Libraries were quantitated and quality control checked using Agilent High Sensitivity 
DNA kit and Kapa Illumina library quantitation kit, as per manufacturers’ instructions. 
RNA-seq libraries were sequenced 50bp single-end using Illumina HiSeq2500 platform. 
2.8 Ultra-low input chromatin immunoprecipitation sequencing  
Ultra-low input native chromatin immunoprecipitation sequencing (ChIP-seq) libraries 
were generated using 2.5% of a whole hypothalamus as input for each 
immunoprecipitation, following previously described protocol (Hanna et al., 2018), 
keeping 10% of that as input. Cells were permeabilised by adding 1/10 volume of 1% 
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triton X-100 and 1% deoxycholate solution. Chromatin was then digested using 2U/µl 
micrococcal nuclease (M0247, NEB) in 10x NEB MNse buffer, 1mM DTT, 10% 
PEG6000. Samples were digested for 7.5mins at 21°C. A solution of 100mM EDTA, 1% 
triton, 1% deoxycholate was added in ratio 1:10 to stop the reaction and samples were 
rested on ice for 10mins. Each sample had 150µl of complete immunoprecipitation buffer 
(20mM Tris-HCl, pH8.0, 2mM EDTA, 150mM NaCl, 0.1% Triton-X100, 1x protease 
inhibitor cocktail, 1mM PMSF) added and samples were incubated at 4°C rotating for 
1hr. Afterwards, input fraction was taken for all samples.  
For antibody binding, two sets of 5µl of Dynabeads Protein A/G beads (10002D and 
10004D, ThermoFisher Scientific) per sample were washed three times in complete 
immunoprecipitation buffer. Antibodies for H3K4me3 (250ng per reaction, Diagenode 
C15410003), H3K27me3 (125ng per reaction, Millipore 07-449), or H3K36me3 (250ng 
per reaction, Diagenode C15410192) in complete immunoprecipitation buffer were added 
to one aliquot of Protein A/G beads per sample and incubated at 4°C for 3hrs. Meanwhile, 
the samples were precleared by adding the other 5µl of washed Protein A/G beads to each 
sample and rotating at least for 2hrs at 4°C. 
The supernatant from antibody-bound beads was discarded, and the pre-cleared 
chromatin was transferred to antibody bound Protein A/G for incubation at 4°C overnight 
with rotation. The next day beads were washed twice with low salt buffer (20mM Tris-
HCl, pH8.0, 2mM EDTA, 150mM NaCl, 1% Triton-X100, 0.2% SDS) and then twice 
with high salt buffer (20mM Tris-HCl, pH8.0, 2mM EDTA, 500mM NaCl, 1% Triton-
X100, 0.2% SDS). Bound DNA was eluted by adding 30µl of ChIP elution buffer 
(100mM NaHCO3, 1% SDS) and incubating for 1.5hrs at 65°C. DNA was purified by 
1.8:1 ratio SPRI bead purification. MicroPlex Library Preparation kit v2 (Diagenode) was 
used as per manufacturer’s instructions to generate libraries of inputs and 
immunoprecipitated samples. Libraries were quantitated and quality control checked 
using Agilent High Sensitivity DNA kit and Kapa Illumina library quantitation kit, as per 
manufacturers’ instructions. Libraries were sequenced using 75bp single-end sequencing 
on the Illumina NextSeq500 platform at the Babraham Institute Sequencing Facility. 
2.9 Cloning 
Plasmids pJET-Dnmt3a1, containing full Dnmt3a1 sequence, and mammalian expression 
vector pCAGbio-eGFP, containing loxP-flanked CAG promoter, AviTag sequence, and 
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eGFP, were kindly provided by T. Baubec (University of Zurich). A point mutation was 
introduced using QuickChange II site directed mutagenesis kit (Agilent) using primers 
(Fwd 5’-GTCATGTGGTTCGGAGCTGGCAAGTTCTCAGTG-3’ and Rev 5’- 
CACTGAGAACTTGCCAGCTCCGAACCACATGAC-3’) and confirmed using Sanger 
sequencing. pCAGbio-eGFP and pJET-Dnmt3a1D329A was cut using Sal I and Not I 
enzymes (NEB), run on a 1% agarose gel and purified using Monarch DNA gel extraction 
kit (NEB). Backbone fragment of pCAGbio and insert fragment of Dnmt3a1D329A were 
then ligated using T4 DNA ligase (NEB) and transfected into DH5α competent cells for 
subcloning (Thermo Scientific), all as per manufacturers’ instructions. Bacterial cells 
were streaked on LB agar plates with 100 µg/ml ampicillin and left overnight in a 37°C 
incubator. The next day, colonies were picked from the plates and grown overnight in 
liquid LB and ampicillin (100 µg/ml) culture. A miniprep purification of plasmid was 
done using QIAprep spin miniprep kit (QIAGEN). 
2.10 ESC culture 
HA36CB1 cell line derived from 129xC57BL/6 mESCs with constitutively expressed 
biotin-ligase (BirA) and recombinase-mediated cassette exchange (RMCE) construct 
(referred to as wild-type) and a variant with AviTag marked Dnmt3a1 were used in 
experiments (Lienert et al., 2011). They were kindly provided by Tuncay Baubec 
(University of Zurich). 
Cells were cultured in serum-containing ESC medium at 37°C and 5% CO2 incubator on 
0.2% gelatin-coated tissue culture dishes. ESC medium was composed of DMEM (High 
glucose, pyruvate, no glutamine, Invitrogen), 15% foetal bovine serum (Invitrogen), 
100µM non-essential amino acids (Invitrogen), 2mM L-Glutamine (Invitrogen), 0.01% 
β-mercaptoethanol (Sigma-Aldrich) and a titrated vial of home-made leukemia inhibitory 
factor (LIF) (provided by T. Baubec, University of Zurich). 
The medium was changed every day and cells were passaged by removing the medium, 
washing with PBS (Invitrogen), then incubating with 0.05% Trypsin-EDTA (Invitrogen) 
for 5min at 37°C and quenching the reaction by addition of DMEM with 9% foetal growth 
serum.  
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2.11 Neural progenitor differentiation 
ESCs were counted and 3.5 million cells were plated on a non-adhesive bacterial dish in 
CA medium (DMEM, 10% foetal bovine serum, 100mM non-essential amino acids, 2mM 
L-Glutamine, 0.01 β-mercaptoethanol). On day 2 medium was changed and cells were 
replated into new dishes. On day 4 medium change was performed, with addition of 5µM 
retinoic acid. On day 6 medium was changed again adding retinoic acid. Cells were 
harvested on day 8. 
2.12 Cell line generation 
2.12.1 Preparation of plasmid DNA prior electroporation 
Plasmids pIC-Cre (Gu et al., 1993) and pCAGbio-Dnmt3a1-D329A, as described in 
Methods section 2.9, were precipitated by addition of 0.3M sodium acetate (Sigma 
Aldrich) and 75% ethanol (Fisher Scientific) overnight at -20°C. DNA was centrifuged 
at 4°C at max speed of table-top centrifuge for approx. 2hr, then washed with 70% ethanol 
and centrifuged for another 30min at 4°C at max speed. DNA was air dried under the 
hood. 
2.12.2 Electroporation 
The cells were detached as per passage protocol and counted to get 2x106 cells for each 
transfection. Cells were centrifuged at 200 g for 10mins and after removal of supernatant 
mixed with 100µl of supplemented Amaxa solution (Lonza). Solution was then combined 
with 15µg pIC-Cre and 25µg of target plasmid, transferred to Amaxa cuvette, and placed 
into the Nucleofector (Lonza) for electroporation under mESC programme. Afterwards, 
cell solution was diluted in ESC medium and plated in two different concentrations. After 
24hrs, one media change was done. On day 2 the selection was started by addition of 3µM 
Ganciclovir. Subsequently media was changed every 2-4 days depending on the dead cell 
numbers, always adding 3µM Ganciclovir.  
2.12.3 DNA extraction 
After 12 days individual colonies were picked and replated individually, splitting each 
colony into two. One part was left for expansion and the other copy was used for PCR 
genotyping to confirm insertion. On day 14 cells for genotyping were lysed in lysis buffer 
(0.025% SDS, 0.3 KCl, 5mM EDTA, 25 mM TRIS pH 8.3, 1% NP-40, 2% Tween-20, 
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and Proteinase K 1mg/ml (Roche). Cells were incubated at 55°C for 1hr, then proteinase 
K was inactivated by incubation at 95°C for 10mins.  
2.12.4 Nuclear protein extraction 
Cell were pelleted for 10mins at 200 g and then resuspended in Buffer A (0.01M EDTA, 
0.01M KCl, 0.01M HEPES, 1mM DTT, 1x protease inhibitor cocktail, 0.1% NP-40) and 
incubated for 10mins at 4°C. Cells were then centrifuged for 10mins at 4°C at 2000 g and 
the cytosolic fraction was removed. Pelleted nuclei were resuspended in Buffer B (17mM 
HEPES, 0.85% glycerol, 0.85mM EDTA, 1mM DTT, 1x protease inhibitor cocktail) and 
incubated in a thermomixer for 1hr at 4°C at 2000rpm. Samples were then centrifuged in 
a tabletop centrifuge at max speed for 10mins at 4°C. The supernatant had nuclear protein 
fraction. Protein concentration was quantified using Qubit protein assay kit (Q33211, 
Qubit), as per manufacturer’s instructions. 
2.12.5 Western blotting 
20µg of nuclear lysate was mixed with Laemmli buffer (2% SDS, 5% β-mercaptoethanol, 
20% glycerol, 0.01M Tris pH 6.8, 0.005% bromophenol blue) and boiled at 95°C for 
10mins. This mixture was loaded in a well of an SDS-PAGE gel with 8% resolving gel 
(46% water, 8.8% acrylamide, 0.39M Tris pH 8.8, 0.1% SDS, 0.1% APS, 0.06% 
TEMED) and 5% stacking gel (70% water, 5.5% acrylamide 0.2M Tris pH 6.8, 0.1% 
SDS, 0.1% APS, 0.1% TEMED). The gel was run in SDS Running buffer (25mM Tris, 
0.19M Glycine, 1% SDS) at 120V.  
The PVDF membrane for western blot (Millipore) was first activated in 100% methanol 
for 3mins and then washed with water. Sponges, Whatman paper, gel and membrane were 
soaked in transfer buffer (50mM Tris, 0.4M Glycine, 0.1% SDS, 20% methanol) and 
proteins were transferred from the gel onto the membrane for 1hr at 100V in the cold 
room. The membrane was washed twice with TBST buffer (01M Tris pH 8, 0.15M NaCl, 
0.1% Tween-20) and incubated at room temperature for 1hr with 5% milk in TBST 
solution. Afterwards, membrane was incubated on a shaker overnight at 4°C with a 
2mg/ml primary antibody for DNMT3A1 (ab2850, Abcam) diluted in TBST. Next day 
the membrane was washed in TBST three times for 10mins and incubated with a 
0.2mg/ml secondary goat anti-rabbit IgG (H+L) HRP antibody (31466, Invitrogen) in 
TBST for 1hr at room temperature. After another three 10min washes with TBST the 
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membrane was incubated in Amersham ECL Western Blotting Detection Reagent 
(RPN2109, GE Healthcare Life Sciences) for 1min and then developed on Amersham 
Hyperfilm ECL (28906836, GE Healthcare Life Sciences). 
For detection of biotinylated proteins, membrane was incubated in Restore Western Blot 
Stripping Buffer (21059, Thermo Fischer Scientific) for 5mins at room temperature. The 
membrane was then washed three times for 10mins in TBS-TX (TBS with 0.1% Triton 
X-100). The membrane was blocked with 4% BSA in TBS-TX for 1hr at room 
temperature. The membrane was incubated with 0.1mg/ml Pierce high sensitivity 
streptavidin-HRP antibody (21130, Thermo Scientific) for 1hr at room temperature and 
washed twice for 10mins in TBS with 0.3% Triton X-100. Afterwards the membrane was 
washed twice for 10mins in TBS with 0.3% Triton X-100 and 0.5M NaCl and finally 
washed once for 10mins in TBS with 0.3% Triton X-100 before detection of protein using 
ECL, as described in previous paragraph.  
2.13 Biotin co-immunoprecipitation for Mass Spectrometry 
Samples were processed together with Joel Wirz (University of Zurich). 
2.13.1 Nuclear extract preparation 
Cells were harvested by detaching with 0.05% Trypsin-EDTA for 5min at 37°C and 
quenching the reaction by addition of DMEM with 9% foetal growth serum. Cells were 
then washed in DPBS and resuspended in nuclear extract buffer 1 (10mM HEPES pH 
7.5, 10mM KCl, 1mM EDTA, 1.5 mM MgCl2, 1mM DTT, 1 x protease inhibitor cocktail) 
and incubated for 10mins at 4°C. Cells were then centrifuged for 10mins at 4°C at 2,000 
g and supernatant was removed. Pelleted nuclei were resuspended in nuclear extract 
buffer 2 (20mM HEPES pH 7.5, 20% glycerol, 1.5mM MgCl2, 0.2mM EDTA, 1mM 
DTT, 1 x protease inhibitor cocktail, 450mM NaCl) and transferred to a Dounce 
Homogenizer. Ten strokes were done using a loose pestle, then the suspension was 
transferred to a fresh tube and centrifuged at 2500 g for 10mins. The supernatant was 
removed, nuclei pellet resuspended in nuclear extract buffer 1 and 300units/ml benzonase 
and incubated rotating for 3hrs at 4°C. Samples were centrifuged at 2500 g for 10mins 
and resuspended in nuclear extract buffer 2 (20mM HEPES pH 7.5, 20% glycerol, 1.5mM 
MgCl2, 0.2mM EDTA, 1mM DTT, 1x protease inhibitor cocktail) and 450mM NaCl. 
Samples were transferred to Dounce homogeniser and 10 strokes were done using a tight 
The role of the PWWP domain in the DNA methyltransferase 3A targeting to the genome 
28  Gintarė Sendžikaitė - 2021 
pestle. Samples were then incubated on a shaker at 4°C for 1hr to extract nuclear proteins. 
Afterwards, they were centrifuged at 16,000 g at 4°C for 15mins, the supernatant fraction 
was kept.  
2.13.2 Streptavidin immunoprecipitation 
Dynabeads M-280 Streptavidin magnetic beads were washed with IP buffer (20mM 
HEPES pH 7.5, 20% glycerol, 1.5mM MgCl2, 0.2mM EDTA, 1mM DTT, 1 x protease 
inhibitor cocktail, 150mM NaCl, 0.3% NP40) three times for 10mins at 4°C. Beads were 
pre-blocked in IP buffer with addition of 1% Fish skin gelatin for 1 hr at 4°C. 
The samples were diluted 1:2 ratio in nuclear extract buffer 2 without NaCl, to achieve 
final NaCl concentration of 150mM. Then samples were centrifuged for 15 min at 16,000 
g at 4°C and supernatant was kept. NP-40 was added to final concentration of 0.3% and 
protein concentration was quantified using Qubit protein assay, as per manufacturer’s 
instructions. Approx. 1mg of nuclear extract was used for one IP, 5% of it kept as input. 
Pre-blocked streptavidin beads were added and samples were incubated overnight with 
overhead rotation at 4°C. The next day beads were washed once rotating for 10mins at 
4°C in wash buffer (20 mM HEPES pH 7.5, 20% glycerol, 1.5 mM MgCl2, 0.2 mM 
EDTA, 150 mM NaCl, 0.3% NP‐40, 1 mM DTT, and 1× protease inhibitor cocktail) and 
then again in the same buffer without NP-40. The beads were washed for 10 min in 
50 mM Tris pH 8.5, 1 mM EGTA, 75 mM KCl, rotating overhead at 4°C.  
Proteins were eluted by adding 200 μl of UA solution (8 M urea (GEPURE00‐66) in 
100 mM Tris–HCl pH 8.2) with 0.1 M DTT and shaking for 30 min at room temperature 
in a thermomixer. Processing for label-free mass spectrometry was done immediately 
afterwards. 
2.14 Label-free mass spectrometry  
The whole supernatant from streptavidin IP was digested using filter-aided sample 
preparation (FASP) method, as per published protocol (Wiśniewski et al., 2009). Samples 
were loaded to the filter unit and centrifuged at 14,000 g for 25mins at RT. This 
centrifugation setting was used for all subsequent steps, unless indicated otherwise. 200µl 
UA solution was added and samples were centrifuged. 100µl of 0.05M lodocetamine in 
UA solution was added, samples were incubated in a thermomixer at 600rpm for 1min, 
then incubated for 5mins on the bench and centrifuged. 100µl of UA solution was added 
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and samples were centrifuged, this step was repeated three times in total. 100µl of 0.5M 
NaCl were added to the samples and centrifuged, this step was repeated twice. 120µl of 
0.05M Triethylammonium bicarbonate with 20ng/µl trypsin were added and samples 
were incubated in a thermomixer at 600rpm for 1min, then overnight on the bench. The 
next day samples were centrifuged and supernatant collected. The samples were acidified 
by addition of trifluoroacetic acid to the final concentration of 0.5%. 
Samples were then desalted with C18 StageTips, made in house at Functional Genomics 
Centre Zurich. StageTips were activated by addition of 145µl 100% methanol, and 
centrifuged for 1min at 2,000 g. This centrifuge speed was used for subsequent 
centrifugations. StageTips were cleaned by adding 145µl of 60% acetonitrile and 0.1% 
trifluoroacetic acid followed by centrifugation for 1min. StageTips were equilibrated by 
adding 145µl of 3% acetonitrile and 0.1% trifluoroacetic acid, followed by centrifugation 
for 1min. This step was done twice in total.  
Digested protein samples were adjusted by adding acetonitrile to the final concentration 
of 3%. Samples were loaded 145µl at a time into the StageTips, followed by 
centrifugation for 1.5min. The flow-through was collected and loaded to the StageTips 
again, followed by centrifugation for 1.5min. The peptides were desalted by adding 145µl 
of 3% acetonitrile and 0.1% trifluoroacetic acid and centrifugation for 1min, repeated 
twice in total. Peptides were eluted using 60% acetonitrile and 0.1% trifluoroacetic acid 
and centrifugation for 2mins, this step was repeated twice. The elutes were snap frozen 
in liquid N2 and vacuum dried. Samples were then dissolved in 3% acetonitrile and 0.1% 
formic acid, briefly sonicated in a sonic water bath for 5mins, and incubated for 10mins 
at RT.  
Samples were further processed by Joel Wirz (University of Zurich) at Functional 
Genomics Centre Zurich, as follows. Dissolved samples were injected by a Waters M‐
class UPLC system (Waters AG) and separated on a C18 reverse‐phase column. High 
accuracy mass spectra were acquired with a Q‐Exactive HF mass spectrometer (Thermo 
Scientific) that was operated in data‐dependent acquisition mode. A survey scan was 
followed by up to 12 MS2 scans. 
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2.15 Data analysis  
2.15.1 Statistical analyses 
All measurements of animal samples were biological replicates and represent individual 
animals. Cell culture replicates are technical replicates, unless indicated that samples 
represent individually derived clones. Basic statistical tests used are described in figure 
legends, where applicable.  
Non-parametric Kruskall-Wallis ranked sum test followed by Wilcoxon sum rank test 
were used for datasets where mean values of genomic tiles are compared across more 
than two genotypes. Notably, these analyses are heavily overpowered due to 
exceptionally large number of variables and almost always show strong significance. The 
test results are listed in the figure legends where applicable for thoroughness of data 
analysis. However, when mean values for two or more genotypes are not showing more 
than net 10% methylation differences, they are considered not biologically significant. 
For detection of differentially expressed/methylated genes/tiles statistical tools designed 
specifically for the type of data were used. 
Analysis of high-throughput sequencing samples was done using Seqmonk visualisation 
and analysis tool, using default settings unless otherwise indicated.  
2.15.2 RNA-seq analysis 
RNA-seq data were trimmed using TrimGalore 0.5.083 or newer versions, then mapped 
using HiSat2 2.1.084 or newer versions to Mus musculus genome GRCm38. Processed 
data was analysed using Seqmonk 1.42.085 or newer versions. Reads over transcripts 
were merged across exons correcting for feature length, quantitated using RNA-Seq 
quantitation pipeline and log2-transformed. Differentially expressed genes were called 
using DESeq with significance threshold of p<0.01 after Benjamini-Hochberg multiple 
testing correction. Mitochondrial genes were excluded. For genome browser views of 
gene expression, selected regions were split into 500bp bins every 50bp and quantitated 
as reads per million transcripts, unless specified otherwise. David 6.786 Functional 
Annotation Tool was used for gene ontology analysis, with categories 
GOTERM_BP_FAT, GOTERM_CC_FAT, GOTERM_MF_FAT, using Benjamini-
corrected p<0.01 significance cut-off. 
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2.15.3 Methylation data analysis 
Methylation data were trimmed using TrimGalore 0.5.083, deduplicated, mapped to Mus 
musculus genome GRCm38, and methylation calls were extracted using Bismark 
0.19.187 or newer versions. Processed data were analysed using Seqmonk 1.42.085 or 
newer versions. Pituitary datasets were down-sampled to the least covered dataset using 
SeqMonk to avoid differential coverage artefacts. Probes were defined as tiles of CpG 
positions and quantified using Bisulphite quantitation pipeline. Tiles in the oocytes, adult 
hypothalamus and neuronal progenitor cells were 100-CpGs where at least 10 are 
covered. In pituitary, liver, E7.5 epiblast and when E7.5 epiblast data was used in 
analysis, tiles of 300-CpGs with at least 10 CpGs covered were used. X and Y genes were 
excluded only from E7.5 epiblast analyses. Differentially methylated regions were called 
using Seqmonk edgeR (for/rev) statistics filter with absolute methylation difference cut-
off of 20%, using multiple-testing corrected p-value ≤0.01. Genomic locations were 
defined as listed in the brackets using feature annotations available in SeqMonk: promoter 
(-1500bp to +500bp around transcription start site), gene body (+500bp to the end of the 
mRNA/gene), intergenic (promoters and gene bodies excluded). CpG island features were 
called based on previously published CpG island coordinate data (Illingworth et al., 
2010). For promoter analysis, 100CpG windows were fused together if distance between 
them were less than 1kb. Random probes were selected from all probes, excluding those 
in the DMR list, and utilised as representative of the genome. Previously described DNA 
methylation ‘canyon’ coordinates were used in DNA methylation valley analysis (Jeong 
et al., 2014) and only those showing methylation under 10% and covered by at least 5 
CpGs in hypothalamus were included. Non-CpG methylation was analysed using 
1000CpH tiles where at least 30 CpHs were covered. 
2.15.4 Ultra-low input and biotin ChIP data analysis 
ChIP-seq data were trimmed using Trim Galore 0.5.083 and mapped against Mus 
musculus GRCm38 genome with Bowtie 1.2.290. H3K27me3 enrichment was 
quantitated using 2kb tiles with a 1kb step, correcting for total count based on the largest 
library, unless stated otherwise. H3K4me3 and H3K27me3 peaks were called using 
MACS peak caller within SeqMonk 1.42.0 or newer versions, using a significant 
threshold of p<0.00001, a sonication fragment size of 1kb, and input controls as a 
reference. When assessment of histone marks was done in relation to DNA methylation, 
DNA methylation tiles were used to quantitate the enrichment. 
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2.15.5 Label-free mass spectrometry data analysis 
Protein identification from MS‐raw data was performed using MaxQuant 1.6.12.0 and 
analysed using Proteus package in R statistical software. Peptide aggregation was done 
by Leading Razor Protein method  (Silva et al., 2006), and samples were normalised by 
matching median intensities. Pairwise statistical comparison was done using limmaDE 
statistical tool. 
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3 DNA methylation in oocytes 
carrying the Dnmt3a-
D329A mutation  
Declaration of author contributions 
Oocyte collections were done together with Courtney Hanna. 
 
Mammalian oocytes show a unique DNA methylation pattern, where only actively 
transcribed gene bodies are highly methylated. The rest of the genome, unlike in a somatic 
cell, is largely unmethylated, thus forming hyper- and hypo- DNA methylation domains 
(Smallwood et al., 2011; Kobayashi et al., 2012; Veselovska et al., 2015). Moreover, only 
actively transcribed genes in the oocyte are marked by histone 3 lysine 36 trimethylation 
(H3K36me3), which  correlates highly with DNA methylation (Xu et al., 2019). Despite 
the unique methylome, there is no specialised DNA methylation machinery in the mouse 
oocyte (Kaneda et al., 2010). A shorter isoform DNMT3A2 together with a germ-cell 
specific co-factor DNMT3L is responsible for DNA methylation establishment, while 
DNMT3B does not play a significant functional role. PGCs undergo epigenetic landscape 
erasure and the unusual oocyte-specific methylation pattern is solely a result of de novo 
methylation events occurring during a meiotic arrest. These circumstances create a perfect 
model to study the impact of the DNMT3A D329A mutation on DNA methylation 
targeting to the H3K36me3-marked fraction of the genome. 
3.1 Assessment of global DNA methylation in oocytes 
In order to assess whether DNA methylation in the oocyte is affected in the presence of 
the D329A mutation, germinal vesicle (GV) oocytes were collected from 24-26 day old 
Dnmt3a+/+, Dnmt3aΔ/+, Dnmt3a+/D329A, and Dnmt3aΔ/D329A female mice coming from one 
litter, as described in the breeding scheme in section 1.12. Briefly, females used in the 
cross were heterozygous for a floxed Dnmt3afl allele and carried oocyte-specific Zp3 
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promoter driven Cre recombinase (Kaneda et al., 2010), which results in offspring 
inheriting either the wild-type allele or the deletion (Δ) of Dnmt3a (Figure 1.6). Due to 
challenges of maternal passage of mutant allele, it was not possible to create a 
homozygous mutant, therefore the mutant allele was passed from heterozygous 
Dnmt3a+/D329A males. I used all four genotypes to account for potential haploinsufficiency 
of Dnmt3a, therefore, if needed, allele number matched pairs could be compared.  
Approximately 75 to 170 oocytes were collected from an individual mouse and these 
would constitute one sample, which was processed using post-bisulphite adaptor tagging 
(PBAT) to generate oocyte methylome maps. In total three to four litter-matched mice 
were used per genotype. Libraries had relatively low levels of duplication, ranging from 
12.5% to 20.4% and had between 19 and 39 million unique deduplicated alignments 
(Table 1). They all passed FastQC checks of raw sequencing data. 
To evaluate the PBAT datasets, the genome was split into tiles containing 100 CpG 
dinucleotides, and only tiles with methylation calls at least 10 CpG dinucleotides were 
used in the analysis. Initially samples were assessed by drawing a similarity tree and a 
correlation matrix, which are based on Pearson distance and pairwise correlations, 
respectively (Figure 3.1). Sample +/D329A_2 showed the lowest correlation with other 
samples, as it branched off from the main distance tree immediately (Figure 3.1a). It also 
had uniquely low pairwise correlation compared to other sample pairs (Figure 3.1b). 
Sample +/D329A_2 also showed a spatial separation in two-dimensional space in 
Principal Component Analysis (PCA) (Figure 3.2a). Given the evidence of dissimilarity 
to all other samples in this experiment sample +/D329A_2 was excluded from further 
investigation. This has improved overall spatial separation of the rest of the samples on 
PC2 (Figure 3.2b). 
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+/+_1 12.5% 38,386,803 
+/+_2 15.1% 22,558,552 
+/+_3 14.9% 19,325,117 
+/+_4 15.5% 23,832,813 
Δ/+_1 17.9% 28,438,378 
Δ/+_2 17.7% 32,110,878 
Δ/+_3 16.1% 23,390,327 
Δ/+_4 14.5% 39,466,786 
+/D329A_1 15.6% 33,928,176 
+/D329A _2 16.9% 28,766,719 
+/D329A _3 20.4% 29,092,007 
Δ/D329A _1 15.1% 33,621,919 
Δ/D329A _2 16.9% 25,347,250 
Δ/D329A _3 13.5% 24,815,042 
Δ/D329A _4 14.5% 28,320,511 
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Figure 3.1. Bulk oocyte sample correlation. A. A data similarity tree indicating Pearson 
correlation distances between individual samples of the genotypes listed. B. Pairwise 
correlation matrix for individual sample pairs, in scale 0 to 1. Numbers denote replicates.  
 
Chapter 3: DNA methylation in oocytes carrying the Dnmt3a-D329A mutation 
Gintarė Sendžikaitė - 2021   37 
 
Figure 3.2. Principal Component Analysis of oocyte samples. PCA was done on 
100CpG tiles, where at least 10CpGs are covered. Each dot represents a replicate sample 
coming from an individual mouse, colour denotes the genotype. PCA plot in A. is before 
exclusion of +/D329A_2 sample and B. is after. 
 
Global DNA methylation in all samples was similar, abeit not identical, and showed a 
distribution usual for the oocyte, where most of the tiles were either hyper- or hypo- 
methylated (Figure 3.3). Mean methylation was 42.9%, 36%, 37.9% and 34% in 
Dnmt3a+/+, Dnmt3aΔ/+, Dnmt3a+/D329A and Dnmt3aΔ/D329A, respectively. Global levels of 
approx. 7% lower DNA methylation in Dnmt3aΔ/+ compared to Dnmt3a+/+ oocytes 
indicated the effect of haploinsufficiency. In agreement with this, Dnmt3aΔ/D329A samples 
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had approx. 4% lower DNA methylation than Dnmt3a+/D329A, suggesting that dosage of 
the wild-type allele was important.  
When genomic tiles of the Dnmt3a+/+ samples were aligned against Dnmt3aΔ/D329A a shift 
in the correlation axis on the scatterplot could be observed, suggesting that many genomic 
locations are more methylated in the wild-type sample (Figure 3.4a). A similar trend was 
observed when comparing Dnmt3a+/+ and Dnmt3aΔ/+ (Figure 3.4b). A comparison 
between Dnmt3aΔ/+ and Dnmt3aΔ/D329A or Dnmt3a+/+ and Dnmt3a+/D329A did not show this 
curved effect of the correlation axis, suggesting that a tendency for hypomethylation 
observed was caused by haploinsufficiency rather than presence of the D329A mutation 
(Figure 3.4).  
 
 
Figure 3.3. Global oocyte DNA methylation. A. DNA methylation levels in individual 
samples. B. DNA methylation levels averaged within the genotype. 100CpG tiles with 
coverage in all samples were used (total of 395,014 tiles). Kruskal-Wallis rank rum test 
resulted in p-value < 2.2e-16, and was significant for all post-hoc pairwise Wilcoxon rank 
sum tests. 
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Figure 3.4. Scatterplots showing alignment of genomic regions between the different 
genotypes. Genotypes are listed on x and y axes. Each dot represents a genomic tile 
covering 100 CpGs, mean methylation value is merged across the replicates. 
 
3.2 Investigating possible somatic cell contamination 
It is evident in Figure 3.3 that the genotype replicates did not have identical distributions 
of methylation of 100-CpG tiles. I considered the possibility that somatic cell DNA 
contamination could contribute to this variation. Oocyte collection is conducted manually 
by dissociating ovaries using tissue digestion enzymes and pipetting force and by passing 
a piece of tissue through gradually smaller diameter pipette tips. The lysis and shear force 
can burst cells and lead to release of some cell nucleus material into the collection buffer, 
resulting in free-floating DNA. Additionally, oocytes are surrounded by granulosa cells, 
many times smaller and substantially more difficult to see under a benchtop microscope. 
As there were on average 100 oocytes in one sample, some contamination by soma is 
difficult to avoid. Since the X chromosome is silenced by DNA methylation in somatic 
cells but not in the oocyte, DNA methylation of X chromosome CGIs can be used as a 
proxy for contamination assessment.  
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Assessment of genomic tiles overlapping X chromosome CGIs showed that some of the 
samples had higher levels of DNA methylation, suggesting presence of some somatic cell 
DNA contamination (Figure 3.5, Table 2). This was particularly pronounced in wild-type 
oocytes, showing >20% mean DNA methylation of X chromosome CGIs, and especially 
in sample Dnmt3a+/+_4, where X chromosome CGIs are methylated to 27.8%.  
 
 
Figure 3.5. DNA methylation of tiles overlapping X chromosome CGIs. Individual 
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Table 2. DNA methylation levels of X-chromosome CGIs. Individual samples are 
listed. In total 971 X chromosome CGIs with coverage in all samples were assessed. 
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Initially, it was hypothesised that, due to the introduction of the D329A mutation, oocytes 
would lose a relatively large proportion of DNA methylation specifically over gene 
bodies. Given that somatic contamination would likely result in evenly distributed 
elevation of DNA methylation across the whole genome, it is unlikely that small levels 
of contamination would mask this effect completely. A visual assessment of genome 
browser tracks for groups gave confidence that minor contamination would not hinder 
further analysis (Figure 3.6).  
 
 
Figure 3.6. Genome browser view of DNA methylation in oocytes. Each tile represents 
100-CpG average methylation values; error bars indicate error of the mean. Hyper refers 
to hypermethylated domains in the oocyte, hypo – domains showing low methylation 
levels.  
 
A prominent feature of the oocyte methylome is the presence of hypo- and hyper- 
methylated domains, and this pattern was clearly seen in all four genotypes in the genome 
browser view (Figure 3.6). Assessment of DNA methylation levels over these domains 
showed minor differences across the phenotypes (Figure 3.7). Hypermethylated domain 
DNA methylation levels appeared to be dependent on the allele number, on average 
samples with two alleles had 9% higher DNA methylation levels than samples with one 
allele only (Table 3). Meanwhile, the difference between Dnmt3a+/+ and Dnmt3a+/D329A, 
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or Dnmt3aΔ/+ and Dnmt3aΔ/D329A samples was in the range of 1.7-4.2%. Hypomethylated 
domains had DNA methylation within the range of 12.2-14.6%, with an exception of the 
Dnmt3a+/+ genotype, which was methylated to 22.6% at hypo- domains. This could be a 
result of higher contamination levels in wild-type samples. Overall, the variation across 
genotypes, especially over hypermethylated oocyte domains, did not indicate major 
global shifts. 
 
Table 3. Mean DNA methylation levels of hyper- and hypo- methylated domains. 






Dnmt3a+/+ 80.0% 22.6% 
Dnmt3aΔ/+ 74.0% 14.6% 
Dnmt3a+/D329A 81.7% 13.6% 
Dnmt3aΔ/D329A 69.8% 12.2% 
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Figure 3.7. DNA methylation levels of hyper- and hypo- methylated domains. Tiles 
of 100CpGs with coverage in all samples were used, replicates are grouped. For both 
hypermethylated and hypomethylated domains Kruskal-Wallis rank rum test p-value was 
< 2.2e-16, and significant for all post-hoc pairwise Wilcoxon rank sum tests. 
 
In addition to hypo- and hyper- methylated domains I assessed other genomic features. 
DNA methylation levels over tiles overlapping CGIs or CGI-containing promoters were 
very similar (Figure 3.8a,b; Table 4). Meanwhile non-CGI promoters had 23.7-28% 
higher DNA methylation level than CGI promoters (Figure 3.8b). Overall, the variation 
in DNA methylation levels across all genomic features corresponded to the number of 
Dnmt3a alleles. Gene bodies were generally highly methylated across all four genotypes; 
again only a minor decrease was observed when one copy of Dnmt3a was missing. 
Meanwhile, intergenic domains had very low methylation, as expected of the oocyte 
methylome (Figure 3.8c). No dramatic differences in the presence of the D329A mutation 
could be seen. Notably, the Dnmt3a+/+ oocytes had the highest DNA methylation in all 
comparisons depicted in Figure 3.8. This, and the lower level of DNA methylation 
observed previously in hyper- domains, could be explained as an artefact of higher 
somatic cell DNA contamination levels found in some of those samples. 
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Figure 3.8. DNA methylation levels of various genomic features. DNA methylation 
levels of A. all CGIs, B. CGI-overlapping and non-CGI promoters, C. gene bodies and 
intergenic regions. 100 CpG tiles overlapping features indicated were used in 
quantification. Kruskal-Wallis rank rum test p-value was < 2.2e-16, and significant for 
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Table 4. DNA methylation levels over oocyte genomic features. Mean for each 











Dnmt3a+/+ 21.3% 18.9% 46.9% 58.6% 27.4% 
Dnmt3aΔ/+ 15.3% 13.0% 39.4% 52.5% 19.7% 
Dnmt3a+/D329A 16.8% 14.5% 41.2% 56.5% 19.4% 
Dnmt3aΔ/D329A 14.6% 12.2% 35.9% 50.2% 17.9% 
 
3.3 Link between oocyte DNA methylation and histone PTMs 
Given that hypermethylated domains in the oocyte correlate with H3K36me3 (Xu et al., 
2019), I next assessed DNA methylation over different histone modifications. Previously 
published datasets for H3K4me3 and H3K27me3 (Hanna et al., 2018) and an unpublished 
H3K36me3 dataset, courtesy of C. Hanna, were used as a reference for high (top 10%) 
and low (bottom 10%) enrichment genomic areas in the oocyte. 
First, I looked at areas that are enriched for H3K36me3. High levels of H3K36me3 
correlated with DNA methylation; on average, these genomic regions had 77.5% DNA 
methylation, while areas with low H3K36me3 enrichment were methylated only to 23.6% 
(Figure 3.9, Table 5). Given that the difference across any two genotypes over low- or 
high- H3K36me3 enriched domains did not exceed 9%, data again confirmed the lack of 
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Figure 3.9. DNA methylation levels at genomic areas linked to histone PTMs. DNA 
methylation distribution in genomic tiles linked to A. H3K36me3, B. H3K4me3, C. 
H3K27me3, D. bivalent chromatin (high H3K4me3 and high H3K27me3). High 
H3K4me3 and high H3K27me3 datasets exclude bivalent tiles. Low refers to bottom 10 
% and high to top 10% of enrichment of genome-wide PTM distribution. Kruskal-Wallis 
rank rum test p-value was < 2.2e-16, and significant for all post-hoc pairwise Wilcoxon 
rank sum tests. The exception was C. low H3K27me3 areas, where post-hoc Wilcoxon 
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rank sum pairwise test for Dnmt3aΔ/+ against Dnmt3a+/D329A p-value (Benjamin Hochberg 
adj.) = 0.079. 
 
Generally, similar trends of DNA methylation were observed in genomic areas with low- 
or high enrichment for H3K4me3, H3K27me3. Broadly, tiles highly enriched for 
H3K4me3 had approximately 14.0% DNA methylation, while areas with low H3K4me3 
enrichment were on average 48.8% methylated. Similarly, high H3K27me3 enriched 
areas had approx. 15% methylation, while low H3K27me3 enriched areas had on average 
44.3% methylation. Bivalent chromatin was on average 8.5% methylated. In all datasets, 
wild-type samples were the ones with highest DNA methylation and the main driver of 
intergenotype-based variability. Overall, these data suggest that the D329A mutation does 
not lead to differences in DNA methylation levels over genomic tiles enriched for specific 
histone PTMs.  
 
Table 5. Mean levels of DNA methylation in the oocyte genomic areas linked to 
histone PTMs. Genotype column indicates alleles of Dnmt3a gene. High H3K4me3 and 
high H3K27me3 datasets exclude bivalent tiles. Bivalent contains those genomic tiles that 
show high H3K4me3 and high H3K27me3. Low refers to bottom 10 % and high to top 






















+/+ 29.9% 79.5% 53.7% 21.1% 49.9% 21.3% 14.5% 
Δ/+ 22.3% 75.1% 46.8% 13.2% 42.8% 13.4% 7.6% 
+/D329A 21.4% 81.7% 49.7% 11.7% 44.3% 12.6% 5.5% 
Δ/D329A 20.9% 73.8% 45.2% 9.9% 40.3% 12.6% 6.2% 
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3.4 Assessment of single-cell oocyte samples 
Bulk oocyte analysis revealed little to no effect of the presence of DNMT3AD329A on 
DNA methylation. However, the interpretation was likely to be confounded by varying 
levels of somatic cell or cell-free contamination. In order to get a more conclusive answer, 
GV oocytes were collected for single-cell DNA methylation analysis. Somatic cells are 
methylated to approx. 70%, while oocyte global DNA methylation is around 40%. Even 
if there was a single somatic cell present, it would immediately skew the global DNA 
methylation level in a sample and therefore it could be easily identified and removed from 
analysis. In addition, oocytes of 20-week old females were collected to account for a 
possibility of progressive accumulation of aberrant DNA methylation during aging. 
Finally, matched Dnmt3a+/+ and Dnmt3a+/D329A littermates were used to avoid the 
confounding dosage effect which was observed in bulk analysis.  
Approximately 20 GV oocytes were collected from two mice of each Dnmt3a+/+ and 
Dnmt3a+/D329A genotype and processed by single-cell bisulphite-sequencing (scBS-seq). 
Samples showing no alignment to Mus musculus genome were excluded, resulting in 21 
Dnmt3a+/+ and 19 Dnmt3a+/D329A oocytes. Full genome coverage is not possible in single-
cell bisulphite sequencing due to DNA degradation, PCR biases, allele drop-outs and 
sequencing costs; it is only possible to recover information on limited CpG sites (Clark 
et al., 2017). Single oocyte libraries had approx. 1 to 4.4 million reads, and approx. 2.41% 
to 10.85% of all CpG sites were covered (individual numbers provided in Appendix 1). 
Given that many cells are assessed and genomic regions covered in each one of them 
would be random, I first looked at DNA methylation quantification of individual cells, 
regardless of whether the genomic tiles assessed were covered in the majority samples or 
not. Pearson correlation was used to assess similarity of individual samples. First, a 
relationship tree based on correlation distance showed one sample – 
7_+/D329A_310.1e_1 – as an outlier (Figure 3.10). Pairwise correlation values between 
most samples were ≥0.65, while the previously indicated outlier showed ≤0.51 correlation 
to other samples (data not shown). Based on this evidence, sample 7_+/D329A_310.1e_1 
was excluded from further analysis. Notably, there was no clear separation of the samples 
based on the processing time (so called batch-effect) or coverage of individual samples 
(Figure 3.11), which was reassuring that the samples are of good quality. Global DNA 
methylation values, independently of genotype, ranged from 27.4% to 36.2%, while X 
chromosome CpG island DNA methylation was between 2.7% to 8.5% (Figure 3.11). 
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Together, this suggested there was no somatic cell DNA contamination, no batch or 
sequencing depth effects in single oocyte samples. 
 
 
Figure 3.10. Similarity tree of individual oocyte samples. The tree is drawn based on 
Pearson distance correlation.  
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Figure 3.11. Single cell oocyte DNA methylation correlation to X-chr CGIs. Global 
DNA methylation relationship to X chromosome CGIs is visualised as a scatterplot. 
Shape denotes genotype, as described in the legend. A. Colour denotes cell collection 
batch. B. Colour denotes number of unique read millions included in the analysis for 
individual samples. Numbers refer to single oocyte samples, corresponding sample names 
are provided in Appendices. 
 
Given that oocytes are a relatively homogeneous cell population and inter-genotype 
variability is not expected, I could benefit from using confidently clean single oocyte 
datasets combined together into groups resembling bulk oocyte samples. I elected to 
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group together 4-6 samples into four pseudo-bulk groups per genotype in order to obtain 
more informative datasets. Individual samples were assigned randomly, to ensure the 
final counts of mapped reads in all four pseudo-bulk groups were as similar as possible, 
between 10.6-11.8 x106 (list is provided in Appendices). The coverage of CpG positions 
in pseudo-bulk samples, compared to individual ones, has increased from 2.7%-8.5% to 
23.2%-25.4%, therefore providing more even and extensive coverage of the genome. 
Since the genome was separated into sequential tiles containing 100 CpG positions, and 
those with at least 10 individual CpG positions covered were used in quantification, usage 
of pseudo-bulking approach resulted in 160,437 out of total 233,658 genome tiles being 
covered in all eight pseudo-bulk samples. These were used in subsequent analysis, 
therefore making the samples directly comparable.  
Independently of the genotype, Pearson correlation between the groups was ≥0.93, while 
assessment of the PCA plot indicated a spatial separation of samples based on the 
genotype (Figure 3.12). Global DNA methylation exhibited the expected bimodal 
distribution, and there were no differences between Dnmt3a+/+ and Dnmt3a+/D329A 
pseudo-bulk samples, nor was there any shift in correlation axis when genomic tiles with 
average genotype values were aligned (Figure 3.13). Overall, the pattern of DNA 
methylation was clear and robustly similar in all samples, with no evidence of somatic 
DNA contamination over intergenic domains (Figure 3.14). Oocyte hypo- and hyper-
methylated domains also showed regular distribution in both genotypes, with no visible 
variation across the pseudo-bulk samples (Figure 3.15). 
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Figure 3.12. Correlation of pseudo-bulk oocyte samples. A. Pearson pairwise 
correlation of pseudo-bulk oocyte samples. B. PCA plot showing separation of individual 
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Figure 3.13. Global DNA methylation of pseudo-bulk oocytes. Alleles of Dnmt3a are 
listed as sample names. Genomic tiles of 100CpGs with at least 10 positions covered were 
used. A. Beanplots showing global DNA methylation distribution of individual pseudo-
bulk samples. Wilcoxon rank sum test using mean tile values for each genotype results in 
p-value <2.2e-16. B. Scatterplot showing mean DNA methylation values for genomic 
tiles in Dnmt3a+/+ against Dnmt3a+/D329A. 
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Figure 3.14. Genome browser view of oocyte pseudo-bulk samples. Alleles of Dnmt3a 
are provided as sample names. Each box represent 100CpG tile. Individual pseudo-bulk 
groupings are shown. 
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Figure 3.15. DNA methylation levels of hypo- and hyper- methylated domains in 
pseudo-bulk samples. 100CpG tiles were used. Wilcoxon rank sum test using mean tile 
values for each genotype results in p-value <2.2e-16 for hypomethylated and p-value = 
0.0117 for hypermethylated domains. 
 
DNA methylation in pseudobulk groups over regions of low enrichment (0-10% fraction) 
or high enrichment (90-100%) in histone marks H3K4me, H3K27me3 and H3K36me3 
was assessed but did not show any apparent differences between Dnmt3a+/+ and 
Dnmt3a+/D329A oocytes (Figure 3.16). Together these data agree with the findings of bulk 
oocyte analysis, and suggest that the D329A mutation does not cause functionally 
significant changes in genomic targeting of DNMT3A in mouse oocytes. 
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Figure 3.16. DNA methylation in pseudo-bulk oocytes samples over genomic 
domains linked to histone PTMs. High H3K4me3 and high H3K27me3 datasets exclude 
bivalent tiles. Low refers to bottom 10 % and high to top 10% of enrichment of genome-
wide PTM distribution. Wilcoxon rank sum statistical test p-values listed in order of PTM 
domains, as they appear in the figure: A. p=0.054, p=0.0005, B. p=0.052, p=8.135e-15, 
C. p=0.754, p<2.2e-16, p<2.2e-16. 
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3.5 Summary and discussion 
In this chapter, I assessed the impact of the presence of the Dnmt3aD329A allele in mouse 
oocytes. I found that the D329A mutation does not dramatically affect the DNA 
methylation pattern in the oocyte. This is true over all genomic features and domains 
marked by varying levels of H3K4me3, H3K27me3, and/or H3K36me3. On the suspicion 
that there were varying levels of somatic cell and/or DNA contamination in bulk PBAT 
datasets, these findings were confirmed using a single-cell approach.  
Redundancy between DNMT3A and DNMT3B makes it challenging to find tissues that 
would allow the dissection of the functionality of only one of these proteins. The mouse 
oocyte is one of those special cases where DNMT3A is known to be solely responsible 
for establishing DNA methylation and at no point during oocyte development is 
DNMT3B required (Kaneda et al., 2004, 2010). Given this, it was chosen as the first place 
for assessment of the impact of the D329A mutation. It came as a great surprise that no 
effect could be observed. There is a clear linear relationship between the key factors in 
de novo DNA methylation in the oocyte: Transcription, SETD2 catalysed H3K36me3, 
and DNMT3A established DNA methylation.  
The first part of the hierarchy is transcription. Once a non-growing oocyte is induced to 
enter the growth phase, a definitive oocyte transcriptome is established. From around the 
mid-stage of oocyte growth, expressed genes start to acquire DNA methylation across 
their gene bodies (Gahurova et al., 2017). Methylation increases during the final stages 
of oocyte growth and is completed by the fully-grown GV stage. High transcriptional 
levels and DNA methylation show high correlation, and approximately 90% of 
methylome establishment has been attributed to transcription events (Gahurova et al., 
2017; Kobayashi et al., 2012; Veselovska et al., 2015). While transcriptional activation 
and DNA methylation go hand in hand, it is unlikely that gene body DNA methylation is 
recruiting transcriptional units to the genome, and therefore it is unlikely that mutation in 
DNMT3A would have a direct effect on gene expression.  
High transcriptional levels are not only linked to DNA methylation but also to  
H3K36me3 (Gahurova et al., 2017; Stewart et al., 2015; Veselovska et al., 2015; Xu et 
al., 2019). H3K36me3 is present in early oocyte growth stages and increases together 
with transcription and DNA methylation during oocyte maturation, persisting until the 
MII stage (Xu et al., 2019). Depletion of H3K36me3 in non-growing oocyte results in 
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dramatic loss and redistribution of DNA methylation and affects all maternal imprints in 
fully-grown oocytes. It also alters the transcriptome, leads to reorganisation of H3K4me3 
and H3K27me3 mark landscape, and causes embryonic lethality (Xu et al., 2019). 
Bridging transcriptional activation and H3K36me3 is the enzyme SETD2 responsible for 
catalysing the H3K36me3 mark. SETD2 is bound to the RNA Polymerase II elongation 
subunit and is therefore able to set H3K36me3 over gene bodies (Yoh et al., 2008). Added 
together, findings from previous studies would strongly suggest that H3K36me3 is the 
key regulator of the oocyte epigenome, including DNA methylation. The only currently 
known way for DNMT3A to be recruited by H3K36me3 is via the PWWP domain 
(Dhayalan et al., 2010).  
The isoform required for DNA methylation in the oocyte is the shorter DNMT3A2 
isoform. It lacks the long intrinsically disordered part of the N-terminus, but retains both 
PWWP and ADD domains. The essential co-factor DNMT3L is also structurally similar 
to DNMT3A, but has the ADD domain only (Bourc’his et al., 2001). Given that the short 
isoform of DNMT3A is conferred by an alternative promoter, and many genes in oocytes 
have oocyte-specific promoters (Veselovska et al., 2015), we can speculate that the 
PWWP domain would be included in the shorter isoform transcript only if it conveyed a 
function in the oocyte.  
If the mutation indeed disrupted the interaction between the DNMT3A-PWWP domain 
and H3K36me3, then we would expect to see a loss of DNA methylation in the oocyte 
domains marked by high levels of H3K36me3. There are three possible interpretations 
for why I do not detect any gross change: 1) the PWWP domain is not essential for 
recruitment of DNMT3A to the H3K36me3 marked genome; 2) the PWWP-D329A 
mutation does not disrupt the interaction in vivo; 3) DNMT3B is able to rescue the defect 
in the DNMT3A-PWWP domain, for example by heterodimerisation and targeting 
through the DNMT3B-PWWP domain. 
The first possibility that the DNMT3A-PWWP domain is not required in oocytes would 
leave a question of why cellular energy and nucleic acid resources would be used to 
transcribe it in the oocyte isoform at all. The evidence for the role of H3K36me3 in DNA 
methylation recruitment is so compelling (Xu et al., 2019) that it would be difficult to 
imagine that another system, rather than a conserved PWWP domain, could be used. 
Could it be just because the PWWP domain is required in a maternal transcript in early 
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embryogenesis? Even so, this would not answer the question of how DNMT3A is 
recruited to genomic domains destined to be methylated. 
A second possibility, that the PWWP-D329A mutation in DNMT3A does not have the 
same effect in vivo as in vitro, is an interesting speculation. One way to test it would be 
to delete the PWWP domain in the oocyte and look at DNA methylation levels. This 
experiment could provide an answer also to the question of whether the PWWP domain 
has a role in the oocyte at all. 
Finally, a third possibility is of DNMT3B stepping in in the time of need. DNMT3A and 
DNMT3B are found in a functional complex in ESCs (Li et al., 2007a). Dnmt3b is 
expressed in the oocyte but deletion of it does not affect DNA methylation or the potential 
of the oocyte to be fertilised and form an embryo (Kaneda et al., 2010). While Dnmt3b is 
upregulated following Dnmt3l deletion (Lucifero et al., 2007), it does not appear to save 
the loss of DNA methylation in the Dnmt3l-/- mouse. Therefore, it is unlikely that a 
redundancy rescue mechanism was triggered by the D329A mutation in DNMT3A-
PWWP domain in the oocyte. 
In summary, this chapter shows that upon introduction of the D329A mutation in the 
DNMT3A PWWP domain, DNA methylation in the oocyte is not affected. Thus, the role 
of the PWWP domain in DNMT3A established de novo DNA methylation in the oocyte 
remains unclear. The negative result in particular highlights potential discrepancies of in 
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4 Mice carrying the Dnmt3a-
D329A mutation exhibit a 
growth retardation 
phenotype 
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Mice carrying the D329A mutation in the DNMT3A-PWWP domain were initially 
generated to assess DNA methylation in the oocyte, where the only active de novo 
methyltransferase is DNMT3A, and the DNA-methylated genome is marked by 
H3K36me3. Although there were no changes found in oocytes of Dnmt3aD329A mice, an 
observation was made that mice carrying the D329A mutation were much smaller than 
their littermates. This phenotype was unexpected, given the initial hypothesis that D329A 
mutation would have a loss-of-function outcome and because of the lack of phenotype in 
the oocyte. Intrigued by this observation, I decided to investigate the growth phenotype 
and underlying pathology. 
4.1 Postnatal growth retardation phenotype 
Initially, a serendipitous observation was made that littermate mice in the colony carrying 
the D329A mutation had varying sized bodies and heads (Figure 4.1). To further assess 
this phenotype, weights of mice from litters of four possible genotypes: Dnmt3a+/+, 
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Dnmt3aΔ/+, Dnmt3a+/D329A, Dnmt3aΔ/D329A were recorded (Figure 1.6). Depending on 
availability, 4-19 pups per sex, per genotype were weighed at day 10, week 4, week 6, 
week 8, and week 12 to follow their growth patterns (Figure 4.2, Table 6). The weights 
were kindly recorded by the Biological Support Unit at Babraham Institute. 
 
 
Figure 4.1. Photographs of littermate mice. A. Photograph showing whole body 
differences of littermate mice. B. Photograph showing head size differences of littermate 
mice. Alleles of Dnmt3a carried by mice are indicated. The ruler is in metric system, 
where one unit equals 1cm. 
 
  
Chapter 4: Mice carrying the Dnmt3a-D329A mutation exhibit a growth retardation phenotype 
Gintarė Sendžikaitė - 2021   63 
 
Figure 4.2. Body weights of mice recorded at different timepoints. Colours denote 
genotype, legend refers to Dnmt3a alleles. Replicate numbers are listed in Table 6. Error 
bars indicate error of the mean.  
Table 6. Individual animals used (n value) in body weight curve generation at times 
indicated. 





+/+ 19 19 18 19 19 18 
/+ 12 12 12 12 12 12 
+/D329A 7 7 8 8 7 7 
/D329A 12 12 12 13 13 11 
Female 10 days 4 weeks 6 weeks 8 weeks 10 weeks 12 weeks 
+/+ 7 7 8 8 8 8 
/+ 11 11 13 13 13 13 
+/D329A 4 4 5 5 5 5 
/D329A 8 8 8 8 8 8 
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Dnmt3a+/D329A and Dnmt3aΔ/D329A mice displayed a postnatal growth retardation, which 
was more severe in males and in Dnmt3aΔ/D329A animals. Mixed model ANOVA (KR-
method) showed that the difference in weights was significantly dependent on genotype 
and time in both sexes (p<0.001, df(males) = 15,229.48, df(females) = 15,142.15), F=0). 
Subsequent pairwise Bonferroni-adjusted t-test comparisons showed that Dnmt3a/D392A 
females become significantly underweight starting from week 4 (p=0.002), with the 
exception of week 8 (p=0.095). Dnmt3a+/D329A females do not show statistically 
significant change. Dnmt3a/D329A males become significantly underweight from week 4 
(p<0.001), and Dnmt3a+/D329A males from week 6 (p<0.001). Dnmt3aΔ/+ offspring were 
indistinguishable from Dnmt3a+/+ in both sexes, indicating no haploinsufficiency of 
Dnmt3a at a phenotypic level. Notably, offspring carrying the D329A allele showed lower 
weights, even in the presence of a wild-type allele, suggesting D329A is a gain-of-
function mutation.  
In humans, dwarfism syndromes are sometimes caused by abnormal activation of the GH-
IGF (growth hormone – insulin-like growth factor) axis (Ranke and Wit, 2018). GH-
releasing hormone (GHRH) is secreted by the hypothalamus and activates anterior 
pituitary cells to release GH. GH directly promotes growth of bones and acts on the liver 
to activate IGF-I secretion. IGF-I enters the circulation and has a generic growth 
stimulation effect in most tissues, at the same time providing a negative feedback stimulus 
back to the pituitary gland. 
I hypothesised that the growth restriction observed could have been caused by hormonal 
imbalance. To test this hypothesis, serum of 14-week old male mice was assessed using 
ELISA. At least four individual animals were used per genotype. However, the levels of 
GH and IGF-I were not significantly different across the four genotypes (p=0.9211 and 
p=0.1374, respectively) (Figure 4.3). 
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Figure 4.3. Levels of growth regulatory hormones in serum. Concentration of A. 
growth hormone and B. insulin-like growth factor-1 in serum of mice of indicated 
genotypes. Genotype refers to Dnmt3a alleles. Kruskal-Wallis is a non-parametric test 
used to assess statistical significance of the distribution. Each dot refers to one mouse. 
 
4.2 Transcriptional changes in Dnmt3aD329A mice 
Dnmt3a is widely expressed in developing mouse brain starting from around embryonic 
day 11.5 (E11.5) to postnatal neurogenesis, and is the only de novo DNA 
methyltransferase expressed from E15.5 onward  (Feng et al., 2005).  To gain insights 
into causes of the abnormal growth RNA-seq was performed on adult (14-week) 
hypothalamus. The libraries were kindly generated by Elena Ivanova. Five replicates of 
Dnmt3a+/+ and four replicates of Dnmt3aΔ/D329A RNA-seq libraries were sequenced to the 
depth of 16.9-18.4 million reads and all passed FastQC checks. During analysis, only 
reads uniquely mapped to the genome were included. Quality control in the SeqMonk 
analysis tool indicated that most of the reads were overlapping gene annotations, and 
approx. 75% of all genes were covered (Figure 4.4). The libraries were generated using a 
directional opposite strand RNA-seq library kit and it was reassuring to observe almost 
all reads mapped on the anti-sense strand. 
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Figure 4.4. Quality control assessment of adult mice hypothalamus RNA-seq 
datasets. Graph shows a percentage of reads falling over genes, and exons in particular. 
Percentages of reads in rRNA or mitochondrial (MT) refer to levels of non-
polyadenylated transcripts. Genes measured show how many genes would have a 
coverage of at least one read. Max data size show relative abundance of reads in all 
samples in reference to the largest one. On sense strand indicate how many transcripts 
fall onto sense strand. 
 
First, expression levels of members of the DNA (de-)methylation machinery were 
assessed (Dnmt1, Dnmt3a, Dnmt3b, Dnmt3l, Tet1, Tet2, and Tet3), but no statistically 
significant differences between Dnmt3a+/+ and Dnmt3aΔ/D329A animals were found 
(Figure 4.5). However, assessment of the whole transcriptome using DEseq (p<0.01, 
Benjamini-Hochberg multiple comparisons correction) identified 259 differentially 
expressed genes (DEGs) between the two genotypes (Figure 4.6). Upregulated genes fell 
mostly within the transcriptional regulator class, as defined by Gene ontology (GO) 
analysis (Figure 4.7). Interestingly, many normally strictly silenced developmental genes, 
such as Tal1, Pou4f1, Wt1, Hoxa7, and Hoxd8, exhibited upregulation in the 
Dnmt3aΔ/D329A hypothalamus.  
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Figure 4.5. Expression of Dnmt and Tet family genes. Abundance of Dnmt and Tet 
gene transcripts in RNA-seq data from female adult hypothalamus. Two-tailed t-test was 
used with Bonferroni-corrected p-value<0.05 significance cut-off. ns.: not significant. 
 
 
Figure 4.6. Differential gene expression. Volcano plot showing gene expression fold 
change and its significance between Dnmt3a+/+ and Dnmt3a/D329A adult hypothalamus. 
Differentially expressed genes were determined using DEseq (p<0.01, Benjamini-
Hochberg multiple comparisons correction). Selected genes showing the most significant 
and highest fold change are named. Colour denotes the status of a gene change in 
Dnmt3a/D329A. 
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Figure 4.7. Gene ontology analysis of differentially expressed genes. Only significant 
terms are shown. Benjamini-Hochberg corrected p-value <0.01 was used as a threshold.  
 
GO analysis did not find a significant enrichment of any functional subgroup within the 
downregulated genes. However, amongst those with decreased expression was the Ghsr 
gene, which encodes a growth hormone secretagogue receptor found in the hypothalamus 
and pituitary. It is activated by the circulating hormone ghrelin, which promotes a positive 
energy balance. Ghrelin stimulates food intake, increases adipogenesis and fatty acid 
storage, while decreasing energy expenditure (Mihalache et al., 2016). Ghsr-/- mouse 
show slightly but not significantly lower body weight than wild-type (Sun et al., 2008), 
suggesting decreased expression of this receptor could contribute to the growth 
phenotype, but is unlikely to be the key player. 
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4.3 Summary and discussion 
Mice carrying a mutant Dnmt3aD329A allele show a significant postnatal reduction in body 
weight. Growth restriction can also be observed in Dnmt3a+/D329A mice and presence of 
the wild-type allele does not rescue the phenotype, suggesting the D329A mutation has a 
dominant effect. The levels of GH and IGF-I were not significantly different between the 
genotypes; therefore, the cause of this defect is unlikely to be hormonal. Transcriptional 
analysis of adult hypothalamus unexpectedly showed transcriptional regulators as the key 
group with differential expression, namely, upregulation. 
DNMT3A is known to be involved in regulation of growth, as de novo germline mutations 
in humans are found in Tatton-Brown-Rahman syndrome (TBRS, DNMT3A-overgrowth 
syndrome) (Tatton-Brown et al., 2014). Patients present with tall stature, macrocephaly 
and intellectual disability. Approximately 50 different mutations have been found in 
TBRS patients, varying from frameshift, missense, indels, stop-gain and whole gene 
deletions and similarly distributed across the whole protein: in intrinsically disordered N-
term domain, PWWP domain, ADD domain and MTase domain (Tatton-Brown et al., 
2018). Dnmt3a+/- heterozygous mice were originally described as being viable, fertile and 
having no immediately noticeable phenotype (Okano et al., 1999). A heterozygous 
Dnmt3a model has been recently revisited and a resemblance to TBRS was identified; 
with mice showing overgrowth tendencies and behavioural phenotypes (Christian et al., 
2020). Nonetheless, these phenotypes had an adult-onset and the dosage effect appears to 
be stronger in humans. 
Gain-of-function mutations in DNMT3A were discovered in three subjects with 
microcephalic dwarfism (Heyn et al., 2019). The mutations are located to the region 
orthologous to D329A in mouse and resulted in microcephalic dwarfism and growth 
restriction. The authors went on to generate a mouse model carrying the W326R mutation, 
which is only two amino acids away from the one described in this thesis. Similarly, both 
our and their mouse models recapitulate growth restriction observed in humans. Patients 
were also tested for GH and IGF-1 levels, which were not affected, in agreement with my 
findings in Dnmt3aD329A mice. They also found that the brain weight was significantly 
lower in Dnmt3a+/W326R mice. This was not investigated in Dnmt3aD329A mice.  
One key difference between human DNMT3A-PWWP and Dnmt3aD329A mouse 
pathologies was the onset of growth restriction; while in mice it manifested postnatally, 
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in patients with DNMT3A-PWWP mutations growth restriction was evident in utero 
(Heyn et al., 2019). Meanwhile, in 84% of TBRS patients, the overgrowth symptom is 
postnatal, similarly as observed in our Dnmt3aD329A mouse model. This parallel indicates 
that DNMT3A might have a significant role in regulation of growth in mammals, but 
some differences in timing exist between mice and humans. Overall, findings in 
DNMT3A-associated pathology suggest that loss-of function mutations in DNMT3A lead 
to overgrowth, while gain-of-function mutations lead to growth restriction phenotypes, 
both in humans and mice, although the mechanism by which DNMT3A is involved in 
this regulation remains unclear. 
Analysis of transcription in hypothalamus showed very few misregulated genes, given 
the extent of the phenotype. As a technical limitation, this could be attributed to a highly 
heterogeneous cell population in the hypothalamus. Based on transcriptomic patterns, 
adult mouse hypothalamus has 45 different cell type clusters, of which 34 are neuronal 
(Chen et al., 2017). Therefore, the effects on expression changes in a subset of them could 
easily be masked by bulk assessment. Nonetheless, it was surprising to observe that the 
targets of altered transcription are normally silenced developmental transcription factors. 
It is likely that the phenotype is caused by multi-genic action, which makes it rather 
difficult to unpick direct causes. Developmental genes are activated in a tightly controlled 
spatiotemporal manner during development; the consequences of expression in an adult 
tissue could be detrimental. On the other hand, expression of these genes could be an 
indirect effect of DNMT3A on DNA methylation. It is possible that changes, such as loss 
or gain of DNA methylation, would alter the local chromatin environment and expression 
changes would be a consequence. This is further investigated in the next chapters.  
To sum up, here I show that presence of the Dnmt3aD329A allele causes a dominant 
postnatal growth retardation in mice. Affected mice do not have detectably altered GH or 
IGF-1 levels, nor do they have altered levels of the DNA methylation or demethylation 
machinery. The cause of the growth restriction phenotype might be related to the de-
repression of developmental regulator genes, which is observed in Dnmt3aD329A adult 
hypothalamus. 
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in adult tissues 
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In Chapter 4, I described the postnatal growth restriction phenotype found in mice 
carrying the D329A mutation in the Dnmt3a gene. These mice exhibit de-repression of 
developmental transcription factors in the hypothalamus. Since DNMT3A is a DNA 
methyltransferase, I wanted to assess whether the methylome of mice carrying the D329A 
mutation is intact and whether changes in DNA methylation could be linked to altered 
gene expression.  
5.1 DNA methylation in Dnmt3aD329A mice 
Genome-wide methylome maps were generated by PBAT sequencing in adult (14-week) 
hypothalamus from mice of all four genotypes to determine whether the D329A mutation 
had an impact on DNA methylation targeting by DNMT3A. Libraries were kindly 
generated by Elena Ivanova. Two to three replicates were generated per genotype. There 
were between 26.7 and 70.9 million reads per sample uniquely mapped and duplication 
rates varied between 3.6% and 6.4% (Table 7). All samples passed FastQC checks. 
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Table 7. Hypothalamus PBAT library details. 
Sample ID Duplication rate 
Uniquely mapped and deduplicated   
alignments (million) 
+/+_1 4.8% 41.9 
+/+_2 5.1% 62.8 
+/+_3 6.4% 46.8 
Δ/+_1 3.6% 26.7 
Δ/+_2 4.4% 34.3 
Δ/+_3 4.8% 39.2 
+/D329A_1 4.3% 58 
+/D329A_2 5.9% 70.9 
Δ/D329A_1 3.9% 39.5 
Δ/D329A_2 4.4% 42.5 
Δ/D329A_3 4.3% 42.5 
 
The genome was binned into 100CpG tiles, and only those with at least 10 CpGs covered 
were used in the analysis. The global DNA methylation levels were similar across the 
four genotypes, at 77.2%, 75.1%, 77.2% and 75% in Dnmt3a+/+, Dnmt3aΔ/+, 
Dnmt3a+/D329A and Dnmt3aΔ/D329, respectively (Figure 5.1). The 2.1% lower global DNA 
methylation level in Dnmt3aΔ/+ compared to Dnmt3a+/+ suggested a degree of 
haploinsufficiency. Similarly, Dnmt3aΔ/D329 showed a 2.2% lower global methylation 
compared to Dnmt3a+/D329A, suggesting ~2% of the genome-wide DNA methylation in 
the hypothalamus is sensitive to Dnmt3a dosage. Although global DNA methylation 
levels were so similar, PCA analysis showed spatial separation of samples (Figure 5.2). 
Replicates coming from the same genotype clustered together, but there was a distinct 
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separation of different genotypes. PC1 separation appeared to be driven by the presence 
of a mutant allele, whilst PC2 separation was likely driven by the number of alleles 
expressed. This effect was highly reproducible between animals. 
 
 
Figure 5.1. Global DNA methylation in adult mice hypothalamus. Colour denotes 
genotype, alleles indicate the status of Dnmt3a. Individual samples represent one mouse. 
100 CpG tiles were used. Kruskall-Wallis rank sum test using mean tile values for each 
genotype results in p-value <2.2e-16 and is significant for all post-hoc pairwise Wilcoxon 
rank sum tests. 
 
 
Figure 5.2. PCA analysis of hypothalamus samples. Colour denotes genotype. Alleles 
refer to Dnmt3a gene. 100 CpG tiles were used.  
 
The PWWP domain of DNMT3A was predicted to target regions of H3K36me3 over the 
genome; the D329A mutation ablated this interaction in vitro (Dhayalan et al., 2010). 
Since the PCA plot indicated that samples with the D329A mutation had a distinct 
The role of the PWWP domain in the DNA methyltransferase 3A targeting to the genome 
74  Gintarė Sendžikaitė - 2021 
methylome, I hypothesised that the D329A mutation would result in loss of DNA 
methylation over H3K36me3 domains. Since actively transcribed genes bodies are 
marked by H3K36me3, and hypothalamus RNA-seq datasets were available (Chapter 5), 
I started this investigation by looking at gene bodies. First, I assigned genes to four 
categories based on gene expression levels: non-expressed (log2(RPKM) < 0), low-
expressed (0 < log2(RPKM) <1), mid-expressed (1 < log2(RPKM) <3), high expressed 
(log2(RPKM)>3); and then examined levels of DNA methylation over these domains. The 
levels of DNA methylation could be attributed to the global methylation differences 
observed across genotypes, which were not associated with gene expression pattern. 
Independently of their expression status or mouse genotype, gene bodies had relatively 
high DNA methylation of more than 68% (Figure 5.3). Within expression classes, the 
variation in mean methylation between genotypes was never more than 3.2%. Similar to 
the observed effect at the level of global DNA methylation, Dnmt3a+/+ and Dnmt3a+/D329A 
samples had approx. 2% lower DNA methylation than Dnmt3aΔ/+ and Dnmt3aΔ/D329A, 
respectively.  
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Figure 5.3. Gene body DNA methylation levels. DNA methylation levels over A. non-
expressed, B. low-expressed, C. mid-expressed, D. high-expressed gene bodies. 
Definition of expression level is as follows: non-expressed:  log2(RPKM) < 0; low-
expressed:  0 < log2(RPKM) <1; mid-expressed: 1 < log2(RPKM) <3; high-expressed: 
log2(RPKM)>3. Alleles indicated refer to Dnmt3a gene. Kruskall-Wallis rank sum test 
results in p-value <2.2e-16 and is significant for all post-hoc pairwise Wilcoxon rank sum 
tests. The only exceptions are in pairs of C. Dnmt3aΔ/+ and Dnmt3aΔ/D329A Wilcoxon rank 
sum test p-value=0.36 and D. Dnmt3a+/+ and Dnmt3a+/D329A Wilcoxon rank sum test p-
value=0.9. 
 
Next, I investigated DNA methylation over promoter regions, dividing them into those 
overlapping CGIs or not. Non-CGI promoters showed a pattern resembling global 
methylation trends, where Dnmt3a+/+ and Dnmt3a+/D329A had approximately 81.8% DNA 
methylation, and Dnmt3aΔ/+ and Dnmt3aΔ/D329A promoters had 2.2% lower DNA 
methylation (Figure 5.4a). However, at CGI promoters the pattern differed. Methylation 
of CGI promoters was bimodally distributed, with mean methylation of 38.7%, 36.9%, 
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40.4% and 39.9% in Dnmt3a+/+, Dnmt3aΔ/+, Dnmt3a+/D329A and Dnmt3aΔ/D329, 
respectively (Figure 5.4b).  
 
 
Figure 5.4. DNA methylation over promoter regions. Levels of DNA methylation over 
tiles overlapping A. non-CGI, and B. CGI promoters. Alleles refer to Dnmt3a gene, 
100CpG tiles were used. Kruskall-Wallis rank sum test results in p-value <2.2e-16 and is 
significant for all post-hoc pairwise Wilcoxon rank sum tests. The only exceptions are 
pairs of A. Dnmt3a+/+ and Dnmt3a+/D329A, and B. Dnmt3a+/D329A and Dnmt3aΔ/D329A, 
where Wilcoxon rank sum test p-value=0.19 and p-value=0.12, respectively. 
 
Higher mean DNA methylation levels at CGI promoter regions in mice carrying the 
D329A mutation was a rather unexpected finding. To further assess this, I used the edgeR 
differential methylation tool to identify genomic tiles with significantly different DNA 
methylation levels between Dnmt3a+/+ and Dnmt3aΔ/D329A samples. It identified 4,184 
differentially methylated genomic regions (DMRs) (p(adj)<0.01), which represent 
approx. 1% of the genome. Surprisingly, 87.5% of the DMRs were hypermethylated in 
Dnmt3aΔ/D329A hypothalamus in comparison to Dnmt3a+/+ (Figure 5.5). The level of DNA 
methylation over DMRs was consistent in all replicates, despite them originating from 
different mice (Figure 5.6). Identified hypermethylated DMRs were normally 
unmethylated, showing approx. 12% and 9.2% DNA methylation in Dnmt3a+/+ and 
Dnmt3aΔ/+ mice, respectively (Figure 5.6a), and methylated at an average level of 37.7% 
and 47.5% in Dnmt3a+/D329A and Dnmt3aΔ/D329A, respectively. Hypomethylated DMRs, on 
the other hand, were relatively highly methylated at approx. 73.1% in Dnmt3a+/+ and 63% 
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in Dnmt3aΔ/+ hypothalamus, and showed a lower DNA methylation of 68.1% in 
Dnmt3a+/D329A and 52.4% in Dnmt3aΔ/D329A hypothalamus (Figure 5.6b). 
 
 
Figure 5.5. DNA methylation differences in Dnmt3a+/+ compared with Dnmt3a/D329A 
hypothalamus. Scatterplot showing correlation of methylation levels of individual 100-
CpG tiles between and Dnmt3a/D329A hypothalamus. Differentially methylated probes 
were determined using the edgeR proportion statistic in SeqMonk (p<0.01 corrected for 
multiple comparisons using Benjamini-Hochberg, methylation difference ≥20%). Pie-
chart indicates how many of DMRs are hyper- or hypo- methylated in Dnmt3a/D329A. 
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Figure 5.6. DNA methylation levels at DMRs in individual hypothalamus samples. 
Beanplots showing reproducible DNA methylation changes over (a) hyper- and (b) hypo- 
DMRs in 14-week adult male hypothalamus across four different genotypes. Each plot 
represents an individual mouse. Hypo: hypomethylated, hyper: hypermethylated, DMR: 
differentially methylated region. 100CpG tiles were used. Kruskall-Wallis rank sum test 
using mean tile values for each genotype results in p-value <2.2e-16 and is significant for 
all post-hoc pairwise Wilcoxon rank sum tests. 
 
In order to dissect whether differential methylation was caused by the different number 
of Dnmt3a alleles or the D329A mutation, the edgeR tool was used to compare Dnmt3a+/+ 
and Dnmt3aΔ/+, and Dnmt3aΔ/+ and Dnmt3aΔ/D329A samples. As predicted, comparison of 
Dnmt3a+/+ and Dnmt3aΔ/+ yielded 351 DMRs, of which 328 were hypomethylated in 
Dnmt3aΔ/+ hypothalamus (Figure 5.7a). In contrast, comparison of Dnmt3aΔ/+ and 
Dnmt3aΔ/D329A samples, yielded 4603 DMRs, of which 4515 were hypermethylated 
(Figure 5.7b). These findings suggest that the hypermethylated DMRs are associated with 
the mutant Dnmt3aD329A allele, while hypomethylated DMRs are linked to the number of 
Dnmt3a alleles and are a result of haploinsufficiency.   
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Figure 5.7. DNA methylation changes in adult hypothalamus between different 
genotypes. Scatterplots showing correlation between methylation levels of 100-CpG tiles 
in hypothalamus of A. Dnmt3a+/+ and Dnmt3a/+ and B. Dnmt3a/+ and Dnmt3a/D329A. 
Differentially methylated tiles were determined using EdgeR (p<0.01 corrected for 
multiple comparisons using Benjamini-Hochberg, methylation difference ≥20%). The 
pie-chart indicates the number of DMRs identified. 
 
5.2 Link between DNA methylation and gene expression changes 
Many genomic DMR tiles were found to be adjacent to each other and some covered areas 
spanning promoters or whole genes (Figure 5.8). Therefore, I set out to understand 
whether the changes in DNA methylation caused changes in gene expression found in 
Chapter 3. DEG regions were separated based on gene expression change, promoter and 
gene body DNA methylation and clustered to identify any patterns. Only approx. 20% 
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misregulated genes were linked to changes in DNA methylation, independently of 
whether they were up- or down-regulated in mutant mice, suggesting that a substantial 
proportion of DEGs may be attributable to indirect, downstream effects of direct targets.  
 
 
Figure 5.8. Genome browser views of representative genes that gain methylation. A., 
B., and C., show three representative affected loci. Methylation profiles for hypothalamus 
for each Dnmt3a genotype are shown. Each block, colour-coded for methylation value, 
represents a 100-CpG tile. Error bars indicate standard deviation. For the mRNA tracks, 
red indicates genes transcribed from left to right and blue indicates genes transcribed from 
right to left. 
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Amongst those genes with altered DNA methylation, two main groups could be identified 
using Euclidean clustering analysis: hypomethylated and hypermethylated promoter 
clusters (Figure 5.9 and Figure 5.10). These were evident in both upregulated and 
downregulated gene sets. Interestingly, almost all genes with hypermethylated promoters  
showed gain of DNA methylation over the gene body too (Figure 5.9, Figure 5.10, Figure 
5.11 and Figure 5.12). This cluster contained the same developmental transcription factor 
genes that are normally strongly repressed in adult hypothalamus, but which are 
paradoxically derepressed in Dnmt3aΔ/D329A (e.g., Hoxa7, Hoxd8, Pou4f1, Tal1 and Wt1). 
This effect was weaker in the downregulated gene set. Genes with hypomethylated 
promoters did not show much change in gene body methylation. 
Overall, a broad gain of DNA methylation over the gene could result from increased 
expression if the promoter remained relatively unmethylated, as was the case for Pou4f1 
(Figure 5.13a), or when the promoter was methylated as well, as for Lxh9 (Figure 5.13b). 
Conversely, the Ghsr gene, which had a methylated gene body in Dnmt3a+/+, gained DNA 
methylation over the promoter region and showed decreased expression (Figure 5.13c). 
Taken together, these findings suggest that the Dnmt3aD329A allele is a driver of aberrant 
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Figure 5.9. Methylation changes over promoters and gene bodies of upregulated 
DEGs. Net methylation differences between Dnmt3a+/+ and Dnmt3a/D392A were 
quantified over promoters and gene bodies. Promoter probes within 1kb distance were 
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Figure 5.10. Methylation changes over promoters and gene bodies of downregulated 
DEGs. Net methylation differences between Dnmt3a+/+ and Dnmt3a/D392A were 
quantified over promoters and gene bodies. Promoter probes within 1kb distance were 
merged. Clustering was performed using the Euclidean complete method. 
 
 
Figure 5.11. DNA methylation trendplot over upregulated genes.  Aggregated 
methylation levels over upregulated gene clusters showing hyper- and hypo- methylated 
promoters, marked in Figure 5.9. TSS: transcription start site, TTS: transcription 
termination site. Distance over gene is relative. 
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Figure 5.12. DNA methylation trend over downregulated genes. Aggregated 
methylation levels over upregulated gene clusters showing hyper- and hypo- methylated 
promoters, marked in Figure 5.10. TSS: transcription start site, TTS: transcription 
termination site. Distance over gene is relative. 
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Figure 5.13. Genome browser views of regions with altered gene expression and 
differential methylation. Genome browser views from of the: A. Pou4f1 locus that is 
de-repressed and exhibits methylation gain over the gene body; B. Lhx9 locus that is 
upregulated and exhibits methylation gain over both gene body and promoter region; C. 
Ghsr locus that is downregulated and exhibits methylation gain over the promoter region. 
Each coloured block represents a 500bp with 50bp step. Raw sequencing reads are shown. 
For RNA-seq the colour indicates direction, where red is a forward read and blue is a 
reverse; libraries were prepared using opposite-strand specific kit. For methylation, red 
means a methylated call and blue means an unmethylated call, each point indicating an 
individual C in CpG context. For the mRNA tracks, red indicates genes transcribed from 
left to right and blue indicates genes transcribed from right to left.  
 
5.3 Aberrant DNA methylation is present in multiple tissues 
In order to understand whether abnormal gain of DNA methylation is specific to 
hypothalamus, I set out to assess other tissues. The pituitary gland was selected for two 
reasons; it is involved in the growth regulatory axis in the brain but structurally is a 
separate region from hypothalamus. In addition to pituitary, liver was selected as a very 
homogeneous tissue, outside of the brain. PBAT libraries were generated for pituitary and 
liver. Three replicate libraries from liver tissue were generated per genotype. Elena 
Ivanova kindly generated two to three replicate libraries per genotype from pituitary 
tissues. The range of duplication was 4.4%-11.1% and 4.4-18.2% in pituitary and liver 
PBAT libraries, respectively (Table 8 and Table 9). All libraries passed FastQC checks. 
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Table 8. Pituitary PBAT library details. 
Sample ID Duplication rate 
Uniquely mapped 
deduplicated reads (million) 
+/+_1 6.9% 24.7 
+/+_2 6.4% 16.2 
+/+_3 9.3% 25 
Δ/+_1 11.1% 50.1 
Δ/+_2 7.1% 23 
Δ/+_3 8.9% 25 
+/D329A_1 10.2% 48.6 
+/D329A_2 10.2% 30 
Δ/D329A_1 4.4% 16.3 
Δ/D329A_2 5% 15.1 
Δ/D329A_3 6% 15.3 
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Table 9. Liver PBAT library details. 
Sample ID Duplication rate 
Uniquely mapped deduplicated 
reads (million) 
+/+_1 17.2% 40.2 
+/+_2 9.3% 38.2 
+/+_3 16.9% 35.4 
Δ/+_1 5.6% 40.9 
Δ/+_2 4.8% 35.2 
Δ/+_3 4.6% 39.3 
+/D329A_1 5.1% 39.1 
+/D329A_2 5.6% 40.9 
+/D329A_3 9.1% 34.9 
Δ/D329A_1 4.4% 36.7 
Δ/D329A_2 9.6% 38.3 
Δ/D329A_3 18.2% 37.43 
 
Pituitary PBAT libraries of Dnmt3a+/+ and Dnmt3aΔ/D329A were sequenced first and had a 
depth of 15.1-24.7 million reads per sample (Table 8). When heterozygous samples were 
added, their sequencing depth ranged between 23-50.1 million reads per sample, and 
therefore were down-sampled during analysis to match the mean number of reads in 
Dnmt3a+/+ and Dnmt3aΔ/D329A. Since the coverage was lower than usual, 300-CpG 
genomic tiles were used to assess DNA methylation levels in pituitary. Liver PBAT 
libraries were sequenced to the depth of 34.9-40.9 million reads per sample (Table 9). For 
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simplicity of later comparisons across tissues and different developmental stages, liver 
DNA methylation analysis showed here was also done using 300 CpG tiles.  
Similar to hypothalamus, global DNA methylation levels in both pituitary gland and liver 
showed barely any difference across the four genotypes (Figure 5.14). The global DNA 
methylation levels in pituitary were at 70.0%, 68.3%, 71.2% and 70.1% in Dnmt3a+/+, 
Dnmt3aΔ/+, Dnmt3a+/D329A and Dnmt3aΔ/D329, respectively. In liver, they were at 71.8%, 
70.4%, 71.5% and 69.9% in Dnmt3a+/+, Dnmt3aΔ/+, Dnmt3a+/D329A and Dnmt3aΔ/D329, 
respectively. PCA analysis showed that individual replicates of the same genotype 
clustered together, but were spatially separated based on the genotype (Figure 5.15). This 
was true for both liver and pituitary, suggesting that within genotype, global methylomes 
are very reproducible but there are genotype-associated differences. 
 
 
Figure 5.14. Global DNA methylation in pituitary and liver. Beanplots indicating 
whole genome methylation levels in A. pituitary and B. liver of adult male mice carrying 
the alleles shown. Tiles of 300 CpG positions were used. Kruskall-Wallis rank sum test 
results in p-value <2.2e-16 and is significant for all post-hoc pairwise Wilcoxon rank sum 
tests, with exception of A. pair Dnmt3aΔ/+ and Dnmt3aΔ/D329A, where p-value=0.17. 
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Figure 5.15. PCA plots for global DNA methylation in pituitary and liver. Colour 
denotes genotype, alleles of Dnmt3a are listed. Tiles of 300 CpGs were used, each dot 
represents an individual mouse. 
 
As in previous analysis, the edgeR tool was used to identify tiles showing differential 
methylation between Dnmt3a+/+ and Dnmt3aΔ/D329A in the pituitary and liver. In total, 696 
genomic tiles were found to be hypermethylated and 323 genomic tiles were 
hypomethylated in pituitary (Figure 5.16a); meanwhile, 210 tiles were hypermethylated 
and 78 tiles were hypomethylated in liver (Figure 5.16b). Comparison of Dnmt3aΔ/+ and 
Dnmt3aΔ/D329 in pituitary found 878 hypermethylated DMRs and only 43 hypomethylated 
DMRs (Figure 5.17c). In liver samples, the same comparison yielded 312 
hypermethylated DMRs and only 5 hypomethylated DMRs (Figure 5.16d). These 
findings mirrored those in hypothalamus, and indicated that an aberrant gain of DNA 
methylation, caused by presence of the D329A mutation, is also found in other tissues. 
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Figure 5.16. DNA methylation differences in liver and pituitary tissues. Scatterplots 
showing correlation between methylation levels of individual 300-CpG tiles between 
Dnmt3a+/+ and Dnmt3a/D329A in adult male A. pituitary and B. liver, and between 
Dnmt3a/+ and Dnmt3a/D329A in C. pituitary and D. liver. Differentially methylated tiles 
were determined using the EdgeR proportion statistic in SeqMonk (p<0.01 corrected for 
multiple comparisons using Benjamini-Hochberg, methylation difference ≥20%). Pie-
chart insets indicate how many of DMRs are hyper- or hypo- methylated.  
 
Out of 600 hypomethylated DMRs originally identified in the hypothalamus, 47 were also 
found in pituitary, 16 were also found in liver, and only 6 were found in all three tissues 
(Figure 5.17). In contrast, less than half of hypermethylated DMRs were specific to 
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hypothalamus. Out of 3,586 hyper-DMRs, 1364 were shared with pituitary, 94 were 
shared with liver, and 534 were shared between all three tissues.  
These findings indicate that aberrant methylation gain could be a result of targeted action, 
rather than random. The overlap of hypermethylated DMRs across three different tissues 
strongly implied that aberrant gain of DNA methylation could be an early event during 
embryonic development, prior to tissue differentiation and specification. 
 
 
Figure 5.17. Overlap of DMRs in hypothalamus, pituitary and liver. Pie charts 
showing how many hypo- and hyper- methylated tiles in hypothalamus overlapped the 
corresponding differentially methylated tiles in pituitary, liver or both. 
 
5.4 DNA methylation gain is progressive in postnatal 
development 
After fertilisation, DNA methylation patterns of terminally differentiated oocyte and 
sperm cells are largely erased, and are followed by a major phase of epigenetic 
programming, including DNA methylation, at the period of E4.5-E6.5 (Figure 1.2) (Smith 
et al., 2012). This is associated with gain of multipotent capacity, required to build 
different tissues during development. To address the possibility that aberrant methylation 
was established during this phase of embryonic remethylation, E7.5 mouse epiblasts (Epi) 
were kindly collected by Jessica Elmer and Wendy Dean from embryos of all four 
genotypes. E7.5 should correspond to a developmental stage by which the genome is 
globally remethylated. Four replicates per genotype, each representing a single epiblast, 
were used to generate PBAT libraries. Duplication rates in these libraries were in the 
range of 24.8-88.4% and they had sequencing depth of 4.8-27.6 million uniquely mapped 
reads (Table 10). All libraries passed FastQC checks. 
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Table 10. E7.5 epiblast PBAT library details. 
Sample ID Duplication rate 
Uniquely mapped 
reads (million) 
+/+_1 68.1% 11.9 
+/+_2 36.6% 24.9 
+/+_3 48.9% 19.5 
+/+_4 25.7% 25 
Δ/+_1 41.4% 20.5 
Δ/+_2 58.5% 15.4 
Δ/+_3 49% 16.9 
Δ/+_4 41% 21.4 
+/D329A_1 75% 7.5 
+/D329A_2 35.5% 18.6 
+/D329A_3 61.3% 16.8 
+/D329A_4 88.4% 4.8 
Δ/D329A_1 24.8% 27.6 
Δ/D329A_2 28% 24.5 
Δ/D329A_3 55.5% 20 
Δ/D329A_4 63.7% 5.5 
 
Individual embryos showed comparable but rather variable levels of global DNA 
methylation, mean level per group was at 77.7%, 77.7%, 74.6% and 74.7%, in Dnmt3a+/+, 
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Dnmt3aΔ/+, Dnmt3a+/D329A and Dnmt3aΔ/D329 epiblasts, respectively. Global methylation 
was more variable in Dnmt3a+/D329A and Dnmt3aΔ/D329A embryos than in Dnmt3a+/+ and 
Dnmt3aΔ/+ (Figure 5.18). PCA showed no separation of samples based on the genotype, 
with exception of two, which corresponded to samples showing lowest global DNA 
methylation within D329A carriers (Figure 5.19a). Pearson distance and pairwise 
correlation assessment showed that the samples were correlating quite closely and did not 
separate based on the genotype (Figure 5.19b, Figure 5.19c). The only outliers, again, 
were those with the D329A mutation and low global DNA methylation. This analysis 
suggested that the variation observed is stochastic rather than specific and could be 
attributable to developmental timing. It is possible that individuals with Dnmt3aD329A 
alleles had a delay in methylation completion in comparison to the wild-type. 
 
 
Figure 5.18. Global DNA methylation in E7.5 epiblast. Beanplots indicating whole 
genome methylation levels assessed over in individual E7.5 epiblasts of different 
genotypes. Tiles of 300CpG positions were used. Kruskall-Wallis rank sum test using 
mean tile values for each genotype results in p-value <2.2e-16 and is significant for all 
post-hoc pairwise Wilcoxon rank sum tests. 
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Figure 5.19. E7.5 DNA methylation similarity across samples. A. A PCA plot showing 
clustering of the majority of the individual E7.5 epiblasts together. B. A data similarity 
tree indicating Pearson correlation distances between individual samples. C. A matrix 
showing pairwise Pearson correlation values for individual sample pairs. 
 
On average, DNA methylation levels over genomic features, such as promoters, gene 
bodies and intergenic regions, were lower in Dnmt3a+/D329A and Dnmt3aΔ/D329A embryos, 
compared to Dnmt3a+/+ and Dnmt3aΔ/+ (Figure 5.20). Interestingly, at CGI promoters 
DNA methylation levels were also lower in Dnmt3aΔ/+ samples. The edgeR tool was used 
to identify genomic regions sensitive to wild-type allele dosage at E7.5 and identified 136 
DMRs (0.13% of the genome). All but two DMRs overlapped a CGI, suggesting that at 
this embryonic stage the susceptibility to dosage is rather specific to areas of high CpG 
density. Meanwhile, comparison of Dnmt3a+/+ and Dnmt3aΔ/D329A embryos found only 5 
DMRs (0.005% of the genome), all of which were hypomethylated. These findings 
suggested that the aberrant DNA methylation observed in multiple adult tissues was not 
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established during the major epigenetic programming event in early embryonic 
development. 
 
Figure 5.20. DNA methylation in E7.5 embryos over genomic features. DNA 
methylation levels in E7.5 epiblast at A. non-CGI promoters, B. CGI promoters, D. gene 
bodies, and D. intergenic regions. Kruskall-Wallis rank sum test results in p-value <2.2e-
16 and is significant for all post-hoc pairwise Wilcoxon rank sum tests. The exceptions 
are pairs B. Dnmt3aΔ/+ and Dnmt3aΔ/D329A, where p=0.98, C. Dnmt3a+/+ and Dnmt3aΔ/+, 
and Dnmt3a+/D329A and Dnmt3aΔ/D329A, where p=0.38 and p=0.55, respectively, D. 
Dnmt3a+/D329A and Dnmt3aΔ/D329A, where p= 0.068. 
 
Hypothalamic neurons undergo further epigenetic modelling during postnatal maturation 
(Li et al., 2014), and so it is possible that aberrant gain of methylation occurred later 
during brain development. To understand whether hypermethylated domains are a result 
of brain-specific epigenetic events, hypothalami of Dnmt3a+/+ and Dnmt3aΔ/D329A mice 
were collected at postnatal day 1 (P1) and day 25 (P25), and PBAT libraries generated 
from individual hypothalami. Since the intention was to check the levels of DNA 
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methylation over hypermethylated domains, only two replicates for each Dnmt3a+/+ and 
Dnmt3aΔ/D329A genotype were collected. Libraries had duplication levels ranging from 
1.8-2.8% and 17.1-54.2 million uniquely mapped reads, they all passed FastQC checks. 
 
Table 11. P1 and P25 hypothalami PBAT library details. P1 – postnatal day 1, P25 – 
postnatal day 25. 
Sample ID Duplication rate 
Uniquely mapped 
reads (million) 
P1_+/+_1 1.8% 18.9 
P1_+/+_2 2.4% 54.2 
P1_Δ/D329A_1 2.4% 35.5 
P1_Δ/D329A_2 1.9% 17.1 
P25_+/+_1 2.50% 36.3 
P25_+/+_2 2.8% 41.3 
P25_Δ/D329A_1 3% 51.9 
P25_Δ/D329A_2 2% 21.2 
 
Together with E7.5 and adult data, I focussed on domains that are destined to be 
hypermethylated in Dnmt3aΔ/D329A adult mice. Dnmt3aΔ/D329A E7.5 epiblast was 
indistinguishable from Dnmt3a+/+ (Figure 5.21 and Figure 5.22). Meanwhile, at P1, a gain 
of DNA methylation could be observed at hyper-DMR regions in Dnmt3aΔ/D329A samples. 
At P25 the methylation increase in hyper-DMRs of Dnmt3aΔ/D329A samples was almost as 
high as observed in adult hypothalamus. The gain appeared to be evenly distributed over 
larger domains spanning multiple DMRs (Figure 5.23). These data suggest that DNA 
methylation gains are progressive throughout development. Furthermore, they are likely 
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to be established in all tissues independently, which would also explain why not all 
hypermethylated tiles are shared by hypothalamus, pituitary and liver.  
 
 
Figure 5.21. DNA methylation changes during development. Beanplots indicating 
DNA methylation levels over A. hyper- and B. hypo- methylated DMRs across 
development in Dnmt3a+/+ and Dnmt3a/D329A animals. Tiles were quantified over adult 
hypothalamus DMRs, which were merged if the distance was less than 1kb.  
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Figure 5.22. DMR heatmap during development. Heatmap showing methylation gain 
at DMRs over time. Shown are 1915 300-CpG tiles, overlapping DMRs identified 
between Dnmt3a+/+ and Dnmt3a/D329A in adult (14-week) hypothalamus. DMRs are 
clustered based on Euclidean method, on the basis of smallest absolute difference between 
quantitation values.  
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Figure 5.23. Genome browser view of progressive DNA gain during development. 
Genome browser view of the Hoxd gene cluster indicating progressive gain across the 
whole domain. For gene and mRNA tracks, the colour indicates direction, where red is a 
forward strand and blue is a reverse strand. Colour-coded blocks indicate tiles of 300-
CpG positions. Error bars indicate standard deviation.  
 
5.5 Hypermethylated loci are enriched in developmental 
transcription factor genes  
In order to understand why and how aberrant methylation is established by 
DNMT3AD329A in the genome, I aimed to identify the unifying feature of these genomic 
regions. Previously, it was observed that many hypermethylated DMRs fell within large 
normally unmethylated genomic regions (Figure 5.24), and CGI promoters had a higher 
DNA methylation in animals carrying the Dnmt3aD329A allele. To further investigate this, 
DMR tiles were separated based on the genomic features, namely promoter, gene body, 
and intergenic regions, they overlapped. The features were additionally split into CGI-
containing or not. Since there were 3584 hypermethylated DMRs and 600 
hypomethylated DMRs, a randomly sampled list of 2000 non-DMR tiles was created as 
a representative of the genome. Surprisingly, I found that over 94.8% of hypermethylated 
domains overlapped CGI containing promoters, gene bodies, or intergenic regions, while 
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hypomethylated domains and random tiles overlapped CGI containing features only in 
20.3% and 7.25% of cases, respectively (Figure 5.25).  
 
 
Figure 5.24. Hoxd gene cluster showing gain of DNA methylation. Representative 
genome browser region showing the Hoxd hypermethylated domain. For gene and mRNA 
tracks, the colour indicates direction, where red is a forward strand and blue is a reverse 
strand. Colour-coded blocks are tiles of 100-CpG positions. Error bars indicate standard 
deviation.  
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Figure 5.25. DMR separation based on underlying features. Percentages of 
hypermethylated and hypomethylated tiles (100-CpG) falling within the genomic features 
indicated, compared with a random set of 100-CpG tiles. 
 
Given that 1) hyper-DMRs were enriched in CGIs, 2) a few developmental genes were 
abnormally methylated and had altered expression in Dnmt3aΔ/D329A hypothalamus, and 
3) hyper-DMR regions show very little DNA methylation in wild-type samples,  the 
findings suggested that abnormal DNA methylation might be targeted to the so-called 
methylation ‘valleys’ or ‘canyons’. Methylation canyons, highly conserved amongst 
vertebrates, are described as large, normally unmethylated, genomic regions, which 
harbour key developmental genes and are marked by H3K27me3, a histone modification 
established by the Polycomb complex (Jeong et al., 2014; Li et al., 2018).  
DNA methylation canyons were initially described in hematopoietic cells (Jeong et al., 
2014). To test the hypothesis that these domains are gaining aberrant DNA methylation 
in hypothalamus, I first looked at the DNA methylation valley annotation in 
hematopoietic stem cells. Out of the 1104 canyons originally defined, 779 were also 
unmethylated (<10% methylation) in Dnmt3a+/+ adult mouse hypothalamus. Comparison 
of DNA methylation levels across canyons in Dnmt3a+/+ and Dnmt3aΔ/D329A 
hypothalamus showed a dramatic gain of DNA methylation in the presence of the D329A 
mutation (Figure 5.26) and suggested these regions might be the target of mutant Dnmt3a. 
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Figure 5.26. DNA methylation levels over DNA methylation valleys. Distribution of 
methylation values over DNA methylation canyon probes in Dnmt3a+/+ and 
Dnmt3a/D329A mice. n = 779, Mann-Whitney Test (p <0.01, UA= 432773, z = -14.57).  
 
GO analysis was used to find gene groups overrepresented within hypo- and hyper- 
DMRs in Dnmt3aΔ/D329A animals. I found that hyper-DMRs were highly significantly 
enriched in genes encoding transcription factor/regulator activity, DNA binding, 
morphogenesis and differentiation genes. Hypo-DMRs were also enriched for 
morphogenesis and transcription factor/regulator activity genes, but to a lower 
significance (Figure 5.27). GO analysis of genes showing hypermethylation in 
hypothalamus, pituitary and liver showed the same GO terms being enriched, suggesting 
the same category of genomic loci is targeted in the different tissues as well (Figure 5.28). 
This further supported the prediction that differential methylation is targeted to DNA 
methylation valleys. 
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Figure 5.27. GO analysis of hypothalamus DMRs. GO analysis of genes overlapping 
differentially methylated tiles. Unless there were less significant terms, the top 24 most 
significant terms per category are shown. Benjamini-Hochberg corrected p-value <0.01 
was used as a threshold.  
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Figure 5.28. GO analysis of hypermethylated DMRs shared between different 
tissues. Only genes overlapping hypermethylated tiles in hypothalamus, pituitary and 
liver were included. Top 25 most significant terms per category are shown. Benjamini-
Hochberg corrected p-value <0.01 was used as a threshold.  
 
5.6 Non-CpG methylation changes as evidence for altered 
DNMT3AD329A recruitment 
Non-CpG (CpH) methylation becomes particularly abundant in neural tissues, where it is 
established postnatally by DNMT3A (Lister et al., 2013; Varley et al., 2013; Xie et al., 
2012). Importantly, CpH methylation is not maintained at DNA replication, so its 
presence is a record of de novo methylation activity since the last replication event and is 
believed to be a signature of where DNMT3A was bound (Ramsahoye et al., 2000). Thus, 
using the PBAT datasets, I investigated CpH methylation in adult hypothalamus as a read-
out of DNMT3A localisation and activity. Because of the abundance of CpH sites in the 
genome, I restricted the analysis to two representative autosomes, chromosomes 2 and 
11. CpH methylation levels showed strong evidence for haploinsufficiency at the 
molecular level. Global CpH methylation was 1.8% in Dnmt3a+/+ and 1.2% in Dnmt3aΔ/+ 
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(Figure 5.29a). Similarly, levels of CpH methylation in Dnmt3a+/D329A were at 1.6% and 
in Dnmt3aΔ/D329A at 0.9%. The smaller global reduction between Dnmt3a+/D329A and 
Dnmt3a+/+ and between Dnmt3aΔ/D329A and Dnmt3aΔ/+ suggests some decrease in 
methyltransferase activity by the mutant protein. Strikingly, however, the pattern over 
hypermethylated DMRs was reversed. In Dnmt3a+/+ CpH methylation at 
hypermethylated DMRs was 1.4% and in Dnmt3aΔ/+ it was 0.9%. In contrast, levels at 
Dnmt3a+/D329A and Dnmt3aΔ/D329A were 1.6% and 1.3%, respectively (Figure 5.29b).  
It is important to note that the Imprint DNA modification kit used to convert unmethylated 
cytosines to uracil has approximately 99% conversion rate. This means that non-CpG 
methylation levels reported here are close to expected 1% non-conversion rate. While the 
values should not be considered as a net quantitative read-out, the relative levels of non-
conversion should be the same in all samples, and therefore the differences observed 
between the genotypes is likely to be real. This difference is clearly visible when assessing 
the samples in the genome browser (Figure 5.30). Comparison of relative CpH 
methylation across pre- and postnatal development showed that this effect first becomes 
evident in the P1 hypothalamus (Figure 5.29c). In summary, these data demonstrate that 
activity of the DNMT3AD329A protein is aberrantly localised preferentially to 
hypermethylated DMRs in the postnatal brain.   
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Figure 5.29. CpH DNA methylation.  A. Global mean CpH methylation values across 
different genotypes, B. Mean CpH methylation values over hypermethylated DMR 
regions. Error bars indicate standard error of the mean. Pairwise comparisons were done 
using a two-tailed t-test. C. Barplot indicating the net difference in mean CpH methylation 
between hyper-DMRs and global levels for Dnmt3a+/+ and Dnmt3a /D329A mice across 
development (E7.5 epiblast, P1, P25 and adult hypothalamus). 1000-CpH tile quantitation 
for chromosome 2 and 11 was used as representative. 
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Figure 5.30. Genome browser view of CpH methylation. Representative genome 
browser view of CpH methylation in adult male hypothalamus. Methylation levels appear 
to be dependent on the number of alleles present, with a decrease observed in Dnmt3a∆/+ 
compared to Dnmt3a+/+. Notably, there is an increase of methylation over hyper-DMR 
regions (highlighted by the box) in the presence of Dnmt3aD329A. Each bar represents a 
1000-CpH tile. For gene and mRNA tracks, the colour indicates direction, where red is a 
forward strand and blue is a reverse strand. Error bars indicate standard deviation.  
 
5.7 Summary and discussion 
In this chapter, I show that while most of the global DNA methylation in Dnmt3aD329A 
adult hypothalamus is similar to wild-type, approx. 2% of the genome shows aberrant 
gain of DNA methylation. The targets of this gain are DNA methylation valleys, where 
many developmental transcription factor genes are located. Some, but not all, of those 
transcription factors show altered gene expression levels associated with DNA 
methylation gain. Aberrant DNA methylation can be observed in multiple tissues and 
occurs progressively throughout development, as a result of differential localisation of 
DNMT3A to the genome.  
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The lack of DNA methylation changes over gene bodies appears to agree with findings 
by Baubec et al. (2015) in ESCs, where they find that it is DNMT3B but not DNMT3A 
localising to and methylating gene bodies. In Dnmt3aD329A E7.5 embryos, I observed a 
stochastic delay in de novo methylation, although it was not localised to particular 
genomic features. In adult tissues, however, I did not observe a loss of DNA methylation 
attributable to the D329A mutation and found no evidence that this mutation alters DNA 
methylation levels at gene bodies. There might be delays in embryonic development, or 
some genotype-unrelated developmental variation in the litters, meaning they are yet to 
complete genomic methylation at the time of collection. The number of replicates 
assessed does not allow to definitively distinguish the cause of lower DNA methylation 
in some samples. Importantly, these differences do not persist and may be recovered with 
time, or DNMT3B may be able to compensate during embryogenesis, supported by 
previous observations that DNMT3A and DNMT3B have partial redundancy in the post-
implantation embryo (Dahlet et al., 2020; Greenberg et al., 2017; Okano et al., 1999). 
The finding that the D329A mutation results in aberrant hypermethylation was somewhat 
unexpected, given the original hypothesis that this mutation is a loss-of-function. 
Nonetheless, the growth retardation found in Dnmt3a+/D329A and Dnmt3a/D329A, but not 
in Dnmt3a/+ , in Chapter 4 was an indication that it could be a gain-of-function, and DNA 
methylation patterns further confirm this hypothesis. Similarly to our observation, Heyn 
et al. (2019) found that human fibroblasts and peripheral blood leukocytes from patients 
with microcephalic dwarfism carrying an orthologous DNMT3A mutation exhibited gain 
of DNA methylation over developmental gene loci. Their mouse model with a W326R 
point mutation in the PWWP domain showed a similar molecular pattern. The fact that 
hypermethylated domains observed in both studies are rich in CGIs, transcription factor 
loci and located to DNA methylation valleys suggest that a particular chromatin 
environment might be recruiting mutant DNMT3A to these locations. Further work on 
this hypothesis can be found in Chapter 6.  
DNA methylation is traditionally considered to be a repressive mark at the promoter 
region, but here I see that gain of DNA methylation over genes can have multiple 
outcomes. I showed examples of it associated with decrease in expression and 
methylation increase over promoter, but also cases where DNA methylation over 
promoters coincided with increased expression. It is possible that some of these genes are 
harboured in DNA methylation valleys and are under a different control, such as that of 
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Polycomb repressive complexes (Li et al., 2018). In such cases, DNA methylation might 
be disrupting the normal repressive mechanisms in place and allow de-repression. Some 
of the genes show gain of DNA methylation over gene bodies, and in a similar 
observation, Hox genes were activated when DNA methylation was targeted to gene 
bodies within these regions in tumours (Su et al., 2018). Here, I found some examples of 
gain of DNA methylation across a large area but a ‘dip’ in DNA methylation over the 
promoter, which could potentially create space for required transcription factor binding 
to initiate expression. Another important consideration is homogeneity of the assessed 
tissue. Hypothalamus being a very heterogeneous tissue (Chen et al., 2017), it is unclear 
whether DNA methylation and transcriptional changes occur in the same cells, and what 
is the extent of their overlap.  
Consistently with the onset of the phenotype, hypermethylation was established 
postnatally by the DNMT3AD329A. Dnmt3a is expressed throughout pre- and postnatal 
development; in prenatal development, the predominant transcript isoform is Dnmt3a2, 
while in postnatal tissues it is Dnmt3a1 (Chen et al., 2002; Manzo et al., 2017). The only 
difference is that the longer isoform contains an N-term intrinsically disordered domain, 
although there are no studies linking the N-terminal disordered and PWWP domains in 
DNMT3A to date. Similarly, it might be the changing environment and transition from 
multipotency to a differentiated state in tissues that is facilitating mutant DNMT3A. 
Alternatively, Dnmt3b is very highly expressed throughout early prenatal development 
and is responsible for the majority of de novo methylation (Auclair et al., 2014). 
Therefore, in this context, the aberrant localisation of the mutant DNMT3A may be 
rescued by heterodimerisation with DNMT3B (Li et al., 2007b; Emperle et al., 2014).  
In summary, here I show that Dnmt3aD329A tissues exhibit progressive aberrant gain of 
DNA methylation at DNA methylation valleys due to altered DNMT3AD329A localisation. 
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In the previous chapter, I found that DNMT3AD329A preferentially localises to and 
methylates DNA methylation canyons, where many developmental transcription factor 
genes are located (Jeong et al., 2014; Li et al., 2018). The expression of these genes is 
controlled by the Polycomb repressive complex and they are marked by both activating 
H3K4me3 and silencing H3K27me3 marks, referred to as bivalent chromatin. This is 
thought to allow easy and well-controlled spatiotemporal activation and silencing 
depending on requirements in different tissues. Bivalent chromatin and DNA methylation 
tend to be mutually exclusive, and therefore I set out to test the hypothesis that the D329A 
mutation allows aberrant targeting of DNA methylation into these domains. 
6.1 Aberrant DNA methylation is targeted to H3K27me3 domains 
I hypothesised that DNMT3AD329A hypermethylated DMRs would be enriched in 
H3K4me3 and H3K27me3. To assess this, I generated H3K4me3, H3K27me3 and 
H3K36me3 chromatin immunoprecipitation-sequencing (ChIP-seq) datasets from adult 
hypothalamus (Appendix 2). Approx. 2.5% of a whole hypothalamus volume was used 
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for each immunoprecipitation and all pull-downs were done from the same chromatin. 
Three Dnmt3a+/+ and Dnmt3aΔ/D329A mice were used per genotype. 
To analyse ChIP-seq libraries, 2kb genomic tiles with 1 kb step were used and the reads 
were quantified correcting for total read count per million reads (RPKM values). First, I 
looked at the distribution of RPKM values for Dnmt3a+/+ input samples (Figure 6.1), and 
excluded tiles outside of the bell-shaped distribution area (i.e. >1.75 RPKM) in input 
samples. This way, genomic locations that show enrichment due to potential duplicate 
reads mapping over the same region are eliminated. Assessment of samples using Pearson 
correlation distance and PCA indicated that samples clustered strongly based on 
precipitated histone mark but not based on the genotype (Figure 6.2 and Figure 6.3). 
Assessment of cumulative distribution indicated that individual samples had similar 
distributions for the same mark, and had a strong enrichment of high value tiles at the top 
10% of distribution, while input, as expected, had a more even distribution of values 
(Figure 6.4).  
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Figure 6.1. ChIP-seq input sample genomic tile distribution. Histograms show the 
distribution of tile values in Dnmt3a+/+ input samples. 
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Figure 6.2. ChIP-seq library similarity tree. A data similarity tree indicating Pearson 
correlation distances between individual ChIP-seq samples, histone PTMs and genotypes 
are listed. 
 
Figure 6.3. PCA of ChIP-seq samples. PCA was done on 2kb tiles, with 1kb step. Each 
dot represents a replicate sample coming from an individual mouse, colour denotes the 
genotype.  
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Figure 6.4. Cumulative distribution plot for ChIP-seq datasets. Distribution of 
genomic tiles in different samples. The tiles are ranked from lowest to highest and indicate 
values found in different datasets at those distribution fractions.  
 
To see whether histone PTMs exhibited expected localisation in the genome, I assessed 
the patterns of PTM enrichment over all mRNAs. As predicted, H3K36me3 was enriched 
over mRNA body, H3K4me3 was strongly enriched at promoter regions, and H3K27me3 
was somewhat enriched at promoters but did not show any particular pattern related to 
mRNA genomic areas (Figure 6.5). Finally, I assessed the genomic landscape on the 
genome browser. I could clearly see that high H3K4me3 enrichment was located over 
promoter and TSS area (Figure 6.6). The associated genes had enrichment of H3K36me3 
over the gene body, suggesting they are actively expressed in hypothalamus. Some 
genomic locations showed bivalent trend and had both H3K4me3 and H3K27me3. 
Bivalent genes with relatively low H3K4me3 levels had a strong enrichment of 
H3K27me3, suggesting these genes are silenced. In general, initial assessment provided 
me with the confidence that ChIP-seq datasets are of good quality. 
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Figure 6.5. Trendplots showing histone PTM library patterns over mRNAs. 
Aggregated RPKM values for A. H3K36me3, B. H3K4me3, and C. H3K27me3 over all 
mRNAs ±2,500bp. Input samples are shown in all plots, in section B. input lines are 
indistinguishable from the x axis. Distance over mRNA is relative. 
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Figure 6.6. Genome browser view of ChIP-seq libraries. Representative genome 
browser view of adult male hypothalamus H3K4me3, H3K27me3, H3K36me3 and input 
datasets grouped per genotype. Each colour-coded block represents a 2kb window with 
1kb step size. For gene and mRNA tracks, the colour indicates direction, where red is a 
forward strand and blue is a reverse strand. Error bars indicate standard error of the mean. 
 
Globally, enrichment for H3K4me3, H3K36me3 and H3K27me3 marks was correlated 
highly between Dnmt3a+/+ and Dnmt3aΔ/D329A samples for all three histone marks, and I 
did not observe a marked shift in the distribution of these marks in the presence of the 
Dnmt3aD329A allele (Figure 6.7). When the distribution of hypo- and hyper-DMRs over 
histone modifications was assessed, there was little to no difference between the two sets 
of DMRs in H3K4me3 and H3K36me3 (Figure 6.8a and Figure 6.8c). However, hypo-
DMRs were found to overlap regions with low enrichment of H3K27me3, while hyper-
DMRs were overlapping areas with mid- and high H3K27me3 enrichment (Figure 6.8).  
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Figure 6.7. Distribution of histone PTM enrichment in hypothalamus. Scatterplots 
showing correlation between enrichments for the following histone modifications 
between Dnmt3a+/+ and Dnmt3a/D329A hypothalamus: A. H3K4me3; B. H3K27me3; C. 
H3K36me3. Tiles of 2kb with a step of 1kb were used for analyses. 
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Figure 6.8. Link between hypothalamus DMRs and histone PTMs. Scatterplots 
showing correlation between enrichments for A. H3K4me3; B. H3K27me3; C. 
H3K36me3 histone modifications between Dnmt3a+/+ and Dnmt3a/D329A hypothalamus 
with those overlapping hypothalamus DNA methylation DMRs colour based on their 
status. Tiles of 2kb with a step of 1kb were used for analyses. 
 
MACS peak caller was used to call peaks in H3K4me3, H3K27me3 and H3K36me3 
ChIP-seq datasets. Peaks are areas showing a clear histone modification enrichment in 
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comparison to surrounding chromatin. Hypothalamus DMRs were labelled based on 
which histone PTM peak they overlapped. The same random tile list was used as 
previously to represent general genome trends. I found that 70% of hyper-DMRs were at 
bivalent chromatin and an additional 26% at H3K27me3 (Figure 6.9), therefore 96% of 
all hypermethylated domains were marked by H3K27me3. Only 18.3% of 
hypomethylated and 19.45% of random tiles fell over bivalent and H3K27me3 marked 
chromatin. In contrast, only 1.8-2.1% of hypo- or hyper-DMRs overlapped the 




Figure 6.9. Hypothalamus DMR and histone PTM overlap. Percentages of 
hypermethylated and hypomethylated DMRs (100-CpG) which overlap bivalent 
(H3K4me3 and H3K27me3), H3K27me3 only, H3K4me3 only, H3K36me3 peaks or 
none. A random set of 2000 tiles (excluding DMR tiles) was used as a whole genome 
representative. Tiles that show overlap with H3K36me3 and H3K4me3 or H3K27me3 
were included in H3K36me3 group. Peaks were called using MACS peak caller in adult 
hypothalamus ChIP-seq. 
 
Aberrant DNA methylation targeting to methylation canyons marked by H3K27me3 
could be explained by two hypotheses. The first hypothesis would be that the D329A 
mutation ablates the recruitment of DNMT3A to H3K36me3, therefore leading to 
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redistribution of DNMT3AD329A to other random genomic regions. Subsequently, mutant 
DNMT3A could methylate those random regions. This aberrant methylation would most 
likely be detected as significant in typically unmethylated places. An alternative 
hypothesis would be that H3K27me3 is actively recruiting DNMT3AD329A, which leads 
to hypermethylation of the genome compartments enriched by this histone mark.  
To test the first hypothesis and identify whether there was loss of DNA methylation at 
regions enriched for H3K36me3, I analysed gene bodies. Gene bodies were separated into 
groups of those showing low- (bottom quintile) or high- (top quintile) levels of 
H3K36me3. There were no differences, apart those observed globally, in levels of DNA 
methylation over gene bodies in any of the genotypes (Figure 6.10).  
 
 
Figure 6.10. DNA methylation levels over H3K36me3 marked gene bodies. Gene 
bodies were separated based on levels of H3K36me3. Low – bottom quintile, high – top 
quintile. Kruskall-Wallis rank sum test results in p-value=4.1e-15 and is significant for 
all post-hoc pairwise Wilcoxon rank sum tests, with exception of Dnmt3a+/D329A and 
Dnmt3aΔ/D329A pair, where p=0.336. 
 
In order to see whether aberrant methylation gain was targeted to all of the normally 
unmethylated regions, or those marked by H3K27me3 specifically, I selected tiles 
showing <10% DNA methylation in Dnmt3a+/+ adult hypothalamus (4.6% of the 
genome). Unmethylated domains were then separated into seven categories: 1) low-
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H3K4me3 (excl. bivalent), 2) high-H3K4me3 (excl. bivalent), 3) low-H3K36me3, 4) 
high-H3K36me3, 5) low-H3K27me3 (excl. bivalent), 6) high-H3K27me3 (excl. 
bivalent), 7) bivalent (high-H3K4me3 and high-H3K27me3), where low- and high- 
enrichment is top and bottom quintile, respectively. 
The levels of DNA methylation across all four genotypes were very similar in all 
unmethylated domains (Figure 6.11a) with low- or high- H3K36me3 and H3K4me3 
levels (Figure 6.11b and Figure 6.11c). DNA methylation was unaffected in regions with 
low-H3K27me3 too (Figure 6.11d). However, regions that were highly enriched in 
H3K27me3 showed much higher levels of DNA methylation in Dnmt3a+/D329A and 
Dnmt3aΔ/D329A hypothalamus. This increase in DNA methylation was also observed in 
regions marked by bivalent chromatin, although to a lesser extent. Thus, hypomethylation 
of genomic domains per se is not sufficient to recruit and activate DNMT3AD329A. 
Meanwhile, a lower gain in DNA methylation at bivalent regions suggests that the 
presence of H3K4me3 remains antagonistic to DNMT3AD329A activity. Together, these 
results support the conclusion that DNMT3AD329A preferentially relocalises to 
H3K27me3-marked chromatin.   
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Figure 6.11. DNA methylation changes at the normally unmethylated genomic 
fraction stratified by histone PTM status. DNA methylation levels across A. 
unmethylated genomic regions (<10% DNA methylation in wild-type hypothalamus) 
amongst different genotypes, over unmethylated regions overlapping low and high B. 
H3K36me3, C. H3K4me3, D. H3K27me3 and bivalent chromatin. Low level - bottom 
quintile (0-20%) of enrichment, high level – top quintile (80-100%) of enrichment. 
Histone mark enrichment was quantitated over 100-CpG DMR tiles. In order of 
appearance: Kruskall-Wallis rank sum test results were A. p-value <2.2e-16 and post-hoc 
pairwise Wilcoxon rank sum tests were significant. B. low K36me3, Kruskall-Wallis p-
value <2.2e-16 and pairwise all significant. High H3K36me3 Kruskal-Wallis was 
p=5.583e-10, significant for all pairs, except Dnmt3a+/D329A and Dnmt3aΔ/D329A. C. low 
H3K4me3 Kruskall-Wallis p=0.571, no significant pairs. High H3K4me3, Kruskall-
Wallis p<2.2e-16, and all pairwise significant. D. low H3K27me3 Kruskall-Wallis 
p<2.2e-16, pairwise comparisons not significant for pairs Dnmt3a+/+ and Dnmt3a+/D329A, 
Dnmt3a+/+ and Dnmt3aΔ/D329A. High H3K27me3 and bivalent, Kruskal-Wallis p<2.2e-16 
and all pairwise comparisons significant. 
 
6.2 Altered chromatin environment at DMR sites 
Because H3K27me3 and DNA methylation show mutual exclusivity in most of the 
genomic contexts (Lindroth et al., 2008; Bartke et al., 2010; Brinkman et al., 2012), I was 
interested in whether the histone landscape would be altered, with DNA methylation 
replacing H3K27me3 at hypermethylated DMRs. To do this I calculated the net change 
in DNA methylation levels (%) between Dnmt3aΔ/D329A and Dnmt3a+/+ and compared it 
to the change in enrichment (RPKM) of H3K27me3 over all DMR regions. The levels of 
DNA methylation were marginally associated with change in H3K27me3. Areas showing 
the higher net methylation gain had a tendency to show lower H3K27me3 enrichment in 
Dnmt3aΔ/D329A samples (Figure 6.12a), but there was no major loss of this histone mark, 
as could have been predicted. Therefore, these marks appeared to co-exist with 
hypermethylated domains retaining a substantial amount of H3K27me3 (Figure 6.13). 
Interestingly, I observed that the extent of DNA methylation gain correlated much better 
with initial enrichment of H3K27me3 over the locus in Dnmt3a+/+, than its loss, and 
therefore high levels of H3K27me3 would be predictive of a higher DNA methylation 
gain (Figure 6.12b).  
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Finally, I used the ChIP-seq data to assess chromatin changes at DEGs. I found that for a 
subset of DEGs the increase in expression was positively linked with changes in promoter 
H3K4me3 (Figure 6.12c). Together, we see that presence of the DNMT3AD329A protein 
results in gain of DNA methylation directly, but indirectly also causes a redistribution of 
chromatin marks at those sites. When assessed all together, I can observe that gain of 
DNA methylation sometimes led to increased gene expression, increase in promoter 
H3K4me3, decrease in H3K27me3 and increase of H3K36me3 over the upregulated gene 
body (Figure 6.13). These findings support the link between H3K27me3 and abnormal 
localisation of DNMT3AD329A, and suggest that the normal histone landscape is affected 
by the aberrant gain in DNA methylation. 
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Figure 6.12. Histone PTM and DNA methylation gain associations. Scatterplots 
showing the relationship between A. gain of DNA methylation in Dnmt3a/D329A 
hypothalamus and change in enrichment of H3K27me3, B. relationship between levels of 
H3K27me3 enrichment at Dnmt3a+/+ and DNA methylation gain, and C. change in DEG 
expression and change in respective gene promoter H3K4me3 enrichment between 
Dnmt3a+/+ and Dnmt3a /D329A.  
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Figure 6.13. D329A mutation caused genomic landscape changes.  Representative 
genome browser views of gene expression, DNA methylation, and distribution of 
H3K4me3, H3K27me3 and H3K36me3 marks in adult male hypothalamus. H3K4me3 
and H3K36me3 are enriched over actively transcribed CGI promoters and gene bodies, 
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respectively. H3K27me3 shows a broad enrichment over transcriptionally silent genes 
and a decrease of enrichment upon methylation gain. Genes A. Pou4f1 and B. Tal1 are 
up-regulated and hypermethylated in Dnmt3a/D329A. Each colour-coded block represents 
a 50bp window with 10bp step size in the gene expression dataset; a 100-CpG window in 
the methylation dataset; and 2kb window with 1kb step size in the histone enrichment 
datasets. For gene and mRNA tracks, the colour indicates direction, where red is a forward 
strand and blue is a reverse strand. Error bars indicate standard deviation. 
 
6.3 Summary and discussion 
Together, findings in this chapter suggest that the function of DNMT3A in vivo is not 
necessarily reliant on its association with H3K36me3. Instead, I see that DNMT3AD329A 
targets H3K27me3-marked chromatin specifically. This gain in DNA methylation is 
strongly associated with initial levels of H3K27me3 but also subsequently led to some 
loss of H3K27me3 over hypermethylated domains. Similarly, genes showing increased 
expression upon hypermethylation have increased levels of H3K4me3 at their promoters. 
The original study showed that the DNMT3A-PWWP domain interacted with H3K36me3 
and the D329A mutation ablated this binding (Dhayalan et al., 2010). Therefore, it is 
rather surprising that I did not find any evidence of DNA methylation changes linked to 
H3K36me3 enrichment. Again, it highlights the discrepancies of studies conducted in 
vitro and in vivo, and raises the possibility that the PWWP domain is not interacting with 
this histone mark or, alternatively, the D329A mutation does not have the same ablation 
effect in vivo. 
By systematically evaluating the histone PTM context, I found that DNA methylation is 
not leaking into all unmethylated fractions of the genome, but rather is specifically 
targeted to the regions enriched in H3K27me3. Therefore, another possible explanation 
would be that it results in altered binding conformation that allows interaction with 
H3K27me3, observed as a target of DNMT3AD329A. Generally, DNA methylation and 
H3K27me3 are considered to be mutually exclusive, at least at DNA methylation valleys 
(Bogdanović et al., 2011; Brinkman et al., 2012; Murphy et al., 2013; Statham et al., 
2012). Thus far, there is no evidence of a direct interaction, binding or repression, 
between DNMT3A or H3K27me3 (Dhayalan et al., 2010; Manzo et al., 2017; Mauser et 
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al., 2017). Nonetheless, DNMT3A has been found to associate with shores of DNA 
methylation valleys, so it might already be located closed to bivalent chromatin and have 
a weak affinity to H3K27me3 (Gu et al., 2018; Manzo et al., 2017). Given that 
H3K27me3 is established by PRC2, and DNMT3A is found as a direct interactor of PRC2 
proteins (Manzo et al., 2017), it is possible that a conformation change caused by the 
D329A mutation somehow enhances this interaction or leads to further recruitment of 
mutant DNMT3A to H3K27me3 domains. Similarly, it has been reported that PRC2 
member EZH2 can directly recruit DNMTs to the genome (Viré et al., 2006).  
Although H3K27me3 and DNA methylation are not generally found together, DNA 
methylation gain at domains marked by H3K27me3 is found in cancer, where the balance 
is possibly tipped, and altered cellular environment allows it (Schlesinger et al., 2007; 
Gao et al., 2014; Takeshima et al., 2015). Similarly, DNA methylation and H3K27me3 
work in concert to silence X chromosome (Galupa and Heard, 2015). The AEBP2 protein 
of PRC2 was shown to target PRC2 to CG-rich and methylated DNA (Gao et al., 2014; 
Wang et al., 2017).  Therefore, PRC2 could maintain the H3K27me3 even in the presence 
of aberrant DNA methylation gain. Conversely, a different study showed that PRC2 is 
involved in an insular chromatin formation at DNA methylation canyons and therefore 
promotes hypomethylation of these domains (Li et al., 2018). The tight interplay between 
DNA methylation and the H2K27me3 mark is potentially modulated by other chromatin 
interacting factors. Together they confer environments where there is mutual exclusivity 
and where permissiveness to co-exist is determined.  
A caveat of whole tissue analysis, especially when relatively low changes in histone 
modification enrichment are observed, is heterogeneity of the tissue. If changes in DNA 
methylation do not occur in all cells, the limited change in H3K27me3 levels could simply 
be a mixture of signals coming from cells that are unaffected and those with a strong 
change. A more definitive way to answer this question would be to conduct a sequential 
ChIP-bisulphite sequencing, where the genome fraction marked by histone modification 
is first pulled down and then DNA methylation levels over those domains are assessed. 
This chapter shows that aberrant gain of DNA methylation is targeted specifically to the 
chromatin marked by H3K27me3 and, to a lesser extent, bivalent chromatin, containing 
both H2K27me3 and H3K4me3.  
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7 Generation of a 
bioDNMTA-D329A ES cell 
line for mechanistic studies 
Declaration of author contributions 
The majority of the work described in this chapter was conducted by the author while 
on an academic visit to Tuncay Baubec’s laboratory (Department of Molecular 
Mechanisms of Disease, University of Zurich). Joel Wirz kindly helped to conduct the 
Co-IP-MS experiment and ran the MS machine.  
 
The limitations of investigating the DNMTAD329A protein in vivo include the small 
quantity of adult hypothalamus tissue, which prohibits many biochemical approaches, the 
cellular complexity of tissue samples, which can confound interpretations, the complex 
whole-body phenotype, and lack of biological tools, such as antibodies suitable for 
immunoprecipitation. These constraints made it challenging to study the impact of the 
D329A mutation on the biochemical properties of the DNMT3A protein. A group led by 
Dirk Schübeler established an elegant recombinase-assisted mapping of biotin-tagged 
proteins (RAMBiO) system in which DNA binding proteins can be tagged individually 
without disrupting protein structure (Baubec et al., 2013). Tagged genetic constructs can 
be inserted into a specific locus in the mouse ESC genome with a known genetic 
background, and robust antibodies or resins can be used to obtain DNMT binding maps 
(ChIP-seq) and identify co-factors/interactors (co-Immunoprecipitation). 
A schematic representation of the generation of ESCs containing a biotinylated protein 
of interest, bioDNMT3A1D329A, is shown below (Figure 7.1). Briefly, ESCs that contain 
a genetically engineered site for recombinase-mediated cassette exchange (RMCE) and 
constitutively express biotin ligase BirA are used. The target site lies at the β-globin locus 
and contains two fused selection elements, hygromycin-resistance (Hy) and Herpes 
Simplex Virus-1 thymidine kinase ganciclovir-sensitivity (HSV-Tk) genes, flanked by 
inverted loxP elements (Lienert et al., 2011). Constructs that contain an AviTag element 
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and gene of interest are introduced to cells together with Cre recombinase. Cre 
recombinase would drive RMCE and the original selection cassette would be exchanged 
by a transgene carrying cassette. Once the transgene is expressed, the AviTag sequence at 
the N-terminus of the gene of interest is translated into a short peptide that is a substrate 
of an E. coli biotin ligase BirA. BirA covalently conjugates free-floating biotin molecules 
to the AviTag peptide making the transgenic protein biotinylated (Beckett et al., 1999). 
Binding of biotin and (strept)avidin is one of the strongest non-covalent molecular 
interactions and many molecular products, such as antibodies and resins, are created to 
harness this unique property. Here, this system was used to create bioDnmt3a1D329A cell 
line for further work.  
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Figure 7.1. Schematic representation of generation of ES cells containing 
biotinylated protein of interest. Stem cells which constitutively express biotin ligase 
BirA and contain a selection cassette with hygromycin-resistance (Hy) and Herpes 
Simplex Virus-1 ganciclovir-sensitivity thymidine kinase (Tk) genes, flanked by inverted 
loxP elements (indicated by triangles), at Globin-β locus are used. A plasmid containing 
a promoter (indicated by black arrow), BirA target AviTag sequence, and gene of interest 
flanked by inverted loxP elements are introduced together with Cre recombinase. Cre 
drives recombinase-mediated cassette exchange (RMCE) and the desired construct is 
inserted into the endogenous locus. Once the gene of interest is translated, BirA would 
covalently conjugate free-floating biotin molecule to the AviTag peptide. Figure modified 
from Baubec et al. (2013).  
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7.1 Generation of bioDnmt3aD329A ES cell lines 
First, the D329A mutation was introduced into the pJET-D3A1 plasmid, which contains 
Dnmt3a cDNA, by site-directed mutagenesis. Dnmt3a1D329A was cut out of pJET-D3A1-
D329A plasmid and ligated into mammalian expression vector pCAGbioTEVeGFP in 
place of eGFP cDNA (both plasmids provided by T. Baubec, UZH Switzerland). Correct 
insertion and absence of spontaneous mutations were assessed by Sanger sequencing. The 
resulting pCAGbioTEV-DNMT3A1_D329A, together with Cre recombinase expression 
plasmid pIC-Cre (Gu et al., 1993), were introduced into HA36CB1 recipient ES cells, 
henceforth referred to as wild-type, by electroporation (Baubec et al., 2013). HA36CB1 
cells already constitutively express BirA ligase and have the RMCE selection locus. After 
electroporation, cells were subjected to ganciclovir selection. Individual clones were 
picked and genotyped to confirm insertion of bioDnmt3a1D329. Four individual clones 
were assessed by western blot and all four showed presence of biotinylated 
DNMT3AD329A protein (Figure 7.2). 
 
 
Figure 7.2. Western blot of transgenic ES cell nuclear extracts for biotinylated 
protein detection. First, primary antibody against DNMT3A1 was used for endogenous 
protein detection. Blot was then stripped and HRP-conjugated streptavidin was used to 
assess biotinylated protein presence. Individual clones represent bioDnmt3a1D329A 
HA36CB1 cell lines; wild-type – HA36CB1 cell line, bioD3A – bioDnmt3a1 HA36CB1 
cell line (positive control) and TKO – DNMT TKO-133 Dnmt triple knock-out cell line 
(negative control) (the latter two provided by T. Baubec, UZH Switzerland). Arrows point 
to the position of bands marked by the antibody or streptavidin-HRP. 20µg of nuclear 
lysate was loaded per well. 
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7.2 Assessment of bioDNMT3AD329A binding factors using Co-
IP-MS 
In order to identify factors that bind bioDNMT3A and/or bioDNMT3AD329A, biotin co-
immunoprecipitation followed by mass spectrometry was done. First, I performed 
extraction of nuclear fractions, followed by co-immunoprecipitation using streptavidin 
coated beads. Pulled-down fractions were run on a mass-spectrometer and identified 
peptides were analysed. Joel Wirz kindly helped me with processing the samples and ran 
them on a mass-spectrometer. The nuclear fraction of ESCs was extracted using 
hypotonic buffers, biotinylated complexes were immunoprecipitated using streptavidin 
beads. Protein cleavage to peptides was done with trypsin, using FASP digestion method 
(Wiśniewski et al., 2009). Protein identification from MS‐raw data was performed and 
mapped to the mouse proteome using MaxQuant label-free quantification. The analysis 
was done using Proteus package in R statistical software (Gierlinski et al., 2018). 
The number of peptides found in each replicate suggested a successful 
immunoprecipitation, since the wild-type cell line had a lower number of peptides found 
than either bioDnmt3a1 or bioDnmt3a1D329A lines, despite equivalent input amounts 
(Figure 7.3a). Pairwise Pearson’s correlation analysis showed high similarity between 
bioDnmt3a1 and bioDnmt3a1D329A clones, with exception of sample bioDnmt3a1#2 
(Figure 7.3b). It showed lower peptide count than other samples of the same genotype 
and separated in PCA (Figure 7.3c). Given these findings, sample bioDnmt3a1#2 was 
excluded from further analysis. The adjusted PCA plot indicated a clear separation of 
wild-type samples, meanwhile bioDnmt3a1 and bioDnmt3a1D329A clones clustered 
together (Figure 7.3d). 
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Figure 7.3. Co-IP-MS sample quality assessment. A. Total count of peptides identified 
by MaxQuant in each replicate of biotin Co-IP-MS. B. Pearson’s pairwise correlation 
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levels between all Co-IP-MS samples. Numbers represent replicates. C. PCA of all 
samples. Notably, replicate 2 of bioDnmt3a1 cell line shows comparatively lower 
correlation with all other samples in panel A and is separated by PCA in panel B 
(indicated by the red arrow). D. PCA of samples with exclusion of replicate 2 of 
bioDnmt3a1 cell line. 
 
Peptides were then aggregated and assigned to proteins using the Leading Razor Protein 
method (Silva et al., 2006). Data were normalised to match median intensities across all 
samples (Figure 7.4). The statistical tool limmaDE was used to find differential 
representation of proteins in a pairwise manner, focusing on bioDnmt3a1 against 
bioDnmt3aD329A clones #A3 and #C3. Plots of fold-change and p-value for these 
comparisons can be found below (Figure 7.5). However, after Benjamini-Hochberg 
multiple comparison adjustments, there were no proteins significantly overrepresented in 
bioDnmt3aD329A clone #A3 and/or #C3 pull-downs when compared to bioDnmt3a1.  
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Figure 7.4. Co-IP-MS sample intensity value normalisation by mean. Panel A. shows 
log10 values of peptide intensities before normalisation and panel B. shows normalised 
intensity values. Numbers refer to replicates. 
The role of the PWWP domain in the DNA methyltransferase 3A targeting to the genome 
140  Gintarė Sendžikaitė - 2021 
 
Figure 7.5. Volcano plots showing differential representation of proteins in 
bioDnmt3a1D329A clones #A3 and #C3 in comparison to bioDnmt3a1. Histograms 
indicate distributions of either log2 fold change of proteins or –log10 p-values. 
 
There were 197 differentially enriched proteins in bioDnmt3a1 compared to wild-type, 
providing a list of potential DNMT3A1 interactors in ESCs. The top 20 hits showing 
enrichment in bioDnmt3a1 samples in comparison to wild-type are listed in Appendix 3. 
It was reassuring to find DNMT3A (log2FC = 3.6) and DNMT3L (log2FC = 3.7) in this 
list, both of which were found to be significantly enriched in bioDnmt3a1 and mutant 
cells lines (Figure 7.6 and Figure 7.7). This assured that the IP indeed pulled-down known 
DNMT3A-binding factors, and suggested that the N-terminal end should be unaffected 
by the biotin tag. Methyl-binding domain 3 (MBD3) protein (log2FC = 3.8), known to 
bind DNMT3A (Datta et al., 2005), was also in the top 20 list (Figure 7.8). DNMT3B 
(log2FC = 2.6) ranked 57 in the list sorted based on significant fold-change. 
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Figure 7.6. Peptide data for DNMT3A. Top panel shows individual peptide intensities 
per genotype group, where every box represents a unique peptide sequence along the 
protein; peptides are displayed in alphabetical order based on amino acid sequence. 
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Figure 7.7. Peptide data for DNMT3L. Top panel shows individual peptide intensities 
per genotype group, where every box represents a unique peptide sequence along the 
protein; peptides are displayed in alphabetical order based on amino acid sequence. 
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Figure 7.8. Peptide data for MBD3. Top panel shows individual peptide intensities per 
genotype group, where every box represents a unique peptide sequence along the protein; 
peptides are displayed in alphabetical order based on amino acid sequence. Bottom panel 
shows peptide intensity per individual sample. A single dot represents one detected 
peptide. 
 
I also identified 14 proteins that were detected in both bioDnmt3aD329A clone co-IPs but 
not in Dnmt3a1 (Table 12). These proteins could be the new interactors of Dnmt3aD329A. 
However, after a brief literature analysis and query of Online Mendelian Inheritance in 
Man database, barely any of the proteins are expected to localise in the nucleus and no 
link to DNMT3A could be made. Therefore, while I could confidently say that co-
immunoprecipitation worked, the analysis of bioDnmt3a1D329A proteins did not yield 
mechanistic insights into the aberrant methylation detected in adult tissues. 
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Genes Protein names 
O88445 
AURKC 







Aurora kinase C (EC 2.7.11.1) 
(Aurora 3) (Aurora/IPL1-
related kinase 3) (ARK-3) 
(Aurora-related kinase 3) 
(Aurora/IPL1/Eg2 protein 1) 
(Serine/threonine-protein 
kinase 13) (Serine/threonine-
protein kinase aurora-C) 
P11440 
CDK1 





Cyclin-dependent kinase 1 
(CDK1) (EC 2.7.11.22) (EC 
2.7.11.23) (Cell division 
control protein 2 homolog) 
(Cell division protein kinase 
1) (p34 protein kinase) 
P68254 
1433T 
21.56 21.33 2 2 Ywhaq 




21.06 20.55 1 2 
Ap2m1 
Clapm1 
AP-2 complex subunit mu 
(AP-2 mu chain) (Adaptor 
protein complex AP-2 subunit 
mu) (Adaptor-related protein 
complex 2 subunit mu) 
(Clathrin assembly protein 
complex 2 mu medium chain) 
(Clathrin coat assembly 
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protein AP50) (Clathrin coat-
associated protein AP50) 
(Mu2-adaptin) (Plasma 








Hyaluronan mediated motility 
receptor (Intracellular 
hyaluronic acid-binding 
protein) (Receptor for 
hyaluronan-mediated 
motility) (CD antigen CD168) 
Q3UGC7 
EI3JA 





initiation factor 3 subunit J-A 
(eIF3j-A) (Eukaryotic 
translation initiation factor 3 




20.34 21.18 3 4 
Tns3 
Tens1 
Tensin-3 (Tensin-like SH2 
domain-containing protein 1) 
Q80VY9 
DHX33 
21.03 22.45 1 2 Dhx33 
ATP-dependent RNA helicase 
DHX33 (EC 3.6.4.13) (DEAH 
box protein 33) 
Q8R2U0 
SEH1 
20.61 21.92 3 2 Seh1l 
Nucleoporin SEH1 (GATOR 





20.59 21.57 3 3 
Nup85 
Pcnt1 
Nuclear pore complex protein 
Nup85 (85 kDa nucleoporin) 
(FROUNT) (Nucleoporin 
Nup85) (Pericentrin-1) 
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Q9CYL5 
GAPR1 




pathogenesis-related protein 1 
(GAPR-1) (Golgi-associated 
PR-1 protein) (Glioma 
pathogenesis-related protein 
2) (GliPR 2) 
Q9CZH8 
CCD77 
21.50 21.81 2 3 Ccdc77 
Coiled-coil domain-
containing protein 77 
Q9JKF1 
IQGA1 










type (ATP-PFK) (PFK-P) (EC 
2.7.1.11) (6-
phosphofructokinase type C) 
(Phosphofructo-1-kinase 
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7.3 BioDnmt3a1D329A neuronal progenitor cell DNA methylation 
Dnmt3aD329A hypothalamus cells gain DNA methylation after the epigenetic 
programming event in early development, likely during differentiation and maturation of 
the neurons. To assess whether this pathology could be recapitulated in a cellular system, 
I differentiated wild-type, bio-Dnmt3a1 and bio-Dnmt3a1D329A ESCs to neuronal 
progenitor cells and assessed DNA methylation.  
Six PBAT DNA methylation libraries were generated; two wild-type and two bio-
Dnmt3a1, where two samples of the same genotype are technical replicates, and one each 
of clones #A3 and #C3 of bio-Dnmt3a1D329A, where samples are biological replicates. The 
duplication levels were between 4.8-5.6% and samples had in the range of 33.1-44.9 
million unique deduplicated reads per sample (Table 13). 
 




Uniquely aligned reads 
(mln) 
wt_1 4.8% 33.1 
wt_2 5.4% 41.4 
D3abio_1 5.6% 44.9 
D3Abio_2 4.9% 35.8 
bioD329A_#C3 5.3% 33.4 
bioD329A_#A3 5.5% 40.9 
 
Initial assessment of the samples showed a separation of bio-Dnmt3a1 samples from wild-
type and bio-Dnmt3a1D329A clones (Figure 7.9). In agreement, it was observed that bio-
Dnmt3a1 cells had approx. 3% lower global DNA methylation (Figure 7.10). To 
understand the changes in the genome better, genomic tiles the size of 100 CpGs were 
The role of the PWWP domain in the DNA methyltransferase 3A targeting to the genome 
148  Gintarė Sendžikaitė - 2021 
plotted for each pair of the genotypes. Unexpectedly, I discovered that bio-Dnmt3a1 
samples had a different distribution of DNA methylation than wild-type, and showed a 
cluster of tiles methylated much higher than the corresponding ones in the wild-type 
(Figure 7.11a). Even more surprisingly, bio-Dnmt3a1D329A clones did not share this 
pattern; bio-Dnmt3a1D329A methylation resembled wild-type (Figure 7.11b,c). 
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Figure 7.9. Separation of NPC DNA methylation samples. 100 CpG tiles were used in 
the analysis, individual samples are shown. A. A data similarity tree indicating Pearson 
correlation distances between individual samples. B. Pairwise correlation matrix for 
individual sample pairs, in scale 0 to 1. C. Principal component analysis.  
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Figure 7.10. Global DNA methylation levels in NPCs. 100CpG tiles were used, each 
plot represents a single sample. Kruskal-Wallis rank sum test for genotype mean results 
in p-value < 2.2e-16. 
 
To assess these discrepancies further, I first looked at different genomic features. Both 
bio-Dnmt3a1 and bio-Dnmt3a1D329A had higher DNA methylation levels than wild-type 
over CGIs and CGI promoters, although it was more pronounced in bio-Dnmt3a1 cells 
(Figure 7.12a,b). Interestingly, statistical pairwise comparison found that differences 
between bioDnmt3a1 and bioDnmt3aD329A over CGI promoters were not statistically 
significant, suggesting that there is a convergence between these two genotypes at CGI 
promoters (Figure 7.12). Wild-type and bio-Dnmt3a1D329A appeared to have the same 
level of DNA methylation over non-CGI promoters, gene bodies and intergenic regions 
(Figure 7.12b,c). Meanwhile, bio-Dnmt3a1 was slightly hypomethylated in comparison, 
which would explain why on a global level it appeared to be methylated less than the 
other cell lines. Domains that become hypermethylated in the hypothalamus of adult 
Dnmt3aΔ/D329A mice had approximately 23.6% DNA methylation in wild-type but 29.9% 
and 27.2% DNA methylation in bio-Dnmt3a1 and bio-Dnmt3a1D329A, respectively 
(Figure 7.13). Hypothalamus hypomethylated domains had 71.6%, 70.4% and 71.7% in 
wild-type, bio-Dnmt3a1 and bio-Dnmt3a1D329A, respectively. 
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Figure 7.11. Assessment of NPC DNA methylation by 100 CpG tiles. Mean values per 
group are used in the analysis. Each dot represents 100CpG genomic tile. 
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Figure 7.12. DNA methylation levels over different genomic regions.  100CpG tiles 
overlapping features indicated were used in the analysis, grouped per genotype. For A. 
all CGIs, B. non-CGI promoters, C. gene body and intergenic regions Kruskal-Wallis 
rank rum test p-value < 2.2e-16, and significant for all post-hoc pairwise Wilcoxon rank 
sum tests. The exception was B. CGI promoters, where Kruskal-Wallis p-value = 9.474e-
10, but post-hoc Wilcoxon rank sum pairwise test for bioDnmt3a1 against 
bioDnmt3a1D329A p-value (Benjamin Hochberg adj.) = 0.056.  
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Figure 7.13. DNA methylation levels over hypothalamus DMRs.  100CpG tiles 
overlapping mouse hypothalamus DMRs were used in the analysis, grouped per 
genotype. For hyper-DMRs, Kruskal-Wallis rank rum test p-value was < 2.2e-16, and 
significant for all post-hoc pairwise Wilcoxon rank sum tests. For hypo-DMRs, Kruskal-
Wallis rank rum test results in p-value = 3.453e-07, but post-hoc Wilcoxon rank sum 
pairwise test for wild-type against bioDnmt3a1D329A p-value (Benjamin Hochberg adj.) = 
0.54.  
 
Initially, I expected to use the bioDnmt3a1 cell line for DNA methylation comparison 
with bioDnmt3a1D329A, given that it would have the same level of expression of the non-
endogenous Dnmt3a1 and the only difference between the two cell lines would be the 
presence of the D329A mutation. However, global and feature-based DNA methylation 
differences suggested that these cell lines are more diverse than anticipated; further 
pairwise comparisons were conducted to understand these differences. 
First, the edgeR statistical tool, with p-value <0.01 and absolute difference >10% cut-off, 
was used to identify differentially methylated tiles between wild-type and bioDnmt3a1. 
There were 4,124 hypermethylated and 5,275 hypomethylated DMRs. Only 0.3% 
hypermethylated tiles matched hypothalamus hypo-DMRs, and 20% of hypermethylated 
tiles matched adult Dnmt3aΔ/D329A hypothalamus hyper-DMRs. Approx. 87.8% of 
hypermethylated tiles overlapped CGIs. Gene ontology analysis indicated two major 
trends for genes that were surrounded by hypermethylated domains: transcription factor 
and neuronal function-related genes (Figure 7.14). Hypomethylated domains were 
enriched in genes associated with neuronal function and neuronal cellular compartments, 
such as synapse (Figure 7.15). 
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Figure 7.14. GO analysis of genes linked to domains hypermethylated in bioDnmt3a1 
NPCs compared to wild-type. 
Next, I looked at differentially methylated tiles between wild-type and bioDnmt3a1D329A. 
There were only 232 DMRs, of which 198 were hypermethylated and 34 were 
hypomethylated. Approx. 57.6% of those hypermethylated were shared with adult 
Dnmt3aΔ/D329A hypothalamus hyper-DMRs; while none of the hypomethylated domains 
matched hypothalamus hypo-DMRs. Gene ontology analysis of genes within 2kb 
distance to DMRs indicated that hypermethylation sites were enriched for transcription 
factor and developmental genes (Figure 7.16). Meanwhile, there were only 19 genes 
nearby the hypomethylated tiles, and no significant enrichment could be identified. 
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Figure 7.15. GO analysis of genes linked to domains hypomethylated in bioDnmt3a1 
NPCs compared to wild-type. 
Finally, a comparison of bioDnmt3a1 and bioDnmt3a1D329A cells found 2,756 hyper- and 
2,688 hypomethylated DMRs, of which only 2% and 0.6%, respectively, matched 
hypothalamus DMRs. Gene ontology analysis of hypermethylated domains showed 
enrichment in protein binding and cellular compartments of cytoplasm, membrane and 
synapse (Figure 7.17). Hypomethylated domains were enriched for a mixture of 
transcription related functions but also membrane, cell junction, and neuronal cell body 
compartments (Figure 7.18). 
Together, this analysis suggested complex dynamics. It would appear that the “positive 
control” bioDnmt3a1 cell line was rather divergent, and could not be used as a meaningful 
control in this case. Meanwhile, wild-type and bioDnmt3a1D329A cell lines were very 
similar but had a small number of DMRs. Given that the majority of the DMRs exhibited 
gain of DNA methylation in the presence of the mutation, and that half of those would be 
hypermethylated in adult mouse Dnmt3aΔ/D329A hypothalamus, I suggest that these cells 
could be at the start of a trajectory observed in hypothalamus. Since there are only about 
200 differentially methylated sites, neuronal progenitor cells are not an ideal model, and 
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Figure 7.16. GO analysis of genes linked to domains hypermethylated in 
bioDnmt3aD329A NPCs compared to wild-type. 
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Figure 7.17. GO analysis of genes linked to domains hypermethylated in 
bioDnmt3a1D329A NPCs compared to bioDnmt3a1. 
 
Figure 7.18. GO analysis of genes linked to domains hypomethylated in 
bioDnmt3a1D329A NPCs compared to bioDnmt3a1. 
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7.4 Summary and discussion 
In this chapter, I show successful generation of ESCs carrying bioDnmt3a1D329A. 
Unfortunately, no novel interactors of DNMT3A could be found and the gain of aberrant 
DNA methylation in neuronal progenitor cells was rather limited. 
The aim of work described in this chapter was to overcome the complexity of brain tissue 
cell type heterogeneity and simplify biochemical experimental approaches by using the 
RAMBiO system (Baubec et al., 2013). Given the knowledge from previous chapters, it 
was expected that mutant DNMT3A would have an effect on DNA methylation even in 
the presence of the wild-type allele. Thus, a wild-type background was used for 
experiments described here.  
This design has its limitations: ESCs already express both de novo DNMTs 3A and 3B to 
a relatively high level and both of these play a role in ESC DNA methylation 
establishment (Chen et al., 2003; Gu et al., 2018). Biotinylated DNMT3A has to compete 
with endogenously expressed protein and free-floating wild-type DNMT 3A, 3B, and 3L 
might be tethering the mutant protein (Chédin et al., 2002; Chen et al., 2005; Suetake et 
al., 2004). This hypothesis is supported by my Co-IP-MS experiment result, where all 
three DNMT3s are identified as significant and some of the most common interactors. 
Expression of the biotinylated mutant protein in Dnmt3a/Dnmt3b double knock-out 
(DKO) cells would eliminate this possibility and the targeting of bioDNMT3AD329A could 
be assessed. But the fact that cell line with DNMT3AD329A does not show lower DNA 
methylation than wild-type suggest that it does not instigate a dominant negative effect. 
It is plausible that the reported reduction in DNMT3A-D329A association with chromatin 
(Dhayalan et al., 2010) in a system where expression and replication levels are high would 
result in the mutant protein not being able to linger around long enough to cause the 
methylation gain. The requirement of low replication rate could be solved if neuronal 
progenitors were matured in culture. While ESCs survive without DNA methylation, they 
fail to differentiate successfully, and in this case wild-type background would be required 
(Chen et al., 2003).  
There were no changes observed in DNA methylation of E7.5 embryos, therefore I 
hypothesised that it is unlikely to see any DNA methylation changes in serum-grown 
ESCs, which would have been originally derived from a similarly aged embryo (Zwaka 
and Thomson, 2005), and immediately started with NPCs for assessment of DNA 
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methylation. However, CoIP-MS requires high numbers of cells and replicates to generate 
robust results and usage of ESCs instead of NPCs was an experimental compromise. If 
the assumption is that aberrant DNA methylation cannot be established in ESCs because 
of a high replication rates, it does not necessarily imply that the potential novel interactor 
is not present and/or bound to DNMT3A in the ESC environment. Similarly, AviTag is a 
very small tag where biotin is added as a post-translation modification (Fairhead and 
Howarth, 2015), hence it is unlikely to disrupt many protein-protein interactions.  
Assessment of DNA methylation in NPCs carrying bioDNMT3A1D329A found a very 
limited effect on DNA methylation compared to wild-type, but why the bioDNMT3A1 
cell line had many differentially methylated sites is rather unclear. During the transition 
from ESCs to NPCs lineage specificity is acquired by changes in DNA methylation and 
chromatin environment (Mohn et al., 2008). The CoIP-MS experiment does not indicate 
any difference between bioDNMT3A1 and bioDNMT3A1D329A cell line proteomes, at least 
at the ESCs stage, but does not give any insight into differences arising in NPCs. 
The bioDnmt3a1 cell line has been generated independently and kept in culture for 
multiple passages, and therefore could have accumulated genetic and epigenetic 
alterations, as observed in human ESCs (Tanasijevic et al., 2009). A better control would 
have been introduction of bioDNMT3A1 into reference wild-type HA36CB1 ESC cell line 
at the same time as bioDNMT3A1D329A, which would provide confidence that differences 
observed are due to the introduced transcripts rather than culture conditions and handling. 
Overexpression of Dnmt3b in adult mouse tissues resulted in slightly increased levels of 
DNA methylation over CGI-rich domains in all cells and tissues (Zhang et al., 2018). 
Assuming that accumulation of aberrant DNA methylation could occur gradually in the 
cells with increased levels of DNMT3A, it is possible that the bioDnmt3a1 line had 
accumulated changes and, hence, why I see a gain in DNA methylation. Similarly, as in 
the Dnmt3b overexpression study, here CGI-rich regions are those showing higher levels 
of methylation.  
While protein epitope tagging in simplified systems, such as cell culture, is a great way 
to study them, the results here highlight the challenges and failure to recapitulate the effect 
a mutation can have in a complex organism.  
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8 Discussion  
The aim of the work described in this thesis was to investigate the role of the PWWP 
domain in DNMT3A in targeting to the genome. To that end, I used a mouse model 
carrying the D329A mutation in the aromatic cage of the PWWP domain (Sendžikaitė et 
al., 2019). This mutation has been previously described to ablate the interaction between 
the DNMT3A PWWP domain and H3K36me3 in vitro and was considered as a robust 
loss-of-function mutation, used as a control in other biochemical work (Bock et al., 2011; 
Dhayalan et al., 2010; Dukatz et al., 2019; Kungulovski et al., 2014; Mauser et al., 2017). 
In characterising this mouse, I found that the D329A mutation does not lead to loss of 
DNA methylation over gene bodies, marked by H3K36me3, which I confirmed in 
different tissues and time points. However, I identified that it is a gain-of-function 
mutation, which causes postnatal growth retardation in mice and progressive 
accumulation of DNA methylation over H3K37me3-marked and bivalent chromatin. This 
hypermethylation results in altered chromatin landscape and derepression of some 
developmental genes. Subsequently, I established an ESC line where biotinylated mutant 
DNMT3A is expressed. Unfortunately, I could not identify any novel binding partners of 
the bioDNMT3AD329A protein in ESCs and saw rather limited changes in DNA 
methylation in NPCs, but this cell line can be used in further work.  
8.1 The PWWP domain and H3K36me2/3 
Given a tight link between gene expression, H3K36me3, and DNA methylation in the 
oocyte, the initial hypothesis appeared very well grounded and the oocyte system an ideal 
platform to test it (Veselovska et al., 2015; Xu et al., 2019). Therefore, it was a great 
surprise to see a lack of strong loss of DNA methylation over H3K36me3 domains.  
The PWWP domain also recognises H3K36me2 (Dhayalan et al., 2010; Dukatz et al., 
2019). Recently, H3K36me2 was found to specifically recruit DNMT3A to non-coding 
euchromatin regions via the PWWP domain and to stimulate its catalytic activity in mouse 
mesenchymal and human breast cancer cell lines (Weinberg et al., 2019; Xu et al., 2020). 
These studies reported that loss of H3K36me2 led to a significant relocalisation of 
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DNMT3A to gene bodies. Upon introduction of a D333A mutation, which is only a few 
amino acids downstream from D329A, this relocalisation was lost. Based on 
interpretation of the accompanying ChIP-qPCR data, there is no significant loss of 
DNMT3A-D333A binding over H3K36me2 domains compared to wild-type DNMT3A, 
and changes at bivalent chromatin are not assessed (Weinberg et al., 2019). 
In the context of the Weinberg et al. (2019) study, it could be hypothesised that 
H3K36me2/3 acts as a tethering mark, and DNMT3A is recruited to H3K36me2 
intergenic chromatin and, to a lesser extent, H3K36me3 at gene bodies. Since DNMT3B 
is thought as the major activity methylating gene bodies (Baubec et al., 2015), it can be 
assumed DNMT3A is only localising to those regions transiently or due to the overlap 
between H3K36me2 and K36me3; but it does not have any functional effect over gene 
bodies. If, upon introduction of a mutation in the PWWP domain, H3K36me3 binding is 
lost, and interaction with H3K36me2 is only slightly affected, the mutant DNMT3A 
would increasingly relocalise to the place of next affinity – bivalent chromatin shores (Gu 
et al., 2018; Jeong et al., 2014; Manzo et al., 2017).  
This theory is somewhat compatible with my data, where I see a small loss of DNA 
methylation over intergenic domains. Compared to the distribution of random genomic 
tiles, CGI-overlapping intergenic tiles are overrepresented (Figure 5.25). Yet, CGI-
containing intergenic tiles constitute only 43 out of 600 (7.2%) tiles that are 
hypomethylated in adult Dnmt3aΔ/D329A hypothalamus, suggesting that recruitment of 
DNMT3AD329A to intergenic domains is not affected strongly. The model proposed would 
rely on high abundance of DNMT3A in the cell together with long residence time on 
chromatin, so that the strength of enzyme-chromatin interaction would in proxy control 
the relative binding of DNMT3A to different targets. It would also require DNMT3A to 
still be recruited and/or stay resident over a H3K36me2/3 domains once the DNA is 
methylated at those loci. 
What is intriguing though, is that the oocyte chromatin landscape is completely different, 
and H3K36me3 is enriched at sites of DNA methylation (Stewart et al., 2015; Xu et al., 
2019).  Deletion of SETD2, an enzyme catalysing H3K36me3, leads to loss of DNA 
methylation over H3K36me3 domains, which are normally hypermethylated in the 
oocyte, and low but widespread gain at hypomethylated domains (Xu et al., 2019). The 
H3K36me2 was found to overlap H3K36me3 and is only associated with transcribed gene 
bodies, therefore the DNA methylation is SETD2 and H3K36me3 dependent (Shirane et 
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al., 2020). This evidence really suggests that H3K36me3 and DNA methylation are very 
strongly linked in the oocyte. Since I do not see change in the oocyte DNA methylation 
over H3K36me3 domains, it can be hypothesised that the D329A mutation fails to disrupt 
the link between H3K36me3 and the PWWP domain in the oocyte. Does the mutation 
fail to interrupt the interaction or is the PWWP domain not involved at all? Given that in 
the oocyte DNMT3A is in a complex with DNMT3L, it could be that DNMT3L 
recruitment acts as a dominant mechanism for genomic targeting. Alternatively, the 
D329A might be a hypomorphic mutation but the effects are masked by an extensive 
timeframe of oocyte growth and de novo methylation establishment.  
Together with findings of other studies, I suggest that the function of DNMT3A in vivo 
may be associated with H3K36me2/3, but that the D329A mutant protein does not affect 
this dynamic to an extent where functional change is observed. 
8.2 The two DNMT3A isoforms 
I chose two main tissues where DNMT3A is the dominant DNA methyltransferase: the 
mature oocyte and the adult brain (Feng et al., 2005; Kaneda et al., 2010, 2004), so that 
redundancy with DNMT3B could be avoided. The system where DNMT3B was not 
expressed, like the adult brain, or was shown to be non-functional and not to rescue DNA 
methylation, like the oocyte, was of particular importance when studying a domain shared 
between the two de novo methyltransferases.  
Although the original study by Dhayalan et al. (2010) tested the shorter DNMT3A2 
isoform, my initial results from oocytes, where only DNMT3A2 is present, did not show 
any change. Discovery of the postnatal onset, growth restriction phenotype, which time-
wise overlaps the switch from DNMT3A2 to DNMT3A1 expression (Manzo et al., 2017), 
provoked an idea that N-terminal domain might be involved in promoting the observed 
ectopic methylation. The PWWP domain is virtually the same between the two 
methyltransferases, while the N-terminal is different, and findings in ESCs showed that 
only the DNMT3B-PWWP domain was required for H3K36me3-marked gene body 
methylation (Baubec et al., 2015). If different domains can act in concert to target 
DNMTs, such as auto-inhibition of the catalytic domain by the ADD domain (Guo et al., 
2015), it is feasible that the less well-studied intrinsically-disordered N-terminal domain 
could have an impact on DNMT3A localisation through another domain, such as the 
PWWP.  
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The long N-term containing DNMT3A1 isoform is expressed from late embryogenesis 
into adulthood in mice (Manzo et al., 2017). Work by Manzo et al. (2017) identified that 
the N-terminal domain was essential in DNMT3A localisation to the shores of bivalent 
chromatin. A similar study found that both DNMT3A1 and DNMT3A2 localise to the 
shores of DNA methylation canyons in ESCs (Gu et al., 2018). In the light of these 
findings, I initially hypothesised that the longer isoform would be the one responsible for 
establishment of hypermethylated H3K27me3 domains in Dnmt3aD329A mice. However, 
mutant DNMT3A1 was not sufficient to introduce dramatic gain in DNA methylation in 
NPCs. Therefore, I can conclude that the isoform alone is not the definitive factor by 
which the DNMT3A PWWP domain is recruited to the genome. 
8.3 Aberrant DNA methylation and H3K27me3 
Unlike the strong antagonistic relationship of DNA methylation and H3K4me3 (Ooi et 
al., 2007; Otani et al., 2009; Zhang et al., 2010), the link between methylation and 
H3K27me3 is complex and not understood so well. While they are mutually exclusive at 
CGIs, there is a certain degree of plasticity where both DNA methylation and H3K27me3 
can co-exist (Brinkman et al., 2012; Statham et al., 2012), as observed in this study.  
I found that H3K27me3-marked chromatin specifically gained aberrant DNA 
methylation, but in vitro studies did not see the mutant PWWP domain acquiring affinity 
to this PTM and there is little evidence of direct DNMT3A-H3K27me3 interaction 
(Dhayalan et al., 2010; Dukatz et al., 2019; Manzo et al., 2017; Mauser et al., 2017). 
While DNMT3s have a strong affinity towards H3K36me2/3, there may be a weak 
affinity towards H3K27me3, such that the abundance of different DNMT3s and their 
interacting proteins could modulate chromatin localisation depending on the cellular 
context.  
Recently, point mutations in the PWWP domain of human DNMT3A have been described 
in a specific class of tumour – hereditary paraganglioma (Mellid et al., 2020; Remacha et 
al., 2018) and in microcephalic dwarfism (Heyn et al., 2019), including a substitution in 
the amino acid residue orthologous to murine D329. In both cases, the mutations are 
associated with gain of methylation of H3K27me3-marked domains containing 
developmental regulatory genes, similar to the findings in my study.  
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Heyn et al. (2019) had suggested non-selective relocalisation of mutant DNMT3A from 
H3K36me2/3 to H3K27me3 sites, simply because the latter are unmethylated. However, 
my detailed analysis of the ectopic DNA methylation in relation to chromatin data 
suggests a role of positive recruitment of the DNMT3A-PWWP mutant protein to 
H3K27me3-marked domains, as I do not observe gain of DNA methylation across other 
unmethylated genome features. It is possible that a conformation change caused by the 
D329A mutation somehow enhances the affinity between DNMT3A and H3K27me3, but 
other proteins only present in an in vivo environment are likely to contribute to this 
interaction.  
A direct association of DNMTs with H3K27me3 regions in some contexts is supported 
by the observation that DNA methylation is dependent on the deposition of H3K27me3 
at a subset of CGIs in extraembryonic ectoderm (Smith et al., 2017). Similarly, 
H3K27me3 sites in ESCs often gain aberrant DNA methylation in cancer (Ohm et al., 
2007; Schlesinger et al., 2007; Widschwendter et al., 2007). In cancer, this 
hypermethylation leads to silencing of differentiation genes and, therefore, to an 
enhancement of self-renewal. In contrast, during development, DNMT3A can silence 
polycomb-target genes in a tissue-specific manner, therefore promoting differentiation 
and lineage determination (Yagi et al., 2020). And although both DNA methylation and 
H3K27me3 are considered repressive modifications, Hox genes can be activated when 
DNA methylation is targeted to their gene bodies in tumours (Su et al., 2018). This is 
similar to my observation of de-repression of strongly silenced genes in Dnmt3aΔ/D329A 
hypothalamus, where methylation is acquired and H3K27me3 is maintained. Moreover, 
theoretically, DNA methylation gain could cause alternative exon usage (Gelfman et al., 
2013; Shayevitch et al., 2018). These examples highlight how functional outcomes of 
DNA methylation gain are very context-dependent and challenging to decipher. 
H3K27me3 is catalysed by the PRC2 (Cao et al., 2002), while the PRC2 protein EZH2 
has been shown to recruit DNA methylation to its target promoters (Viré et al., 2006). 
DNMT3A has also been found to interact with PRC2 when establishing the boundaries 
between the DNA methylated and PRC2-repressed chromatin (Gu et al., 2018; Manzo et 
al., 2017). The regulation of these hypomethylated, H3K27me3-marked domains 
involves a complex and still poorly understood interplay between PRC2, DNMT3A and 
TET DNA demethylases (Figure 8.1). During lineage commitment, DNMT3A can 
methylate gene bodies of PRC2 targets in a tissue-specific manner (Yagi et al., 2020), 
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which suggests the mechanisms of permitting DNMT3A to enter the core of these 
domains are in place. DNA methylation generally, albeit not always, inhibits PRC2 
binding and activity in vitro (Bartke et al., 2010; Wang et al., 2017) and can block the 
deposition of H3K27me3 (Brinkman et al., 2012; Jermann et al., 2014). In this study, I 
found H3K27me3, albeit with a tendency to be reduced, to remain at the hypermethylated 
DMRs. This can be due to the non-proliferative environment in the neurons, where 
nucleosomal turnover is relatively low or simply be a signal coming from different cells, 
as hypothalamus is such a heterogeneous tissue (Chen et al., 2017). 
I would speculate that DNMT3A regulation at PRC2-bound bivalent chromatin could be 
altered by the D329A mutation. At this time, it is unclear how the D329A mutation may 
have altered the properties of DNMT3A to enhance its interaction with H3K27me3 and/or 
with members of the PRC2, allowing it not only to target the boundaries but the protected 
core of bivalent domains as well as (Figure 8.1b). One possibility is that H3K36me2/3 
acts as a sink for wild-type DNMT3A, and loss of affinity for this interaction would 
permit mutant protein to localise specifically to bivalent chromatin, therefore overloading 
DNMT3A at the bivalent chromatin shores. 
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Figure 8.1. Model of molecular mechanisms in act at bivalent domains. A. A 
representation of current understanding of bivalent domain regulation. The PRC2 
complex deposits H3K27me3 and compacts chromatin across the promoters and 
surrounding regions of transcriptionally silent, developmental genes (Boyer et al., 2006). 
TET proteins are recruited, which result in active removal of DNA methylation and 
protection of bivalent chromatin from de novo DNMTs (Gu et al., 2018). DNMT3A is 
recruited to bivalent chromatin shores through an unknown mechanism, enabling active 
establishment of DNA methylation at the boundaries (Gu et al., 2018; Jeong et al., 2014; 
Manzo et al., 2017). Through the competing actions of TETs and DNMT3A there is a 
cycle of DNA methylation turnover at the boundaries of bivalent domains. B. 
Representation of bivalent chromatin dynamics in the presence of DNMT3AD329A. The 
mutant protein is able to access bivalent chromatin and establish methylation across the 
whole domain. The presence of DNA methylation appears to influence the local 
chromatin environment and result in H3K27me3 reduction, potentially due to exclusion 
of PRC2 from methylated DNA. As a consequence, some genes become de-repressed and 
show an increase in promoter H3K4me3, while others maintain their transcriptional 
silencing; this likely dependents on the availability and strength of necessary transcription 
factors. 
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There has been considerable focus on what defines the boundaries of these domains, 
which is thought to rely on a dynamic equilibrium between DNMT3A and TET proteins 
(Gu et al., 2018; Jeong et al., 2014; Li et al., 2018; Manzo et al., 2017). Knock-outs of 
either protein strongly affect domain boundaries, whilst the core regions remain protected 
through an unknown mechanism. The protection of these domains is exemplified by a 
Dnmt3b overexpression mouse model that shows aberrant gain of methylation genome-
wide and a marginal increase (<10%) across H3K27me3-marked domains (Zhang et al., 
2018). Therefore, it is likely that relocalisation of irregularly high levels of mutant 
DNMT3A could tip the balance between DNMT3A and TETs at those sites, and they are 
no longer protected from DNA methylation (Figure 8.1). Together, these findings suggest 
that aberrant targeting of DNA methylation could occur not solely due to direct 
H3K27me3 recruitment, but due to changes in protein-protein interactions, in particular 
with PRC2 or quantitative imbalance with TETs. 
8.4 Future directions and concluding remarks 
Work presented in this thesis provides insight into the complex ways of how DNMTs use 
their domains in order to faithfully establish DNA methylation, and how they are guided 
by chromatin PTMs. Many aspects of the mechanisms remain unclear and will benefit by 
further investigations. 
First, I would like to provide general notes, which should be taken in consideration when 
designing subsequent studies of DNMTs. Whenever a new model is designed, whether it 
is a mouse or a cell, it is important to introduce small protein tags at endogenous DNMT 
sites. Ideally, these should be tested in wild-type genetic background to ensure there is no 
interference of protein-protein interactions. These tags could be different for the two 
DNMT3A isoforms, which would allow clarification whether a particular one is involved 
in the process of interest. Multiple laboratories have successfully used these tags and there 
appear to be no significant drawbacks (Emperle et al., 2018; Fuks et al., 2001; Gao et al., 
2020; Manzo et al., 2017; Weinberg et al., 2019), while they provide easier 
immunoprecipitation, staining, and blotting for assessment of presence of DNMTs.  
Studies of DNMTs can benefit greatly by use of systems such as oocyte and the brain. 
For the investigation of H3K36me3 recruitment of DNMT3A specifically, it would be 
very helpful to generate a model where DNMT3B expression is definitely silenced and/or 
the PWWP domain of DNMT3A is deleted. This should provide insights whether the 
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domain is really needed for H3K36me3 recruitment and clarify if the D329A mutation 
has a different outcome in vivo.  
For the investigations in the brain, constructs missing PWWP and/or N-terminal domain 
could be used. The N-terminal domain target DNMT3A1 to bivalent chromatin shores 
but is it the wild-type PWWP domain responsible for autoinhibition at the bivalent 
chromatin core? Does ablation of the whole domain recapitulate the D329A mutation and 
allow targeting of aberrant DNA methylation to canyons? My findings that gain-of-
function effects of the DNMT3A-D329A mutant cannot be easily recapitulated in 
neuronal progenitor cells suggest that these defects emerge or accumulate later in 
development. Use of cerebral organoids, which recapitulate embryonic brain 
development and can be matured in a dish (Marshall and Mason, 2019), would allow the 
scale and assessment of multiple constructs, and allow introduction of combinations of 
mutations, such as knock-out of H3K36me2/3 and H3K27me3 catalysing enzymes. Also, 
this would reduce the resources, time and use of animal models. Similarly, organoids can 
be built using human ESCs, and therefore DNMT3A mutations causing Tatton-Brown-
Rahman overgrowth or microcephalic dwarfism could be studied specifically in an 
environment resembling human brain (Heyn et al., 2019; Tatton-Brown et al., 2014).  
The Dnmt3a-D329A mouse model still has a lot of potential to answer questions of how 
DNMT3A is involved in physiology and growth regulation. Further assessment of brain 
histology would allow elucidation of microcephalic tendency. Is there a defect in neuronal 
proliferation or differentiation? Is the migration and spreading of the neurons affected in 
the brain? Which cell types fail to be established or are overrepresented in the mutant 
brain? Finding the path from mutation to molecular pathology to the phenotype is the key 
to understanding a vast number of developmental disorders linked to epigenetic 
regulators, and this model can be used to further investigate microcephalic dwarfism 
(Heyn et al., 2019). Similarly, the biotinylated-DNMT3A-D329A mutant cell line I 
established could be used to investigate the chromatin binding of mutant DNMT3A. It is 
a remaining question whether the whole protein relocalise, or is it is generally bound to 
the affected areas but the chemical methylation reaction can only proceed when some 
safeguarding mechanisms are down. The question remains whether in cancer 
environment, where hypermethylation is found, mutations have inactivated safeguarding 
mechanisms, and whether similar mechanisms are in play in the presence of the D329A 
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mutation. Similarly, the biotinylated-DNMT3A-D329A mutant cell could be used for 
neuronal maturation and in organoid formation. 
For investigation of the impact of DNA methylation on the local chromatin environment,  
CRISPR-Cas Sun-Tag recruitment of DNMT3A could be used (Huang et al., 2017). This 
method employs recruitment of protein complex to genomic loci using catalytically 
inactive Cas9 with a guide. Cas9 is fused with antibody epitopes. The protein of interest, 
e.g. DNMT3A, is then also fused to single-chain variable fragment (scFv) which then 
guides it to the target locus for DNA methylation. A less specific approach is binding 
DNMT3A catalytic domain to zinc-fingers with promiscuous affinity to chromatin 
(Broche et al., 2020). This way a hypothesis of non-targeted DNA methylation 
relocalisation could be assessed. These and similar methods could be used to methylate 
different genes which gain DNA methylation in Dnmt3aD329A mouse, and quantify the 
contribution of this to underlying gene expression, local chromatin environment and the 
growth phenotype. Another advantage of this system would be the ability to induce these 
changes using temporal- and tissue-specific recombinases and to identify critical 
timepoints in development. 
In summary, here I provide a characterisation of the growth phenotype and underlying 
molecular changes of the Dnmt3aD329A mutant mouse model. I found that the interaction 
between H3K36me3 and the mutant DNMT3A is not altered in the oocyte. I demonstrate 
that the mutant DNMT3A exhibits specific, altered targeting to H3K27me3-marked 
chromatin in the mouse brain. The aberrant gain in DNA methylation across these 
domains is only observed in postnatal development, suggesting that the non-proliferative 
environment, coinciding with DNMT3A1 isoform expression in adult tissues, unmasks 
this effect. This study provides further insights into the regulation of bivalent chromatin 
domains and the role of the DNMT3A PWWP domain. This model will be valuable for 
future investigations into the role of DNA methylation abnormalities in cancer and the 
growth regulatory function of DNMT3A. 
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Appendix 1. Single-cell oocyte samples. 
Table with sample numbers used in Figure 3.11, individual oocyte sample IDs, group to 
which they were assigned for pseudo-bulk analysis in Chapter 3.4, number of unique 














5 2_+/+_310_1c_1 +/+_1 2 5.21 
16 3_+/+__310_1d_2 +/+_1 1.6 5.07 
17 3_+/+__310_1d_3 +/+_1 2.1 6.12 
32 6_+/+__310_1c_5 +/+_1 1 2.41 
33 6_+/+__310_1c_6 +/+_1 4.4 10.86 
15 3_+/+__310_1d_1 +/+_2 3.3 9.73 
29 6_+/+__310_1c_2 +/+_2 1.6 5.10 
35 6_+/+__310_1c_8 +/+_2 1.4 3.82 
38 7_+/+__310_1d_2 +/+_2 2.6 7.66 
39 7_+/+__310_1d_3 +/+_2 1.7 5.32 
7 2_+/+_310_1c_7 +/+_3 1.8 4.45 
21 3_+/+__310_1d_7 +/+_3 2.9 8.45 
28 6_+/+__310_1c_1 +/+_3 1.6 4.53 
31 6_+/+__310_1c_4 +/+_3 1.2 3.02 
34 6_+/+__310_1c_7 +/+_3 1.3 3.19 
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37 7_+/+__310_1d_1 +/+_3 2.3 6.44 
6 2_+/+_310_1c_5 +/+_4 2.1 5.48 
18 3_+/+__310_1d_4 +/+_4 2.2 6.30 
19 3_+/+__310_1d_5 +/+_4 1.8 5.15 
20 3_+/+__310_1d_6 +/+_4 2.6 6.49 
30 6_+/+__310_1c_3 +/+_4 2 5.10 
4 2_+/D329A_310_1b_7 +/D329A_1 4 10.07 
12 3_+/D329A__310_1e_5 +/D329A_1 3.1 8.43 
14 3_+/D329A__310_1e_8 +/D329A_1 3.1 8.95 
22 6_+/D329A__310_1b_1 +/D329A_1 1.4 3.85 
3 2_+/D329A_310_1b_6 +/D329A_2 3.4 8.30 
8 3_+/D329A__310_1e_1 +/D329A_2 2.6 6.96 
10 3_+/D329A__310_1e_3 +/D329A_2 3 8.30 
36 7_+/D329A__310_1e_2 +/D329A_2 2.6 6.98 
2 2_+/D329A_310_1b_4 +/D329A_3 2.8 7.50 
9 3_+/D329A__310_1e_2 +/D329A_3 3.5 8.80 
24 6_+/D329A__310_1b_3 +/D329A_3 1.8 4.89 
25 6_+/D329A__310_1b_4 +/D329A_3 1.7 4.98 
26 6_+/D329A__310_1b_5 +/D329A_3 1.8 5.28 
1 2_+/D329A_310_1b_3 +/D329A_4 3 7.35 
11 3_+/D329A__310_1e_4 +/D329A_4 1.8 4.63 
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13 3_+/D329A__310_1e_6 +/D329A_4 3.4 9.22 
23 6_+/D329A__310_1b_2 +/D329A_4 1.6 3.98 
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Appendix 2. ChIP-seq library summary. 
Sample ID Genotype ChIP antibody Uniquelly mapped reads 
1_127.1a +/+ K4me3 26,065,430  
2_127.1b Δ/D329A K4me3 25,531,851  
3_127.1c +/+ K4me3 24,742,605  
4_136.7a +/+ K4me3 25,346,843  
5_136.7c Δ/D329A K4me3 20,052,247  
6_136.8a Δ/D329A K4me3 28,877,523  
7_127.1a +/+ K27me3 23,941,847  
8_127.1b Δ/D329A K27me3 23,927,549  
9_127.1c +/+ K27me3 25,697,305  
10_136.7a +/+ K27me3 30,991,066  
11_136.7c Δ/D329A K27me3 39,804,568  
12_136.8a Δ/D329A K27me3 30,309,992  
13_127.1a +/+ K36me3 32,880,597  
14_127.1b Δ/D329A K36me3 29,937,232  
15_127.1c +/+ K36me3 29,471,102  
16_136.7a +/+ K36me3 28,734,886  
17_136.7c Δ/D329A K36me3 30,238,060  
18_136.8a Δ/D329A K36me3 28,528,176  
20_127.1a +/+ input 18,726,261  
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21_127.1b Δ/D329A input 39,855,286  
22_127.1c +/+ input 28,176,825  
23_136.7a +/+ input 30,719,847  
24_136.7c Δ/D329A input 32,097,044  
25_136.8a Δ/D329A input 28,336,929 
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Appendix 3. bioDNMT3A-interacting proteins in mouse 
ESCs. 
Table of top 20 proteins showing significant interaction with bioDNMT3A1 bait, in 
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